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The abbreviations used in this thesis are as laid down 
in the Biochemical Journal Instructions to Authors (revised
1978) with the following additions :
BHK-21/C13
BS-C-1 cells
HSV
PRV
EBV
EHV
VSV
EMC virus 
p.f.u.
SDS
EDTA
TCA
DMSO
PPO
TEMED
HEPES
DTT
MDL
SS
DS
Baby hamster kidney cells, clone 13. 
African green monkey kidney cells. 
Herpes simplex virus.
Pseudorabiesvirus.
Epstein-Barr virus.
Equine herpesvirus.
Vesicular somatitis virus. 
Encephalomyocarditis virus.
Plaque forming unit.
Sodium dodecyl sulfate.
Ethylene diamine tetraacetate. 
Trichloroacetic acid.
Dimethylsulfoxide.
2,5'-diphenyloxazole.
N,N,N',N', tetramethylethylene diamine 
N-2-HydroxyethyIpiperiz ine-N’-2-ethane
sulfonic acid.
Dithiothreitol.
Messenger dependent lysate.
Single stranded.
Double stranded.
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Summary
Inhibition of protein synthesis has been studied in cells infected with PRV*
Infection of HeLa, C13 and BS-C-1 cells with PRV showed
that in the case of HeLa and C13 cells inhibition was rapid 
and substantial but for B-SC-1 cells it was gradual and 
apparently limited. Moreover, C13 and BS-C-1 cells showed 
some stimulation of protein synthesis at 1 hr post-infection 
with subsequent inhibition. Because of the simple inhibition 
kinetics, HeLa cells were mostly used for further studies.
Cell-free translation studies were carried out using mRNA 
from PRV infected cells. Immediate-early mRNA's (mRNA made in 
the infected cells before any viral protein synthesis) and late 
mRNA’s were isolated from HeLa cells infected with PRV for 5 hrs 
in the presence and in the absence of Cycloheximide respectively. 
Hybridisation data for the poly(A) containing RNA showed the 
presence of, at least, of viral transcripts in the Immediate- 
early mRNA preparation. Cell-free translation of this 
preparation in the Messenger Dependent reticulocyte lysate 
system showed the presence of some viral proteins but a large 
number of host proteins were also synthesized. Simultaneous 
addition of both viral and host mRNA's did not result in the 
preferential translation of viral mRNA in the cell free system 
and both cytoplasmic and polysomal late poly(A) RNA's allowed 
the synthesis of the same spectrum of proteins.
K dependence studies in the MDL system did not reveal any 
difference in the optima for the translation of host, IE and 
late mRNA'8 though polyacrylamide gel electrophoresis of the 
translation products showed that at least one host and one viral 
protein were slightly resistant to high K concentrations in
the system. Studies in the wheat germ extract showed an 
identical K optima for all these mRNA's. Again, protein 
synthesis dm vivo under hypertonic conditions showed that 
synthesis of both host and IE proteins were susceptible to 
elevated salt concentrations to the same extent.
When protein synthesis was studied in the presence of 
inhibitor of elongation rate, viral mRNA's were not apparently 
more efficient than host mRNA's in initiating protein synthesis. 
So there appears no selectivity in the inhibition of host 
^protein synthesis.
Investigations of the inhibition of protein synthesis 
revealed that both PRV and HSV-1 caused marked polysome 
disaggregation in the absence of viral protein synthesis. There 
was an increase in the extent of polysome disaggregation by PRV 
when the number of infecting virus particles was increased. 
Moreover, heat and u.v. inactivated PRV caused substantial 
disaggregation of host polysomes.
In similar studies, both normal, infective and inactivated 
PRV caused an almost equal extent of inhibition of protein 
synthesis at 8 hrs post infection. By 24 hrs post infection, 
infective virus produced cytopathic effects whereas inactivated 
viruses did not. Again, infective viruses caused about 80% 
inhibition of RNA synthesis by 8 hrs post infection whereas by 
that time inactivated-viruses caused only 25% inhibition.
In the cell-free translation system, exogenous mRNA 
translation was inhibited by both normal and inactivated PRV 
and this inhibition was not due merely to addition of exogenous 
proteins. The extent of inhibition increased with the addition
VI
of increasing amounts of both normal and inactivated PRV.
So inhibition of protein synthesis is caused by the virus 
particles which causes polysome disaggregation and might act 
in some other steps of protein synthesis.
By 6 hr post infection there was induction of an RNase 
activity which under cell-free conditions selectively 
degraded host mRNA. No mRNase activity was associated with 
either normal or inactivated PRV.
These experiments revealed that in PRV infected HeLa cells, 
translatable host mRNA's are present when IE proteins are being 
made. There is no evidence of any selective translation of 
viral mRNA either in the intact cell or in cell-free systems.
The only evidence for selectivity resides in the mRNase which 
degrades host mRNA but not viral mRNA. Again in the intact 
cell or in cell-free systems, inhibition of protein synthesis 
is caused by the virus particles themselves and does not involve 
infected cell protein synthesis. This inhibition also involves 
polyribosome disaggregation by the virus particles.
vil
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Chapter 1. Introduction.
1.1. General introduction.
The consequence of productive infection hy animal viruses 
is the inhibition of host macromolecule synthesis. This 
inhibition is reflected in the gradual cessation of host protein 
synthesis with concomit ant synthesis of virus specific proteins 
in the infected cell. Though early in infection the infected 
cells show selectivity in translating viral mRNA's, late in 
infection the translation machinery often loses its activity 
until the infected cells show a cytopathic effect and eventual 
lysis. Knowledge about the mechanism of inhibition is scanty 
and indeed the ' mechanism is likely to vary from virus to virus 
and perhaps even from one host to another. However, various 
suggestions have been put forward to explain inhibition. It 
could be due to structural protein component(s) of the infecting 
virus which renders the translation system inactive. Again it 
could be the result of changes in the intracellular ion concen­
tration following changes in the membrane permeability after 
infection, or again inhibition might be due to a modification of 
some component(s) of the translation system so that viral mRNA 
is selectively translated. In some cases it.has been suggested 
that there is induction of RNase activity in the infected cells, 
which selectively cleaves host mRNA's. A number of these 
possibilities are discussed later in this thesis.
1.2. Viruses
Viruses are infectious pathogenic entities depending on the 
host cell metabolism for propagation (Lwoff, 1957). The infectious
-2-
extracellular particle is called the virion. It consists of 
a nucleic acid, DNA or RNA, enclosed in a protein coat (the 
capsid). In some viruses the capsid may become surrounded by 
a membraneous material, the envelope. Thus, viruses are 
entities whose genomes are elements of nucleic acid which 
replicate inside living cells using the cellular synthetic 
machinery and cause the synthesis of new particles which can 
transfer the viral genome to other cells (Luria jet , 1978).
1.3. Herpesvirus.
In 197 5 the International Committee for Taxonomy of viruses 
defined herpesviruses as those having the following characteristics
The virion consists of a capsid, 120 - 150mm in diameter, 
surrounded by a lipid containing envelope. Buoyant density 
(CsCl) of the virion is 1.27 - 1.29 g/cm^. The capsid is 
icosadeltatetrahedral with 162 hollow capsomers and with a buoyant 
density (CsGl) of 1.305 g/cm . The capsid surrounds a core 
containing DNA wrapped round a protein spool. There are about 
33 protein species in the virion with molecular weight in the 
range of 25,000 to 290,000 _ . _ .
The genome consists of a linear ds DNA with both terminal 
reiteration and internal repetition of terminal sequences. G + C 
content .varies from 33 to 74%. The molecular weight is in the 
range of 92 - 135 x 10^
Virus multiplication begins in the nucleus and is completed 
by the addition of a glycoprotein membrane as the virus passes 
through the inner lamella of nuclear membrane into the endoplasmic 
reticulum. Margination of chromatin and intranuclear inclusion
-3
bodies are characteristics (Fenner, 1976).
At present about 70 viruses fulfil the criteria for inclusion 
within the herpesviruses. They are diverse in their host and 
disease associations and also in biochemical properties. Indirect 
evidence exists for the involvement of Epstein-Barr Virus (EBV) 
[Epstein, 1978; The et. aA. , 1978J and Herpes Simplex Virus,
Type 2 (HSV-2) [Nahmias ^  aL., 1970j in human cancer.
1.3.1. Pseudorabies virus (PRV): Clinical symptoms.
Pseudorabies or Aujeszky disease was among the earliest 
viral disease recognized (Aujeszky, 1902). The infecting virus. 
Pseudorabies virus (PRV), is the only member of the herpesvirus 
to cause natural infection in swine (Andrews, 1962). It normally 
infects swine, cattle, dog, sheep and cats (Gustafson, 1970).
The virus has a wide cell culture host range, replicating in 
rabbit, lamb, dog and monkey kidney cells, in HeLa cells and in 
chicken embryo cells (Kaplan, 1969) . In cell monolayers PRV 
causes granulation and clumping of the cells with eventual lysis.
Naturally occurdLng PRV infection is acquired by droplet 
infection or ingestion (Gustafson, 1970). Infection is latent 
in the adult swine but severe in newborn, with about 100% 
mortality in newborn compared to nil in adult. Virus multipli­
cation occurs in tonsillar and pharyngeal tissues from which it 
reaches brain via olfactory nerves (Gustafson 1970, McFerran &
Dow, 1965). Moreover, leukocytes attracted to the infected 
area carry the virus to different organs, especially to placenta 
from whence it invades the foetus causing abortion (Gustafson,
1970).
“ 4“
Signs of PRV infection includes high fever, anorexia, 
d&pression, slight coughing and vomit ing, with diarrhoea in 
some and constipation in others. The disease is mostly 
characterized hy symptoms referable to the central nervous 
system. The name "Pseudorabies" comes from its clinical 
similarities to rabies.
Recovery from naturally occurring disease confers a high 
degree of immunity. Antibody titres attain maximum in three 
weeks after recovery and are maintained for at least 18 months.
1 .3.2 . Structure of the herpesviruses
Most of studies on the structure of the herpesviruses have 
been carried out on Herpes Simplex Virus (HSV). However, some 
structural studies on PRV are also discussed. The virus consists 
of an innermost core of DNA and protein, surrounded by capsid, 
tegument and^at the outermost side^envelope (Roizman & Furlong,
1974). The virion consists of protein, DNA, lipid and polyamines
1.3.2.1. Core.
The core consists of DNA wrapped round a protein plug.
Epstein (1962) observed that the central region of the virion is 
sensitive to DNase. Again, Furlong .£t , (1972), using the
technique of selective extraction of uranyl ions bound to DNA 
in a stained preparation, showed that the electron dense region 
making up the toroid contains DNA. The core also contains 
spermine in addition to protein and DNA (Roizman, 1978).
Olshevsky and Becker (1970) identified two core proteins in HSV,
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and Kaplan & Ben-Porat (1970) reckoned three PRV proteins to he 
associated with the core. However, Hyman (1980) has found four 
proteins bound tightly but non-covalently to HSV-DNA and these 
proteins are bound at four specific sites, that is near the ends 
and within the internal inverted terminal repeats (Wu _et aJ.. ,
1979).
1.3.2.2. Capsid.
The capsid is a moderately electron dense structure separated 
from the core by an electron translucent shell. It consists of 
l62 capsomers arranged in 2-, 3- and 5-fold symmetry in the form 
of an icosadeltatetrahedron (Wildy e_t aj.. , I960). The electron 
translucent region between thé core and the capsid is called the 
pericore. The nature of the material in the pericore is unknown 
and it could be an extension of the protein plug on which the 
DNA is wound.
1.3.2.3. Tegument.
The tegument is defined as the structure located between the 
capsid and the envelope (Roizman & Furlong, 1974) and is said to 
be a fibrous coat around the capsid (Morgan _et , 1968;
Schwartz & Roizman, 1969). The polypeptides comprising the 
tegument are present in most virions, but the amount seen is 
variable from virion to virion, even in the same, cell (Fong _et al.
1973).
1.3.2.4- Envelope.
The envelope is a trilaminar membrane with spikes projecting
-6-
from the outer surface (Fong et_ a_l., 1973). It is composed of 
glycoproteins, glycolipids and lipids (Morgan e_t , 1954). 
Though the envelope is derived from the host cell membrane 
(Watson & Wildy, 1963), it contains virus specific proteins 
(Ben-Porat & Kaplan, 1972; Spear & Roizman, 1972). The 
envelope of PRV appears to be derived in large measure from the 
inner nuclear membrane from areas which are newly synthesized 
after infection (Ben-Porat & Kaplan, 1971; 1972). The relative 
abundance of different envelope proteins differ in different 
herpesviruses, at least with respect to the degree of glycosy- 
lation (Keller , 1970) .
1.3.3. DNA of the herpesviruses.
The DNA is linear, double-stranded and with molecular weight 
95 - 150 X 10^ daltons (Wilkie, 1973; Mossmann & Hudson, 1973; 
Delius & Clements, 1976; Stevely, 1977; Geelan e_t aR. , 1978; 
Stinski , 1979). Single stranded nicks occur in the DNA
so that upon alkali dehatur ation there appear DNA single strands 
of fragments as well as of unit length (Wilkie, 1973; Roizman 
et al., 1974; Lee et al., 1971, Graftstrom et al., 1975; 
Wadsworth e_t aJL. , 1975). It is not known whether these alkali- 
labile regions correspond to true single-stranded nicks or gaps, 
or to the insertion of ribonucleotides which have been reported 
to be linked covalently to HSV* DNA (Hirsch & Vonka, 1974).
The G + G content varies from 33 moles % in Rabbit lymphoma 
virus DNA (Goodheart 1972) to 74 moles % in PRV DNA (Russell & 
Crawford, 1964). HSV DNA contains a terminal sequence which is
repeated internally in inverted forms flanking two unique
-7-
sequences of 10 x 10^ . . .. (Short or S sequence) and ^
75 X 10^^ f:. • (Long or L sequence) [Sheldrick & Berthelot,
1974], Analysis of the HSV genome with restriction endonuclease 
(Hayward jet , 1975; Clements ejt , 1976), partial 
dénaturation mapping (Delius & Clements, 1976) and nucleic acid 
hybridisation studies (Wilkie & Cortini, 1976) has shown that 
the S and the L unique sequences are relatively inverted in 
different DNA molecules within the population, leading to four 
genomic arrangements. PRV DNA has a single set of palindromic 
sequences of 5.4 % 10^  ^ ï:.', which surround a short unique
sequence of about 10 x 10^ d'"' Inversion of this short
unique sequence gives rise to two isomeric forms. PRV DNA
has a molecular weight of 95 x 10^ T " ' ’ (Stevely 1977;
Ben-Porat et. .ëA* ? 1979) .
The mechanism responsible for the random orientation of 
short and long unique sequences in HSV is not known, although 
available evidence favours a high frequency of legitimate 
recombination through internal inverted repetition, rather than 
independent' replication and joining of the long and the short 
unique sequences (Roizman, 1978).
1.3.4 . Structural proteins.
High resolution polyacrylamide gel electrophoresis showed 
the presence of 30 polypeptides of molecular weight range of 
25,000 to 280,000 in the Herpes Simplex Virion (Spear & Roizman, 
1972; Heine e^ aj.. , 1974; Cassai e_t a^. , 1975) .
Pseudorabies virion contains at least 20 polypeptides (Stevely,
1975). A number of HSV-1 and HSV-2 polypeptides are processed
following synthesis and this modification involves phosphory­
lation, glycosylation and possibly other modifications 
resulting in increased apparent molecular weight (Pereira _ejb al. , 
1977; Fenwick & Roizman, 1977) . Herpes Simplex Virion 
contains glycosylated and phosphorylated polypeptides.
1 .3 .5. Other components.
In addition, the virion contains spermine and spermidine 
in the ratio of 1,6 - 0.2 : 1.0. This is sufficient to 
neutralize half of the viral DNA phosphate groups. (Gibson & 
Roizman, 1971).
1.3.6. Infectious unit.
Naked nucleocapsids are not infectious (Stein et al.,1970; 
Rubenstein & Kaplan, 1975). The reason is not known, probably 
without envelope the virus cannot adsorb to the cell surface. 
Viral DNA, native as well as alkali denatured, is infectious 
(Lando & Ryhiner, 1969; Sheldrick , 1973).
1.4. Reproductive Cycle.
Virus multiplication starts with the attachment of the 
virus particles to the host cell surface. Enveloped particles 
adsorb more readily than the naked particles. There follows 
the penetration of the virion into the cell. This could be 
either by pinocytosis (Epstein ai., 1964) or by fusion of 
envelope to the cell membrane (Morgan jet aj.. , 1968). Viral DNA 
is rapidly uncoated in the cytoplasm, from which it enters the
nucleus to direct virus specific RNA synthesis. After a 
rapid synthesis of virus specific macromolecules infectious 
virus particles are assembled and released from the cells 
(Watson, 1973) .
The reproductive cycle depends on the nature of the host 
and the nature of the virus; the multiplicity of infection; 
temperature of incubation and the nutritional property of the 
medium (Roizman, 1978). At 37°C with 50 p.f.u./cell in HSV-1 
infected HEp-2 cells the cycle lasts for 17 hrs (Roizman &
Furlong, 197%) and in PRV* infected BHK-21 cells at 50 p.f.u./cell, 
the cycle is shorter, 12 hrs (Tyler ejb , 1974).
1.4.1. Viral RNA synthesis.
After infection the first step towards replication is the 
synthesis of vir*fe specific RNA. Viral RNA is transcribed from 
the viral DNA in the nucleus (Wagner & Roizman, 1969a, 1969b; 
Roizman aj.. , 1970) , and it follows the same mechanism that 
occurs in uninfected cells. Transcription is carried out by 
host RNA polymerase II (Preston & Newton, 1976; Costanzo _et al. , 
1977; Ben-Zeer & Becker, 1977). No virus induced RNA polymerase 
activity has been detected (Lowe, 1978). A small amount of viral 
RNA synthesis, at times late in infection, is resistant to 
#-amanitin, which may be due to synthesis by RNA polymerase III 
(Ben-Zeer £t _al., 1976) and the possibility of virus Induced 
modification of the host enzyme is not ruled out.
1.4.1.1. Characteristics of viral RNA : structure.
Posttranscriptional modification of viral RNA is almost
— 10 —
identical to that of cellular mRNA. Total nuclear transcripts 
are larger than polysome associated viral mRNA*s (Stringer et al., 
1977). Cytoplasmic viral mRNA has as a 5'-terminal "Gap" as is 
found in most eukaryotic mRNA's (Bartkoski & Roizman, 1976; 1978; 
Moss et al., 1978). Early viral transcripts have an internal 
methylated base in the form of m^A, which is missing from late 
mRNA's (Bartkoski & Roizman, 1976; 1978). Another post- 
transcriptional modification is the polyadenylation of mRNA in 
the nucleus at the 3' end (Bachenheimer & Roizman, 1972; Ben- 
Porat _et , 1972) . However viral mRNA lacking a poly(A) 
tail but having the same sequence as poly(A) containing RNA ,has 
been found on the polysomes (Stringer aj_. , 1977) . Cytoplasmic 
poly(A) containing RNA represents most, if not all, of the viral 
RNA sequence present in the cytoplasm (Silverstein ejt aj^ . , 1976).
1.4.1.2. Characteristics of viral mRNA : synthesis.
The expression of herepesvirus genome during productive 
infection is temporaly regulated (Kozak & Roizman, 1974; 
Swanstrom & Wagner, 1974; Swanstrom _et a_l. , 1975). Immediate- 
early (IE) mRNA's are synthesized in cells very early after 
infection and also accumulate in infected cells when protein 
synthesis is inhibited from the beginning of the infection.
Early mRNA's are synthesized after the initial viral protein 
synthesis in the infected cells but before viral DNA synthesis 
and late mRNA's are synthesized after viral DNA synthesis.
Some IE mRNA's continue to appear on polysomes as functional 
mRNA's even late in infection but at a concentration different 
from the original concentration (Anderson et al., 1980),
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Some late mRNA’s detected before viral DNA replication also 
show difference in abundance (Stringer ^  aj^ . , 1977; Anderson 
et al. , 1980; Kozak & Roizman, 1974) . It is also found that 
some host poly(A) RNA is synthesized and associates with the 
polysomes late in infection (Stringer ejb 1977).
Kozak & Roizman (1974) found that the nuclear IE RNA of 
HSV-1 is homologous to 50^ of the DNA whereas Cytoplasmic IE RNA 
hybridizes to 10^ of the DNA. Late cytoplasmic RNA's are 
homologous to 43^ of the DNA and possess no symmetrical trans­
cripts whereas late nuclear transcripts are homologous to 50% 
of the DNA and possess symmetrical transcripts. Early after 
infection nuclear precursor and cytoplasmic poly(A) RNA's are 
essentially of the same size but late in infection nuclear 
precursors are larger than cytoplasmic poly(A) RNA’s (Holland 
_et , 1979; Jones & Roizman, 1979).
Clements _£t a^., (1977) found that the genetic complexity 
of the nuclear and the cytoplasmic IE RNA of HSV-1 is the same, 
possibly the use of different cell lines or the different 
hybridisation techniques used are responsible for the disparate 
results. Both nuclear and cytoplasmic IE RNA’s are complementary 
to non-contiguous regions of the virus genome, which are 
primarily located at, or near, TR^/IR^ (terminal and inverted 
repeats flanking the L unique sequences) and TRg/iRg (repeats 
flanking the S unique sequence) [elements _^t aJ_. , 1977; Jones 
et al. , 1977; Stringer ^  aJL. , 197^ . Watson e_t , (1979) 
have identified at least five IE mRNA’s in HSV-1 infected cells. 
The genome location and the direction of transcription of these 
sequences have also been determined (Anderson et al., 1980;
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Clements ejt , 1979). A 4.2 kb species transcribed from the
TRg/iRg region with the 3' end distal to Ug (Small unique 
sequence) codes for a polypeptide of molecular weight 175,000 and 
a 2.8 kb species from TR^/lR^ with the 3 ’ end towards codes 
for a polypeptide of 12Q000 molecular weight. Of the three 1.8kb 
species, one transcribed from Ug near TRg with the 3' end in the 
Ug codes for a polypeptide of 68,000 molecular weight, a second 
one from near IR with the 3 ’ end in the U codes for a
±1 li L
polypeptide of 63,000 molecular weight and the third is trans­
cribed from IRg region with the 3 ’ end in Ug.
In the case of PRY late mRNA is complementary to 50^ of the 
DNA and IE RNA to 10^ of the genome. IE mRNA hybridizes to 
the terminal repeats and given a TR of 9.9 x 10^ daltons 
(Ben-Porat ejfc aJ.. , 1979) IE mRNA is transcribed from 1% of the 
total complexity of the viral genome (Feldman e_t , 1979).
Using short term labelling it is found that the restricted trans- 
scription is not due to degradation of a larger transcript 
(Feldman e^ £ l ., 1979).
Early mRNA is transcribed from regions throughout the 
genome, but the sequence at or near the junction between UÙ^
and the repeats are particularly well represented. Late mRNA 
is also transcribed from the whole genome and the middle of Ug 
is, transcribed only late in infection (Feldman e_t a^. , 1979) . 
Early and late mRNA's differ only in relative abundance of the 
transcription from different regions of the genome (Clements et. 
al., 1977) which explains why the early to late transition is not 
affected by viral DNA amplification. However, IE protein 
synthesis is a prerequisite for the IE to early transition and
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this could be affected by a modification of the host RNA
polymerase or by changing the template activity of the viral
DNA. The regulatory role of IE polypeptides has been suggested 
by their modification and translocation to the nucleus (Pereira 
et al., 1977; Fenwick e_t a^. , 1978) and also by their DNA
binding capacity vitro (Hay & Hay, 1980).
Thus strict transcriptional control is observed in herpes­
virus infected cells. It is possible that the controls might 
operate at the level of the selection of which transcribed 
sequences are transported to the cytoplasm as mRNA’s.
1.4.2. Viral protein synthesis.
Viral mRNA’s after being synthesized in the nucleus appear 
in the cytoplasm and are translated to give virus specific 
proteins (Sydiskis & Roizman, 1966; 1967). After infection 
there is an initial decline in protein synthesis due to dis­
aggregation of host polysomes, followed by an increase during 
which viral proteins are synthesized and finally an irreversible 
decline. The gradual switch-over from host specific to virus 
specific protein synthesis is reflected in the formation of 
rapidly sedimenting virus specific polysomes (Sydiskis & Roizman, 
1966; Ben-Porat ejb aj.. , 1971) .
Though herpesvirus does not cause complete shut down of 
host protein synthesis, virus specific proteins can be detected 
by using the following criteria : (a) changes in electrophoretic
or kinetic profiles of the proteins synthesized after infection;
(b) stimulation in the rate of synthesis after infection,and
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(c) immunoprécipitation by virus specific antigens (Honess & 
Roizman, 1973) . About 52 virus specific proteins have been 
detected in HSV-1 infected cells and a similar number is found 
in HSV-2 infected cells (Honess & Roizman 1973; Powell &
Courtney 1975; Bookout & Levy, 1980). Analysis of the proteins 
of five herpesviruses - HSV-1, HSV-2, PRV ; BMV (Bovine Melalitis 
Virus) and EAV (Equine Abortion Virus) - shows diversity in the 
electrophoretic mobilities (Killington ejb a].., 1977), indicating 
that the protein composition of herpesvirus is diverse.
1.4.2.1. Regulation of Protein Synthesis.
Protein synthesis in herpesvirus infected cells is highly 
controlled. Kinetically, virus specific proteins in HSV-1 
infected cells have been differentiated into three groups - 
Of, 3 and Y (Honess & Roizman, 1974). Using metabolic inhibitors 
a model of sequential ordering and coordinate regulation of the 
synthesis of virus specific proteins has been proposed (Honess 
& Roizman 1974; 1975). ^-polypeptides synthesized immediately 
after infection are responsible for the switching-on of p-poly­
peptide synthesis which, in turn, shut off ^-polypeptide synthesis, 
A similar scheme has been proposed for p and y-polypeptide 
synthesis. (y- and 0-polypeptides contain both structural and 
non-structural proteins but y-polypeptides are all structural.
IE polypeptides in PRV infected cells, analogous to the #-poly- , 
peptides of HSV-1, do not include structural proteins (Ben-Porat 
è 1  ±1- , 1975) .
In this regulatory process, it has been found that functional 
or-polypeptides are required to induce p-polypeptide synthesis
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and different a-polypeptides appear to be responsible for 
the regulation of the synthesis of different p-polypeptides 
(Pereira 8^. , 1977). At the same time functional 
p-polypeptides are required to inhibit ^-polypeptide synthesis. 
Though y-polypeptide synthesis coincides with viral DNA 
replication, some y-polypeptides are synthesized before viral 
DNA synthesis.but in reduced amounts (Powell ^  , 1975;
Honess & Watson, 1977). It has been proposed that transcription 
of progeny DNA is necessary for optimal y-polypeptide synthesis 
(Roizman 1978).
Similar regulation of protein synthesis has been observed 
in HSV-2 infected cells (Powell & Courtney, 1975) and Murine 
Cytomegalovirus (MGMV) infected cells (Moon _et aJL. , 1979).
In the case of PRV IE proteins synthesized after withdrawal of 
a Cycloheximide block imposed from the beginning of infection 
correspond to ^-polypeptides (Ben-Porat _et , 1975) . So it is 
possible that this cascade regulation of protein synthesis is a 
common property of the herpesvirus.
1.4.2 2. Modification and translocation of viral proteins.
Modification of herpesvirus specific proteins does not 
involve rapid posttranslational cleavage as observed in picorna- 
virus infected cells (Honess & Roizman, 1973). Phosphorylation 
of a large number of structural and non-structural proteins of 
HSV (Pereira e^t a_l. , 1977; Marsden _et a_l. , 1978; Bookout & Levy 
1980) and of structural proteins of PRV (Stevely 1975) has been 
reported. Glycosylated polypeptides have been found in purified 
Herpes Simplex virions (Roizman, 1978). Kaplan & Ben-Porat (1976)
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have shown a non-structural sulfated glycoprotein in PRV 
infected RK-cells.
Translocation of structural proteins to the nucleus 
(Spear & Roizman, 1968; Ben-Porat _et .al., 1969) is related to 
capsid formation. Translocation occurs through the nuclear 
membrane and is likely to be determined by the affinity of the 
polypeptides for various constituents in the nucleus (Fenwick 
et al., 1978). Almost all the ^-polypeptides and a few p- 
polypeptides from HSV-1 and HSV-2 infected cells are found in the 
nucleus (Bookout & Levy 1980; Pereira e^ aJL. , 1977; Cabral et al. 
1980) and most of them have DNA binding properties (Bookout &
Levy, 1980; Fenwick _et 8^. , 1978; Hay & Hay, 1980). Since 
^-polypeptides control translation of p-polypeptides and p- 
polypeptides can, in turn, regulate the translation of both c^ - 
and y-polypeptides, so the DNA binding capacity of or- and some 
p-polypeptides could have a function in transcriptional control,
VP 175 is found to be arranged in the nucleus in a marginated 
pattern in HSV-1 infected cells (Cabral _ejb a_l., 1980). Though 
the significance of this finding in HSV-1 infected cells is 
unknown, a similar binding of HI parvovirus antigen to peripheral 
nucleolar chromatin has been suggested to be responsible for 
early morphological disruption and eventual destruction of the 
nucleus (Singer 1976). Nucleolar disaggregation in HSV-1 infected 
cells has also been documented (Schwartz & Roizman, 1969).
1.4.3. Viral DNA Synthesis.
Protein synthesis in the infected cell is necessary to 
initiate viral DNA synthesis, but once DNA synthesis is established
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inhibition of protein synthesis has little effect on it 
(Cheng ejb , 1975). New DNA polymerase activities have 
been -reported in cells infected with HSV, PRV, MCMC, EAV (see 
Allen _e_t a_l. , 1977) Vericella Zoster Virus (VZV) [Miller & Rapp, 
1977J and EBV (Muller e_t aA. , 1977) . After infection the 
activity of cellular DNA polymerase a declines, coinciding with 
the inhibition of cellular DNA synthesis (Muller £t , 1977). 
HSV-DNA synthesis appears to be catalyzed by the virus coded 
DNA polymerase (Muller & Zahn, 1979), since the change in the 
activity of the enzyme parallels viral DNA synthesis. HSV-DNA 
synthesis is suggested to be promoted by an RNA initiator which 
is removed from the mature DNA by RNase H (Muller e_t , 1980) . 
PRV also uses its own DNA polymerase for DNA synthesis (Halliburto: 
& Andrew, 1976). PRV DNA replication occurs in the form of a 
concatamer (Jean & Ben-Porat 1976; Ben-Porat & Veach, 1980;
Ladin _ejb s^. , 1980) . Maturation is accomplished by a capsid 
or non-capsid protein(s) (Ladin _ejb a^. 1980). A few other
DNA related enzymes have been described in herpesvirus infected 
cells e.g. Thymidine kinase and alkaline DNase, but their 
importance to viral DNA synthesis is not clear (Ben-Porat &
Kaplan, 1973).
1.4 .4 . Assembly of the virion and release from the cells.
After virus specific macromolecules are synthesized co’re 
and capsid are assembled in the nucleus (Roizman &. Furlong, 1974), 
but the actual flow of events leading to assembly is not clear. 
Perdue e_t aJL. , (1976) have suggested that DNA is inserted into
capsid without a preformed core. Ladin et al., (1980) have
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also produced evidence that the capsid proteins are assembled 
first into an empty shell, into which DNA is encapsidated.
Though the envelope has been thought to be acquired by budding 
through the cytoplasmic membrane, there are good reasons to 
believe that the membrane is acquired by budding through the 
inner nuclear membrane (Watson, 1973; Rodriguez & Dubois-Dalcq,
1978). Release could be through budding into a channel which 
occur via reverse phagocytosis (Morgan et. aJL. , 1959) or even 
by cell lysis (Watson ejb aj.. , 1964) .
1.5. Alterations in cell structure and function.
The eventual consequence of productive infection by HSV is 
cell death (Roizman, 1978). Though the actual cause of cell 
death is obscure, the symptoms involved are a drastic reduction 
or even ceassation of host DNA, RNA and protein synthesis and 
changes in the membrane structure .
1.5.1. Structural alterations.
The infected cell nucleus exhibits gross changes in the 
structure of the nucleolus, the distribution of chromatin and 
the composition of the nuclear membrane. The nucleolus is 
often displaced towards the nuclear membrane (Schwartz & Roizman, 
1969). A diagnostic feature is the displacement and condensation 
of chromatin at the nuclear membrane early in infection There 
is substantial chromosome breakage in the infected cells.
Cytoplasm shows little that can be related to herpesvirus 
infection, except that there is an increase in the length and
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frequency of the number of microvilli (see Roizman, 1978).
Changes in transmembrane potential observed in HSV infected 
cells may reflect leakiness of the infected cell membrane 
(Fritz & Nahmias, 1972).
1.5.2. Effects on cellular RNA synthesis.
Infection of cells with herpesviruses leads to a gradual 
decrease in the rate of RNA synthesis, as revealed by low levels
3
of H - uridine incorporation into acid precipitable material 
(Ben-Porat & Kaplan, 1973; Roizman et. £l.* , 1970) . The 
decrease in the RNA synthesis involves both a reduction in the 
synthesis of 45 S precursor RNA as well as an abortive processing 
to 28 S and l8 S rRNA (Roizman _et aJL. , 1970).
The effect of herpesvirus infection on host mRNA synthesis 
is not well characterized. However, Stringer ejt al.,( 1977) 
have shown the presence of some host mRNA's on polysomes even 
late in infection. Their functional ability is reflected by 
the presence of newly synthesized host proteins late in infection 
(Honess & Roizman, 1973; Powell & Courtney, 1975). In the case 
of PRV host mRNA's having a low turn-over rate are synthesized 
at times late in infection. But they are not functional though 
considerable amounts are found in the cytoplasm of the infected 
cells (Rakusanova £t , 1972). So it appears that in herpes­
virus infected cells functional host mRNA synthesis is not 
inhibited completely.
Few data on the mechanism of inhibition of host RNA 
synthesis and processing are available. Sasaki ejb eü.., (1974) 
have noted the presence of an inhibitor of nucleolar RNA 
polymerase in HSV-infected cells but its role is unknown.
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Lowe (1978) has found unaltered levels of RNA polymerase II 
activities in HSV-1 infected BHK cells even at 8 hrs post­
infection. An alternative to the presence of an inhibitor is 
that an increased concentration of HSV-1 DNA in the nucleus 
with preferential affinity of RNA polymerase II for the viral 
genome may lead to reduced host RNA synthesis.
1.5.3. Effects on cellular protein synthesis.
In HSV infected cells the inhibition of host protein synth­
esis may first be detected at 2 hrs post-infection. The time 
of complete inhibition depends on the nature of the virus and 
the nature of the host cells. Cessation of host protein 
synthesis is accompanied by a decrease in the number of poly­
ribosomes and a concurrent drop in amino acid incorporation 
(Honess & Roizman, 1973). The mechanism of inhibition of 
host protein synthesis is not clear Inhibition of RNA 
synthesis could be a contributing factor. A few possible 
mechanisms of inhibition of host protein synthesis following 
infection will be discussed later in the Introduction (1.7).
1.5.4. Effects on cellular DNA synthesis.
Inhibition of host DNA, synthesis has been observed in cells 
infected with PRV (Kaplan & Ben-Porat 1963), HSV-1 (Roizman & 
Roane, 1964). EAV ( 0 * Callaghan _et a_l. , 1968) and EB'V (Nonoyama 
& Pagano, 1972; Gergely e^jt £l. 1971). Kaplan (1973) has
suggested that inhibition of host protein synthesis contributes 
to the inhibition of host DNA synthesis. Another possible 
explanation is that virus specific proteins may bind to cellular
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DNA (1,4.2.2) and thus prevent host DNA replication.
1.6. Protein synthesis in eukaryotes.
In eukaryotic cells transcription and translation occur in 
distinct cellular compartments, which require proper transport, 
stabilization and alignment of the macromolecules taking part in 
protein synthesis. Moreover, the involvement of a large number 
of ribosomal proteins, initiation factors and other components 
required for protein synthesis makes this a very complex process
1.6.1. Mechanism of translation.
The mechanism of protein synthesis involves three different 
processes - initiation, elongation and termination.
1.6.1.1. Initiation.
Initiation covers the events of protein biosynthesis which 
lead to the formation of the 80 S initiation complex consisting 
of one 80 S ribosome and one mol of initiator tRNA (Met. tRNA^) 
bound to the ribosomal P site and mRNA (see Bielka & Stahl 1978). 
Met tRNA* forms part of a ternary complex consisting of equimolar
T
amounts of elF-2 (initiation factor 2), GTP and the tRNA before 
being able to bind to a 40 S ribosomal subunit to form the 
quarternary 40 S initiation complex. elF-1 and elF-3 stabilize 
this complex and contribute to the subsequent binding of 
mRNA. mRNA binding depends on elF-4A, -4B, -4C and -4D together 
with ATP hydrolysis. This 40 S initiation complex with mRNA 
associates with the 60 S ribosomal subunit in the presence of 
elF-5 and GTP to yield the 80 S initiation complex. GTP
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hydrolysis during 60 S subunit binding releases all initiation 
factors.
1.6.1.2. Elongation.
The elongation process in protein biosynthesis has been 
reviewed by Weissbach & Ochoa (1976) and Clark (1980). Binding 
of aminoacyl tRNA to the A site is proceeded by the formation 
of a ternary complex consisting of 1 mol each of aminoacyl tRNA, 
elongation factor, EFI and GTP. Binding involves GTP hydrolysis 
and the GDP-EFI complex released can be recycled. Peptide 
formation is catalyzed by peptidyl transferase. This is 
followed by translocation of peptidyl tRNA from the A site to 
the P site and this process requires EF-2 and GTP hydrolysis.
The number of ribosomes in the polysome is determined by the 
length of the mRNA, the availability of ribosomes and tRNAs, 
and the initiation efficiency of the mRNA. Under saturating 
conditions, one ribosome can bind to 4O-IOO nucleotides (Legon, 
1976).
1.6.1.3 Termination.
Termination involves the release of the completed peptide 
chain from the mRNA-ribosome complex and this process requires 
release factor (RF) and GTP. RF binds to ribosome when the 
termination codon is in the A site. It is interesting that here 
codon recognition is by protein, not by tRNA. GTP dependent 
binding of RF to the A site seems to invoke esterase activity at 
the peptidyl transferase centre, resulting in the hydrolysis of 
peptidyl tRNA. After GTP hydrolysis RF is released, the
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ribosome dissociates into subunits and initiation can occur 
again (Caskey, 1980).
1.6.2. Recognition during initiation.
In prokaryotic systems there is an interaction between 
nucleotide sequence near the 3 ’ terminus of 16 S rRNA and purine 
rich sequences proceeding the AUG codon. Moreover, lF-2, lF-3 
and ribosomal proteins, SI and S12 can produce changes in the 
rRNA or mRNA configurations and by affecting their interactions 
can determine the affinity of ribosomes for a given cistron 
(Revel, 1977). It is possible that in eukaryotes such RNA-RNA 
and RNA-protein interactions play a role in mRNA recognition by 
ribosomes.
Though capped mRNA's bind more readily to ribosomes 
(Oanaani jejfc aJL. , 1976) uncapped mRNA's are also found to be 
translated efficiently in the cell-free systems. After analysis 
of the nucleotide sequences between cap and the AUG codon, it 
has been proposed (Steitz & Jakes, 1975) that in eukaryotes, as 
in bacteria (Shine & Dalgarno, 1975), a short sequence of mRNA 
near the 5' end of AUG base pairs with a complementary region 
near the 3' end of 18 S rRNA. Both (1979) has shown that such 
interaction is possible on either side of the AUG codon but that 
the required codon sequences occur more consistently on the 3' 
end of AUG. Such interactions may increase the rate and stability 
of mRNA binding to ribosomes and thus help initiation.
Kozak (1978, 1979) has suggested a scanning mechanism in 
which the 40 S subunit binds to the 5' end of the mRNA and
subsequently migrates to the interior of the chain, stopping
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when the first AUG codon is encountered. Base-pairing within 
the 5' region of mRNA could bring cap and AUG codon into 
optimal alignment, thus helping initiation (Ahlquist et al.,
1979). The high degree of secondary structure which has been 
demonstrated in many mRNA's (Van ejb a_l. , 1976; Brentani ejt al. , 
1977; Heindall _et aj-., 1978)may facilitate selection of the 
correct 5' terminal AUG codon, because extensive migration of 
the 40 S subunit occurs in mRNA having no secondary structure 
(Kozak, 1980). Moreover, differences in the affinities for 
initiation factors (1.7.3) and differences in the secondary 
structure of the mRNA's may contribute to variation in the 
translation efficiency among mRNA's.
1 .6 .3. Regulation of Protein biosynthesis.
Cells could regulate protein biosynthesis in a number of 
ways, for example by changes in the level of initiator tRNA, 
by regulating the number of active 40 S ribosomal subunits or 
by sequestering the mRNA in cytoplasmic RNP (Gross jet ajl. , 1973; 
Rosbash & Ford, 1974).
It is important to point out that different mRNA's differ 
in their rate of polypeptide chain initiation. A kinetic 
treatment of initiation and elongation allowed Lodish (1974) to 
propose that any non-specific reduction in the rate of polypep­
tide chain initiation at, or before binding mRNA will result in 
preferential inhibition of translation of mRNA's with lower rate 
constants for chain initiation. So with changes in the overall 
rate of chain initiation, translation of different mRNA's would 
appear to be affected differently. The theory also suggests 
that any increase in Initiation will favour the weakest binding
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mRNA while an increase in elongation will favour the strongest 
binding mRNA.
In several systems the amount of protein synthesized is 
not directly related to the amount of mRNA present. For 
example, in rabbit reticulocytes the a and the 3 globin chains 
are present in the ratio of 1:1 but a mRNA is present in excess 
of 3-mRNA. Since the elongation rate in both cases is the same 
the differences in translation must be due to differences in the 
initiation rate (Lodish, 1971). It is not clear whether these 
differences can be attributed to differences in mRNA structure, 
as in the case of RNA phage RNA (Revel, 1977). However, 
addition of eIF-4A and eîF-4B change 01 globin mRNA translation 
relative to 3-mRNA without increasing the ov.erall rate of 
translation. This effect could not be due to an increase in the 
concentration of the overall rate limiting factor but must 
influence the efficiency of mRNA in initiation complex formation 
(Kabat & Chappell 1977). Reviewing a variety of results Revel 
& Groner (1978) propose, contrary to Lodish, that mRNA's do not 
have unique initiation constants. They claim that the efficiency 
of mRNA recognition by ribosomal machinery is due to the overall 
kinetic parameters of the initiation system.
In the rabbit reticulocyte system it has been found that 
deprivation of haem. results in a decline in the rate of 
peptide chain initiation and this effect is due to the phosphory­
lation of the small subunit of elF-2 by a cyclic AMP independent 
kinase (see Farrell , 1977). It is possible that
phosphorylation prevents interaction of elF-2 with one or more 
cofactors such as elF-2 stimulatory protein (ESP) [deHaro & Ochoa, 
1978, deHaro 2Ï al_. , 1979 ] , stabilisation factor (Ranu & London
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1979), co-elF-2A (Dasgupta , 1978) and co-elF-2B (Das
et al., 1979) which are necessary for normal functioning. It 
seems likely that control of the rate of initiation is a very 
complex phenomenon. It is possible that more than one step in 
the initiation process is subjected to control and also that 
several different control systems may work together. For 
instance, ds RNA in the cell free extracts can cause the 
phosphorylation of elF-2# (Leven & London, 1978) as well as 
induce an endonucleolytic activity which degrades mRNA (Clemens 
& Williams 1978; Williams _ejfc , 1979) (see l . ÿ  . Such control 
mechanisms, though mainly examined in the context of interferon, 
may be part of a more general control system limiting the rate 
of polypeptide synthesis.
1.7. Inhibition of protein synthesis in virus infected, cells.
Inhibition of cellular protein synthesis and selective 
translation of animal virus mRNA's during the course of productive 
infection have been observed in cells infected with adenovirus 
(Levine & Ginsberg, 1967), herpesvirus (Sydiskis & Roizman, 1966), 
vaccinia virus (Hanafusa, I960) mengovirus (Baltimore £t al.,
1963), poliovirus (Penman & Sumners, 1965) and VSV (vesicular 
somatitis virus) [xaoi e_t , 1970; Wartz & Younger, 197^ .
In the case of herpesvirus, in some systems, a decrease in 
protein synthesis which occurs early in infection has been noted / 
and is due to a decrease in the synthesis of cellular proteins. 
This is followed by an increase in the overall rate of synthesis 
as virus specific proteins are being made and finally there is an 
irreversible decrease (Ejercito ^t a A ., 1968). With only a
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few exceptions little is known about the mechanism of inhibition. 
The following are possibilities that could explain inhibition 
of protein synthesis after virus infection.
1.7.1. Inhibition by RNA degradation.
In poliovirus infected cells cellular mRNA's released from 
the decaying polyribosomes are unable to reenter the ribosomes 
(Willems & Penman, 1968), but can still be isolated and trans­
lated in a cell free system (Abreu & Lucas-Lenard, 1976). No 
host mRNA degradation has been observed in cells infected with 
vaccinia virus (Rosemond-Hornbeak & Moss, 1975), VSV (Nishioka & 
Silverstein, 1977) or picornavirus (Willems & Penman 1968;
Colby ejb a_l. , 1974; Fttrnandez-Munoz & Darnell, 1976) . On the 
other hand in HSV-1 infected Friend erythroleukemia cells 
considerable degradation of host mRNA occurs (Nishioka & Silver­
stein 1977; 1978a; 1978b) and degradation of host mRNA's has 
also been observed in polfoma transformed cells infected with 
HSV-1 (Pizer & Beard, 1976). It is further suggested that an 
early viral protein, possibly an a polypeptide, is required in 
HSV-1 infected FL cells for the degradation of hostmRNA to 
occur (Nishioka & Silverstein, 1978b).
1.7.2. Inhibition by membrane leakiness and hypertonicity.
In poliovirus, VSV and reovirus infected cells, the mRNA's 
translated after exposure of the cells to hypertonic medium are 
predominantly viral (Nuss et, a_l. , 1975). A number of susceptible 
cell lines show membrane leakiness after viral infection.
These include mouse cells infected with EMC virus (Farnham &
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Epstein 1965), HeLa cells infected with poliovirus (Carrasco & 
Smith, 1976), BHK cells infected with Semliki Forest virus (SFV), 
mouse cells 3T6 infected with mengovirus and CVl cells infected 
with SV-40 (Contreras & Carrasco, 1979). Based on both in 
vivo and 3m vitro experimental findings it has been suggested 
that changes in membrane permeability due to binding of a 
picornavirus coat protein(s) cause changes in the intracellular 
ion concentration (high Na"^  ions) which favour viral mRNA 
translation but inhibit host protein synthesis (Carrasco, 1977). 
Changes in membrane leakiness with distortion of monovalent ion 
gradients, loss of ATP and some other components necessary for 
translation have been observed in EAT cells infected with 
mengovirus (Egberts ejt , 1978) , in B-HK cells infected with 
Sindjbis virus (Garry jet , 1979) and in Sendai virus infected 
HeLa cells (Fuchs e_t ajL. , 1978). But in the case of HSV-2 
infected vero cells inhibition of both host and viral protein 
synthesis occurs at high salt concentrations (Fenwick & Walker
1978). Again in PRV infected HeLa cells host proteins and 
late viral proteins are equally sensitive to high salt concen­
trations (Stevely & McGrath, 1978).
1.7.3. Inhibition due to changes in initiation factors.
It has been suggested that in EMC virus infected cells 
direct competition between host and viral mRNA's for elF-4B is 
responsible for inhibition of host protein synthesis (Golini 
et al., 1976). In picornavirus infected cells inhibition of 
host protein synthesis occurs at the level of initiation (Leib- 
owitz & Penman, 1971). Using a cell free translation system
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it appears that discrimination is caused by initiation factors.
But which initiation factor is the initial target of virus 
infection is controversial. While inactivation of elF-4B 
has been demonstrated in poliovirus infected cells (Rose at al., 
1978; Padilla ejt , 1978) elF-2 is the target in EMC virus 
infected cells (Kempfer at a_l. , 1978) . There are also reports 
that the effects of infection could be at the level of elF-4A 
(Blair e_t a_l., 1977). Again, the cap structure at the 5 ' end 
of most eukaryotic mRNA's facilitates the initiation of translatioi 
(Shatkin, 1976), Poliovirus induced inhibition of translation 
of capped mRNA can be reversed by a protein (mol, wt. 24,000) 
found in association with elF-3 and elF-4B of rabbit reticulo­
cyte ribosomes (Rose at a^. , 1978; Sonenberg e_t aj^ ., 1980) and 
this protein is identical to cap binding protein (CBP). CBP-is 
essential for the translation of capped mRNA (Sonenberg at al.,
1980). It appears that poliovirus infection leads to the 
inactivation of some crucial property of CBP, so that capped 
host mRNA translation is inhibited but uncapped poliovirus mRNA 
is translated (Rose ab al., 1978; Sonenberg , 1980;
Trachsel at a_l. , 1980) , It is also found that in reovirus 
infected mouse X, cells there is cap independent translation 
possibly as a result of inhibition of CBP as in poliovirus 
infected HeLa cells (Skup & Millward, 1980). No information is 
available on the effects of herpesvirus infection on initiation . 
factors.
1 .7.4 . Inhibition by general effects on initiation.
In HSV-1 infected cells inhibition of protein synthesis is
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accompanied by a decrease in functional polyribosomes.
Inhibition appears to occur at the level of peptide chain 
initiation (Silverstein & Engelhardt, 1979), Nonetheless, it has 
been found that host mRNA's enters polyribosomes late in infectior 
even though host protein synthesis is severely curtailed (Stringer 
et al., 1977). It has been claimed that some translational 
control process selectively represses host protein synthesis.
If true, this could be the result of modification of the mRNA 
at some initiation site, perhaps at the site for ribosomal 
binding or initiation of translation, or it could be due to 
binding of some virus specific proteins to mRNA reducing its 
translatability. Further possibilities include destruction 
of tRNA molecules or modification of the ribosomal subunits or 
a combination of several of the above. Phosphorylation of ribo­
somal subunits in vaccinia virus infected cells has been reported 
(Kaerlin & Horak, 1976) though its relation to inhibition of 
protein synthesis is not clear. In haem^-depleted reticulocyte 
lysate, the inhibition of protein synthesis is accompanied by 
phosphorylation of ribosomal proteins (see Farrell , 1977).
Phosphorylation of ribosomal protein has been observed in HSV-2 
infected vero cells and it appears that phosphorylation is not 
responsible for suppression of host protein synthesis (Fenwick 
& Walker, 1979). Phosphorylation of ribosomal proteins S6 
and S16/S18 in PRV infected BHK-21 cells and S6 in HSV-1 
infected BHK-21 cells has also been observed (l. Kennedy,
Personal Communication). Early after infection of AGMK cells 
with SV-40 there is an alteration to the ribosomes, probably 
involving the induction of a new initiation factor and this
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allows regulation of the species of mRNA to he translated 
(Nakajima & Oda 1975).
1.7.5. Inhibition by structural component of the virus.
Using metabolic inhibitors and also u.v. irradiated virus 
it has been shown that macromolecule synthesis is not required 
to inhibit protein synthesis in vaccinia virus infected cells 
(Rosemond-Hornbeak & Moss, 1975). In VSV infected cells 
inhibition of host RNA and protein synthesis occurs even when 
highly irradiated virus is used (Huang & Wagner, 1965; Wagner 
& Huang, 1966; Yaoi _ejb ad. , 1970) and it appears that inhibition 
is due to u.v. resistant component(s) of the virus. Selective 
inhibition of host macromolecule synthesis occurs in cells 
infected with Frog Virus 3 inactivated by heat, u.v. irradiation 
and Y-irradiation (Goorha & Granoff, 1976; Raghow & Granoff,
1979). There are also reports that in cells infected with VSV 
(Baxt & Bablanian, 1976), Vaccinia virus (Esteban & Metz, 1973), 
reovirus (Shaw & Cox, 1973) and SFV (Wengler & Wengler, 1976) 
inhibition of host protein synthesis is caused by a component(s) 
of the infecting virus. Intact and heat disrupted poliovirus 
causes greater inhibition than an equivalent amount of virus 
RNA in reticulocyte lysate and inhibition is independent of 
viral protein synthesis (Racereskis ad. , 1976). The formatio; 
of 40 S initiation complex is inhibited in cytoplasmic extracts 
derived from cells infected with vaccinia virus in the presence 
of cordycepin and also in reticulocyte lysates incubated with 
purified cores (Person _et ad. , 1980) indicating that inhibition 
of host protein synthesis is mediated by a virion associated
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component(s). Loss of ability to disaggregate polyribosomes 
using u.v. irradiated HSV-1 has been reported (Sydiskis &
Roizman, 1967) and it has been suggested that this inability 
could be due to the inactivation of sensitive component(s) 
required for inhibition when a high u.v. dose is used. Ben- 
Porat e_t a_l. , (1971) have suggested that breakdown of host 
polyribosomes in PRV infected RK cells requires the synthesis of 
infected cell proteins. However, in HSV-2 infected vero cells 
inhibition occurs although no virus specific proteins are 
synthesized. In these experiments, infection of whole cells with 
u.v. irradiated virus and infection of cytoplasts provided the 
evidence for the lack of requirement for. viral protein synthesis 
(Fenwick & Walker, 1978).
1.8. The Interferon system.
Interferons are polypeptides which are mainly glycosylated 
and are secreted by the virus infected cells. The interferons 
promote the establishment of an antiviral state in infected cells 
(Finter, 1973). Treatment of animal cells in culture with 
interferon reduces their ability to support virus multiplication.
Recent studies have shed some light on the mechanisms 
involved in interferon action. Interferon induced enzymatic 
activities and their role in the antiviral state have been 
reviewed by Baglioni (1979). It has been found that exposure of 
cells to interferon results in an increase in the activity of an 
enzyme, 2', 5' oligo nucleotide polymerase (2,5 oligo A poly­
merase) which synthesizes a series of oligo nucleotides, pppA 
(2*p5'A)^ from ATP (Kerr & Brown, 1978). This 2,5 oligo A
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polymerase activity has been studied by Baglioni ejt , (1979) 
and Minks ejt f (1979). Baglioni _et _al., (1979) have observed 
a correlation between the induction of 2,3 oligo A polymerase 
and the inhibition of viral RNA synthesis in EMC virus infected 
HeLa cells. A similar observation has been made on VSV 
replication in chick embryo cells (see Baglioni , 1979) . In 
interferon treated, VSV- and MLV (Murine Leukemia Virus) - 
infected cells 2,5 oligo A polymerase binds to the virion core.
The enzyme is inactive in the virion but following infection and 
uncoating it becomes active and causes destruction of the virion 
(Wallace & Revel, 1980). Association between cellular and viral 
components as a part of interferon induced antiviral state has 
also been observed in that uncoated reoviruses isolated from 
interferon treated infected cells, inspite of having ds RNA and 
coat proteins, are unable to synthesize full size mRNA's (Galster 
& Lengyl, 1976).
Infection of interferon treated cells with mengovirus increase 
RNase activity in a subcellular fraction known to contain viral 
replicating complex (see Baglioni, 1979). It has been observed 
that pppA (2'p5'A)^ synthesized by 2,5 oligo A polymerase 
activates an endonuclease which indiscriminately cleaves both 
cellular and viral raRNA’s, free or polyribosomes, bound (Clemens 
& Williams 1978, Baglioni , 1978). But it has been
suggested that different mRNA;s may be cleaved at different rates 
(Ratner et al., 1977, Epstein & Samuel, 1978). It seems 
probable that this endonuclease cleaves at specific nucleotides 
as does .a restriction endonuclease.
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Though accumulation of viral mRNA is inhibited in 
interferon treated infected cells, it is not yet clear whether 
this inhibition is due to an impairment of transcription, 
translation or cleavage of the viral transcripts. There is a 
postulate that interferon treatment decreases the probability 
of initiating viral mRNA transcription but premature termination 
or even degradation has not been ruled out (Marcus & Sekellick, 
1978). Nelson & Baglioni (1979) have demonstrated with cell 
free extracts that in interferon treated cells there are enzyme 
activities which can shave" single-stranded nascent viral mRNA 
from the double - stranded core of replicative intermediate, but 
this has not been observed in intact cells.
It has been known that both synthetic and viral ds RNA's 
induce synthesis and secretion of interferon in animal cells 
(see Torrence & De Clercq 1977). Farrell _^t aJL. , (1977) have 
found that ds RNA can inhibit initiation in reticulocyte lysates 
by phosphorylation of elF-2e by a C fclic AMP independent kinase 
which is antigenically different from the protein kinase found 
after haeme depletion in reticulocyte lysates (1.6.3). This 
kinase mediates its effects via phosphorylation of a 65,000 mol. 
wt. ribosome associated protein (Ohtsuki aJL. , 1980). But 
activation of this enzyme would lead to general inhibition since 
all proteins are initiated via elF-2. Probably activation of 
kinase by ds RNA represents a pathway of inhibition of virus 
replication different from that of 2',5' oligo A polymerase/, 
endonuclease (Farrell ejt , 1978). If the latter enzymes 
fail to act, the kinase may block protein synthesis before 
structural proteins are produced in sufficient amounts for virus 
assembly.
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A further suggestion has been made that discrimination 
between host and viral specific protein synthesis in interferon 
treated infected cells could be due to tailoring of tRNA's for 
host mRNA (Falcoff e_t ^ , 1976; Zilberstein e_t al. , 1976).
This sequestering of tRNA could limit its availability for 
certain mRNA's .
1.9. Aim of the Project
Pseudorabies virus (PRV) Pig Herpesvirus 1 causes 
inhibition of host protein synthesis after infection. Compared 
to other herpesviruses there is little published work on the 
mechanisms behind the aspect of PRV infection. In this project 
a number of aspects of protein synthesis in PRV infected cells 
were studied in an attempt to explain the mechanism by which 
the virus inhibits protein synthesis. These aspects are as 
follows :
A. Though PRV is known to have a wide cell culture host range, 
it was decided to investigate whether the virus caused a 
similar inhibition of protein synthesis in three different 
cell lines - HeLa, 013 and BS-C-1,
B. Hypertonic conditions of the medium do not offer any selective 
advantage to the synthesis of either HSV-2 specific proteins 
(Fenwick & Walker, 1978) or PRV specific proteins at times 
late in infection (Stevely & McGrath, 1978). Again i^ vitro 
translation studies do not show any selective advantage of late 
PRV mRNA translation at elevated k^ concentrations (McGrath
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& Stevely, 1980) . In the case of these viruses inhibition 
of protein synthesis occurs early after infection. So 
studies were carried out to investigate whether Immediate- 
early mRNA have any selective advantage in hyper­
tonic conditions, both in vivo and vitro.
C. There are reports that some viruses including HSV-2 cause 
inhibition of host protein synthesis by some component(s) 
of the infecting virus particles, that is without the 
synthesis of any new virus protein (1.7.5). Here three 
different types of experiments were carried out to study the 
effects of PRV particles on host protein synthesis.
(a) U.V. and heat inactivated viruses were used to • 
study their inhibitory effects on RNA and protein 
synthesis.
(b) Host polyribosome disaggregation was studied in cells 
infected in the presence of inhibitors of protein 
synthesis as well as in cells infected with inactivated 
PRV.
(c) Particle effects were also studied by adding normal 
as well as inactivated PRV to cell-free translation 
systems.
D . Host mRNA degradation has been reported in Friend erythro- 
leukemia cells infected with HSV-1 (1.7.1). Investigations 
were carried out to study mRNase activity in PRV infected 
HeLa cells.
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Chapter 2. Isolation and Characterisation of
Poly(A) containing RNA.
2.1. Introduction
In growing cells the active mRNA's are bound to the poly­
ribosomes and so the isolation of polyribosomes provides a 
convenient source of translateable mRNA*s. In herpes-virus 
infected cells, at times late in infection polyribosomal RNA's 
are mainly viral (Stringer et. ÊA» ; 1977). Early after infection 
Immediate-early (IE) mRNA’s are found in the infected cells. Under 
normal circumstances the concentration of IE mRNA is very small.
But if protein synthesis is inhibited in the infected cells during 
infection, IE mRNA accumulates in a greater abundance and becomes 
bound to polyribosomes when the inhibitor of protein biosynthesis 
is removed (Rakusanova ejt aj^., 1971). So the isolation of poly- 
ribosomal RNA from HeLa cells infected for 5 hrs in the presence 
and in the absence of Cycloheximide makes it possible to isolate bot 
IE and late viral mRNA's . Since cytoplasmic host and viral mRNA’s 
are polyadenylated at the 3 ’ end (Rakusanova et al,, 1972; Bachen- 
heimer & Roizman, 1972; Brawerman, 1976), isolation of poly(A) 
containing RNA from infected and mock-infected cells allows 
isolation of viral and host mRNA's respectively.
2.2. Isolation of polyribosomes.
Polyribosomes were isolated from HeLa c.ells, mock-infected or 
infected with PRV in the presence or in the absence of cycloheximide 
as described in Materials and Methods. The use of heparin during 
the preparation inhibited RNase activities, giving a better yield. 
However, given the variation in cell growth which does occur from
time to time, the yield varied from 4O-6O A . units per 1000 x
260nm
6
10 cells.
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The typical profiles of mock-infected and infected cell, 
polyribosomes on sucrose gradients are shown in Fig. 2.2.1.
2.3. Preparation of Poly(A) Containing RNA.
2.3.1. Extraction of polyribosomal RNA.
The polyribosomal fractions from sucrose gradients were 
collected and the polyribosomes were pelleted by high speed 
centrifugation. The RNA was extracted from the pellets by phenol: 
chloroform:isoamylalcohol, using a pH 9.0 extraction buffer, as 
described in Materials and Methods. From the polyribosomal RNA, 
poly(A) containing RNA was separated by affinity chromatography 
on oligo [dT] cellulose columns.
2.3.2. Affinity Chromatography.
Poly(A) containing RNA’s can be isolated by virtue of their 
affinity for oligo-fdTj- cellulose (Aviv & Leder, 1972; Edmonds & 
Caramela, 1969) or poly(U)-sepharose (Adesnik ejt , 1972;
Lindberg & Persson, 1972) . Though a greater and purer yield of 
poly(A) containing RNA is obtained with poly(U)-sepharose chromat­
ography (Bishop e_t a_l. , 1974; Vass, 1975) the presence of farmamid« 
and SDS in the elution buffer makes this technique less attractive. 
These denaturing agents are very difficult to remove from the final 
preparation without losing mRNA, whose concentration is already 
very small and moreover, any trace amount of these agents inhibits 
in vitro translation studies. Thus the oligo-[dT]- cellulose 
chromatographic technique was used to isolate poly(A) containing RNA
After dissolving the polyribosomal RNA in loading buffer the 
poly(A) containing RNA was bound to oligo [dT] cellulose by pass­
ing the preparation through a preequilibrated column, as described
Fig, 2,2.1. Polyribosome profiles in mock-infected and PRV 
infected HeLa cells.
Confluent monolayers of HeLa cells were mock-infected or 
infected with PRV at 50 p.f.u./cell in the presence and in the 
absence of Cycloheximide (50|Ug/ml). At 5 hrs post infection 
Cycloheximide treated cells were washed to remove Cycloheximide, 
After 15 min incubation in normal medium, cells were harvested, 
homogenized and the cytoplasmic extracts were layered on 
15 -30% (w/v) sucrose gradients in RSB. The gradients were 
centrifuged at 27,000 r.p.m. for 110 min in 4*^ 0 in the Beckman 
SW27 rotor and analysed, thereafter, using a Gilford 2000 
recording spectrophotometer which monitored absorbance at 260nm,
Mock-infected cell polyribosomes. 
•Immediate-early polyribosomes (PRV infected) 
Late polyribosomes (PRV infected).
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in Materials and Methods. Loosely bound RNA’s, mostly non- 
poly(A) containing ribosomal RNA's, were washed off by 
intermediate buffer. Bound poly(A) containing RNA was eluted 
by elution buffer of low ionic strength. Reprecipitation with 
ethanol removed traces of SDS present in the preparation.
The mRNA activity of the preparation was studied by translation 
in the MDL system (see Chapter 3).
2.4. RNA-DNA hybridisation.
Poly(A) containing RNA was hybridized to PRV DNA bound to
nitrocellulose filter discs to determine the presence of virus
specified RNA. HeLa cells, mock-infected or infected with PRV
32to prepare IE mRNA, were labelled with inorganic P-phosphate 
(5mCi/bur1er) in phosphate free medium for 3 hrs. Two burlers 
of mock-infected and infected cells were labelled and three 
burlers of unlabelled cells of each type were added. This 
treatment allowed the isolation of a reasonable amount of 
labelled poly(A) containing RNA.
Poly(A) containing RNA was dissolved in 0,1 x SSC and 
aliquots were hybridized to PRV DNA bound to nitro-cellulose 
filter discs, as described in Materials and Methods. The data 
(Table 2.4.1) shows the presence of virus specified transcripts 
in the Immediate-early mRNA preparation.
2.5. Discussion.
Extraction of polyribosomal RNA from virus infected cells 
and isolation of poly(A) containing RNA allows a convenient 
method of obtaining viral mRNA's, In PRV infected cells, at
41-
Table 2.4.1.
mock-infe cted and PRV infected (IE) cells to
PRV DNA bound to nitrocellulose filters ,
Poly(A) containing Input Bound %
RNA Mg cpm cpm Bound
Mock-infected 
HeLa 0.5 13,000 140 1.07
IE RNA 0.5 4,000 260 6.5
IE RNA 1.0 8,000 540 6.75
Each of the filter discs contained 5jug PRV DNA.
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times late in infection, the polyribosomal poly(A) containing 
RNA's are mostly viral. In this laboratory it has been shown 
by McGrath (1978) that at 5 hrs post-infaction at least 50^ 
of the transcripts present in the infected cell polysomes are 
viral. For the IE preparations made, the proportion of viral 
transcripts is at least 5%, Since the hybridisation does not 
reach the saturation limit, the proportion of the virus genome 
represented in the transcripts cannot be estimated. The prepar­
ation of IE mRNA clearly contains a large number of host mRNA's 
(see also in vitro translation studies. Chapter 3).
Hybridisation in the presence of increasing amount of viral DNA 
allows determination of the amount of viral RNA presents, In the 
present case the data donot give such a clear idea but the 
presence of some viral RNA in the preparation is evident®
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Chapter 3. Translation of mRNA in the Messenger 
Dependent Lysate (MDL) System.
3.1. Introduction
In general it has been found that mRNA from one cell type 
can be translated in cell extracts or intact cells of a different 
type without a requirement for specific factors or components. 
Numerous eukaryotic cell-free systems efficiently and faithfully 
translate exogenous mRNA's. Cell-free translation systems 
have been reported from Krebs II ascite cells (Kerr ejt , 1972; 
Swan e_t £l_. , 1972), rat and mouse liver cells (Sampson &
Borghetti 1972; Sampson ejt , 1972), HeLa cells (McDowell at al. , 
1972), reticulocytes (Berns , 1972; Pelham & Jackson 1976),
wheat germ (Roberts & Paterson, 1973; Zagorski, 1978) and rye 
embryo cells (Carlier & Peumans, 1976), Some of these systems 
have a high concentration of endogenous mRNA's and added mRNA can 
only be translated to the extent that it can compete with these 
endogenous mRNA's. Rabbit reticulocyte lysates provide a complete 
eukaryotic cell-free system which can reproducibly and faithfully 
translate a wide range of exogenous mRNA (Pelham & Jackson, 1976) 
and pretreatment with micrococcal nuclease makes the preparation 
low in endogenous mRNA, Compared with the wheat germ extract 
system which produces a high proportion of incomplete translation 
products, this unfractionated messenger dependent- lysate (MDL) 
system is capable of synthesizing proteins of very high molecular 
weight (Benoff & Nadal-Ginard, 1979; Pelham, 1979). At the 
same time it is easier and more convenient to prepare the MDL 
system than most others which have been described. Therefore,
- 4 4 “
this system was the one mainly used to study the cell free 
translation of PRV infected cell mRNA’s.
3.2. mRNA activity of viral and host mRNA's
An mRNA is an RNA species which can serve as a template for 
protein synthesis. In an efficient translation system it has the 
ability to stimulate incorporation of radioactive amino acids into 
TCA precipitable material.
Poly(A) containing RNA, isolated from mock-infected and 
PRV infected cells, was translated in the MDL system. The 
translation system contained all the components described in 
Materials and Methods. The concentration was kept at llOmM 
and Mg*^ concentration at 2.2mM. Incubation was at 30^C for 
60 min (any changes from this standard condition are noted in 
the figure legends) after which the reaction was stopped and the 
TCA precipitable material was counted to determine the radioactiv­
ity incorporated. The poly(A) containing mRNA's showed 
significant mRNA activity in stimulating radioactive aminoacid 
incorporation into TCA precipitable material. Table 3.2.1 
gives the results obtained for two different MDL preparations.
Incorporation of TCA precipitable radioactivity was studied 
as a function of time. After incubatioh at 30°C, the reaction 
was stopped at appropriate times by quick transfer on to ice.
5fj,l aliquots were counted in duplicate to determine acid 
precipitable radioactivity. The results (Fig. 3.2.1.) show 
increasing incorporation up to 60 min and this time was chosen 
as the standard incubation time,
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Table 3.2.1.
mRNA activity of exogenous mRNA Tn the Messenger 
Dependent Lysate (MDL) System.
mRNA
Concen­
tration 
of mRNA 
(Mg/ml)
MDL -1 (a ) MDL -2 (b)
cpm/5^1 stimulation 
(X endogenous)
cpm/jul stimulation 
(X endogenous
Endogenous - 4,200 - 20,420 -
HeLa mRNA 5.2 18,900 4.5 246,630 12.0
Immediate- 
early (IE) 
mRNA
8.0 26,880 6.4 182,320 8.9
Late mRNA 7.8 - - 184,000 9,0
(a) The assay mixture contained 50/il MDL-1 (prepared in the lah)
plus 7.5jul of a solution containing the specified amount of
3 5the appropriate mRNA and 20 j^ Ci 8-methionine.
(h) The 25jul assay mixture contained 10/il of MDL-2 (commercially 
prepared), a specified amount of the appropriate mRNA and
13fj,l of a mastermix containing all necessary components plus 
40 nC± ^^8-methionine.
After 60 min incubation at 30°G, aliquots ( 5jul from the assay 
mix with MDL-1 and Ifj,! from the assay mix with MDL-2) were counted 
in duplicate by the filter disc method to determine the TCA 
precipitable radioactivity. K concentration was llOmM and Mg 
2 .2mM.
Fig. 3.2.1. Kinetics of ^^8-Methionine Incorporation into
proteins in the MDL system, specified by 
HeLa mRNA.
The 57o 1 assay mixture contained 50/^ 1 of the MDL and 
2pM0i ^^8-Methionine plus 6^g/ml HeLa mRNA. Incubation was 
at 30^0. At appropriate times 5^1 aliquots were counted in 
duplicate by the filter disc method to determine the TCA 
precipitable radioactivity.
- “
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3.3. Characterisation of translation products.
One important use of i^ vitro translation studies is to 
characterise the proteins specified hy the mRNA. The mRNA 
isolated as Immediate-early mRNA from PRV infected cells 
contained a large number of host mRNA's and so the translation 
products would contain a number of host proteins. However, it 
was possible to detect virus specific proteins by SDS-poly- 
acrylamide gel electrophoresis and autoradiography.
3 58-Methionine containing translation products were denatured 
with SDS (2^, w/v), 3-mercaptoethanol (5%, v/v), glycerol (20^, 
v/v) and heated for 2 min in a boiling water bath, and then 
applied onto the polyacrylamide gel (Materials and Methods). 
Autoradiography of the dried gel (Fig. 3.3.1) showed a large 
number of host proteins along with a number of Immediate-early 
viral proteins (Track C). The molecular weight of those poly­
peptides which appear to be virus specified are given in 
Table 3.3.1. The late mRNA specified products also contained 
some host proteins (Fig. 3.3.1, Track D), but the major products 
are viral. The molecular weight of various products are again 
given in Table 3.3.1.
Since after infection the translation apparatus is said 
to be adapted to synthesize mainly viral proteins, it is possible 
that viral mRNA's have some selective advantage over host mRNA's 
during translation. An attempt was made to study whether 
simultaneous addition of host and viral mRNA's resulted in pre­
ferential translation of viral mRNA's. Analysis of the 
translation products shows no obvious selective advantage for 
late mRNA (Fig 3.3.2) over host mRNA in the MDL system.
Fig. 3.3.1. Products of exogenous mRNA translation in the 
Messenger Dependent Lysate (MDL) System.
HeLa mRNA (10.2^g/ml), IE mRNA {9, J+^g/ml) and Late mRNA 
(I2.4^g/ml) were translated in the MDL System, as described 
in Materials and Methods. Translation products were labelled 
with ^^S-Methionine ( 1500juCi/ml) . Samples were processed by 
denaturing with SDS {2% w/v), 3-mercaptoethanol (5^ v/v) and 
heating in boiling water bath for 2 min. Appropriate amounts 
of sample were applied on to a SDS-polyacrylamide gel containing 
10^ (w/v) acrylamide and 0.3% (w/v) bis-acrylamide. After 
electrophoresis at 20mA overnight the gel was dried and 
exposed to X-ray film for autoradiography. Molecular weight 
markers were used to determine the molecular weight of unknown 
proteins.
Counts applied.
Track A Endogenous 50,000
B HeLa mRNA 220,000
G IE mRNA 307,000
D Late mRNA 387,000
-48-
155,000
68,000
21,000
"755,000
p 68,000
G
" ^ 1,000
n 13
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Table 3.3.1.
Polypeptides synthesized by virus specific
mRNA's in the MDL System.
Nature of Polypeptides 
the mRNA
’*3Molecular weight xlO
a 177
b 112
c 63
IE mRNA ^ 52
e 36
f 28
g 25
A 177
B 112
C 94
D 89
E 79
Late mRNA ^ 63
G 60
H 50
I 39
J 37
K “ 31
L 26
M 23
HeLa mRNA, IE mRNA and Late mRNA were translated in the MDL 
System (Materials and Methods) and the translation products 
were analyzed by polyacrylamide gel electrophoresis and 
autoradiography. Using marker proteins of known molecular 
weight the molecular weight of virus specific proteins were 
determine d .
Fig. 3.3.2. Products of exogenous mRNA's translated in 
the MDL System.
Each assay mixture contained the specified mRNA's in 
addition to ^^S - methionine (lOOO^Ci/ml). After 60 min 
incubation at 30°G, the translation products were processed 
and analyzed by polyacrylamide gel electrophoresis and 
autoradiography.
Tracks
Aj Late mRNA ( 8.6 yg/ml )»
B» Late mRNA ( 7*2 )
and HeLa mRNA (8.4 /
C, HeLa mRNA ( 8.4 )®
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It has been suggested that in some systems the virus mRNA's 
may displace host mRNA's from the polyribosomes (Ben-Porat ejb al., 
1971). If this is so, then mRNA isolated from the whole 
cytoplasm should give different translation products from mRNA 
isolated from the polyribosomes only. Poly(A) containing RNA 
was isolated from the cytoplasm of cells infected for 5 hrs with 
PRV. Analysis of the translation products of cytoplasmic and 
polyribosomal poly(è) containing RNA shows no significant 
difference in the pattern of the proteins synthesized (Fig. 3.3.3)
3.4. Discussion.
The two MDL systems - one prepared in the lab and one 
commercially prepared, give similar stimulation of protein synthesis 
by adding mRNA. The translation products of the IE mRNA pre­
paration show the presence of a large number of host proteins.
It has been claimed that in Cycloheximide treated HSV-1 infected 
cells IE proteins are mainly synthesized after withdrawal of 
the drug (Roizman ejb , 1974). Howeverother results show 
the synthesis of a number of host proteins as well (Preston, 1979) 
Our finding for PRV is similar to that of Preston (1979) in that 
we find host mRNA's on the polyribosomes when IE proteins are 
being made. The hybridisation data also suggested the. presence 
of a large amount of host mRNA in the IE mRNA preparation.
Still it is possible to detect at least seven IE polypeptides 
in the translation products of the IE mRNA preparation. The 
situation is different with late mRNA's. The translation 
products show mainly viral proteins, with a few host proteins.
y 2. a
Fig. 3.3.3. Polypeptides synthesized in the MDL System
specified by polyribosomal and Cytoplasmic 
Late mRNA.
The assay mixture contained polyribosomal Late mRNA
(9.2^g/ml) and Cytoplasmic late mRNA (13.2/ig/ml) in addition
3 5to all the necessary components and S-methionlne (l200^Ci/ 
ml). After 60 min incubation at 30°C, the translation i 
products were processed and analyzed by SDS-polyacrylamide 
gel electrophoresis and autoradiography.
Track A Polysomal late mRNA
Track B Cytoplasmic late mRNA.
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During infection the infected cells are said to 
preferentially synthesize viral proteins. Simultaneous 
addition of almost equal amounts of host and viral mRNA's 
does not show preferential translation of viral mRNA's . So 
it can he argued, by this criterion, that any selectivity of 
translation does not reside in the mRNA.
Normally, translatable mRNA’s become bound to polyribosomes 
In an attempt to investigate the presence of translatable mRNA 
in the cytoplasm free from polyribosomes, it is found that 
polyribosomal and cytoplasmic poly(A) RNA’s specify the same 
proteins. This indicates that in PRY infected cells all 
translatable mRNA's are not preferentially bound to 
polyribosomes.
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Chapter 4 . Protein synthesis in cell-free systems 
at different K*** concentrations.
4 .1 . Introduction
Changes in the intracellular ion concentrations after
virus infection and their possible correlation with selective
inhibition have been discussed in 1.7.1. In a cell-free
translation system it has been shown that late PRV mRNA has no
selective advantage over host mRNA at elevated K concentrations
(McGrath & Stevely, 1980). Since In herpesvirus infected cells
inhibition of protein synthesis occurs early after infection
and in MCMV infected cells Immediate early proteins have been
shown to be resistant to high salt concentrations, it was of
interest to investigate whether IE PRV mRNA has any advantage
+
over host mRNA at elevated E concentrations.
4*
4 .2 . K optima for translation of viral mRNA's in the cell- 
free translation systems.
•j-
The optimal concentration of K required for the translation 
of host and viral mRNA's in the MDL system and in the wheat germ 
extract system was determined by varying the concentration of
"f"
exogenous U added to the assay mixture. The assay mixture in
+ +
the MDL system contained 2.2mM Mg and appropriate concentrations 
of KCl or KOAc. The reaction rate was followed by determining
•f-
the TCA precipitable radioactivity at different k concentrations. 
Fig 4 .2 .1. shows the translation of HeLa, IE and Late mRNA's 
at different KOAc concentrations in the MDL System. All three
types of mRNA showed the same k’*' optima in the range of lOO-llOmM.
SS-i
+
Fig. 4.2.1. Effects of different concentration of K
on exogenous mRNA translation in the MDL 
system.
The assay mixture containing HeLa mRNA ( 10.2/ig/ml) , 
IE mRNA ( 9. 6ju g/ml ) and late mRNA (I2.2jug/ml) were varied 
with respect to concentration by the addition of 
different concentrations of KOAc. Mixtures containing 
lOOOjuCi ^^8-Methionine per ml was incubated at 30°C for 
60 min. ljul aliquots were counted, in duplicate, by 
filter disc method to determine the TCA precipitable 
radioactivity.
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When KCl was used instead of KOAc as the source of k*** both 
HeLa and IE mRNA .^s showed a K optima in the same region 
(Fig, 4.2.2). At concentrations above 125mM all classes 
of mRNA showed a gradual inhibition of translation.
Analysis of the translation products by polyacrylamide
gel electrophoresis and autoradiography showed that viral
proteins apparently did not have any selective advantage over
host proteins at higher concentrations (Fig. 4.2.3). To
+
clarify the effects of high concentrations of k on protein 
synthesis the gel autoradiograph was traced and portions of the 
gel tracing containing a few prominc^nt protein bands are shown 
in Fig. 4 .2 .4 . From the tracing it appeared that one IE 
polypeptide (^, Molecular Weight 31,000) showed a gradual 
decrease in synthesis when the k concentrations were changed 
from 100 to 150mM as did host proteins Bland On the other
hand, another IE polypeptide (^, Mol. wt. 52,000) and a host 
protein B3showed some resistance to the effects of elevated k 
concentrations. The areas corresponding to these five proteins 
were computed and setting lOOmM value as 100% the areas at 
other salt concentrations are given in Tables 4.2.1 and 4.2.2. 
While it is recognized that the darkening of. the film is not 
linear with respect to radioactivity it is, nonetheless, 
reasonable to take the areas as a rough guide to relative 
incorporation*. The tables show the impression gained as to 
relative resistance by visual observation to be correct.
A commercial wheat germ extract system gave an almost 
identical k*** (KOAc) optima for HeLa, IE and Late mRNA
translation in the region of 100 - 115mM (Fig. 4.2.5).
s-7«-
Fig. 4.2.2. Translation of exogenous mRNA's in the
MDL System at different KCl concentrations
The MDL translation system was programmed with HeLa
mRNA (l0.2^ig/ml) and IE mRNA (9.6//g/ml) with 400#Ci
3 5 +8-Methionine per ml. The concentration of k was
varied by adding different concentrations of KCl. After
60 min incubation at 30°C, 5/il aliquots were counted, in
duplicate, . to determine the TCA precipitable radioactivity.
---------- a HeLa mRNA.
•—  e IE mRNA preparation
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Fig. 4.2.3. Protein synthesis in the MDL System
at elevated concentrations.
The assay mixtures containing HeLa mRNA (l0.2^g/ml),
3 5
IE mRNA preparation (9.6#g/ml) and lODO/jjCi 8-Methionine per 
ml plus different concentrations of KOAc were incubated at 30°C 
for 60 min. The translation products were processed and 
analysed by polyacrylamide gel electrophoresis and auto­
radiography .
An equ 'al^  ' amount of protein was applied on each gel 
track.
Tracks 1 to 5 HeLa mRNA's; Tracks 6 to 10 IE mRNA's ;
+ +
Tracks 1 and 6 50mM K ; Tracks 2 and 7 75mM K ;
Tracks 3 and 8 lOOmM ; Tracks 4 and 9 125mM K^ ; and
Tracks 5 and 10 150mM K*. .
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Fig. 4.2 .4 . Tracing of portions of the gels
containing translation products 
specified by IE mRNA preparation 
at different salt conc. in the MDL 
System.
Gel tracks from Fig. 4.2.3. -containing translation
products specified by IE mRNA preparation at lOOmM, 125mM 
.+
and 150mM k concentrations were scanned and. traced.
0100 mM K0.8
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Table 4.2.1.
^_____ . .___________   ^ 35,
at various concentrations in the MDL
System.
Nature of the 
polypeptides lOOmM If"*" 12 5mM 150mM
it, Immediate-early 
polypeptide
100 70 33
fiif Host polypeptide 100 78 20
Host polypeptide 100 133 34
Host polypeptide 100 12 B 160
ÿ, Immediate-early 
polypeptide
100 103 44
Considering the lOQmM value as 100 percent, the percent
3 5incorporation of S Methionine in a few polypeptides 
specified hy IE mRNA preparation at higher % concentrations, 
as traced in Fig. 4.2.4. was measured.
1-
Table 4.2.2.
3 5Relative incorporation of S-Methionlne
4-
at different K concentrations in the MDL 
System.
Nature of the 
polypeptide
% of the total 
lOOmM
incorporation. 
125mM
k "
■ 150mM
k "
A, Immediate-early 
polypeptide
46 43 58
Host protein 54 57 42
Total 100 100 100
6^ Host protein 25 29 14
0^ Host protein 16 18 43
ÿ. Immediate-early 
polypeptide
■ 59 53 43
Total 100 100 1,00
35The percent incorporation of .S-Methionine in the polypeptides
+
was measured at three different K concentrations.
6z
Fig, 4.2.5. Exogenous mRNA translation in wheat germ
extract system at different concentrations
A commercially available wheat germ extract system was
used to translate HeLa mRNA ( 8.4jLlg/.nil), IE mRNA (7.5/zg/ml)
and Late mRNA (7.8^g/ml) at different KOAc concentrations.
3 5The assay mixture containing 750/iCi 8-Methionine per ml 
was incubated at 25^0 for 60 min. lf,il aliquots were 
counted, in duplicate, to determine TCA precipitable 
radioactivity.
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But a wheat germ extract system prepared in this lab showed 
an optimal concentration 66-76mM for HeLa and Late PRV mRNA's 
whereas IE mRNA's showed an optimum in the range of 84-92mM 
(Fig. 4,2.6).
4.3. Discussion.
Proteins do vary in their resistance to high salt
concentrations in cell-free systems but PRV IE mRNA's as a
class are not especially resistant. There has been a
suggestion that in the wheat germ extract system inhibition of
protein synthesis at higher KCl concentrations is not due to
high concentration but is due to the higher Cl” concentration
(Weber et al., 1977), because the optimal is higher if KOAc
is used instead of KCl. But in the MDL system the k"*" optima
did not change when KCl was used instead of KOAc. Since the
IE mRNA preparation contains only 5% virus specific RNA, it
is possible that their high optima is overshadowed by the li
optima for the large number.of host mRNA’s. Analysis of the
translation products showed no obvious resistance by any IE
proteins at higher k concentration. With a commercial wheat
germ extract system, these messages again, show an identical
k optima for translation. But extracts made in this lab
+
showed a lower k optima for HeLa and Late PRV mRNA's compared 
to IE mRNA. The reason for this different behaviour in the 
two wheat germ extract systems is not clear. It is possible 
that the extract systems prepared from different batches of 
wheat germ might differ in their properties. It is also 
possible that in the wheat germ extract system prepared in the
lab there is a limiting amount of some factor(s) required
Fig. 4.2.6. Effects of different concentrations of
K on the translation of exogenous mRNA’s 
in the wheat germ extract system.
The wheat germ extract system prepared in the laboratory 
was used to translate HeLa mRNA (8.4/ig/ml), IE mRNA (7.5Pg/ml) 
and Late mRNA (7.8/ig/ml) at different KCl concentrations.
(Late mRNA was a gift from B.M. McGrath). The reaction
3
mixture containing lOOf^Ol H-Leucine per ml was incubated 
at 25°C for 60 min. 5jul aliquots were counted,in duplicate, 
to determine TCA precipitable radioactivity.
-o HeLa mRNA
^  IE mRNA. 
Late mRNA
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for translation, leading to the effects shown. In the MDL 
as well as in the commercial wheat germ extract system a 
higher concentration of this factor would result in the failure 
to show discrimination. For example, it has been reported 
(Shih ejfc a2,. , 1980) that the wheat germ extract system cannot 
translate EMC virus mRNA completely under standard conditions 
unless it is supplemented with a salt wash from reticulocyte 
ribosomes. Probably the wheat germ extract system lacks some 
factor(s) without which most of the exogenous messages can be 
translated but not all. This factor is present in the ribosomal 
salt wash from reticulocytes. Later batches of our own wheat 
germ extract system together with the commercial wheat germ 
system all gave identical optima for all mRNA's and so this 
finding could not be followed up although it had been obtained 
previously on a number of occasions. Our gel system at that 
stage was still being developed and so no autoradiographs are 
available of the early results. We cannot, therefore, place 
weight on this work and must conclude that the bulk of the 
studies indicate no difference between the translation 
properties of IE, late and HeLa mRNA's.
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Chapter 5. Protein synthesis in cells infected 
with herpes viruses.
5.1. Introduction
Inhibition of cellulo* protein synthesis and selective 
translation of viral mRNA's occur during the course of productive 
infection by many animal viruses, for example, herpesvirus 
(Sydiskis & Roizman, 1966), vaccinia virus (Hanafusa, I960), 
adenovirus (Levin & Ginsberg, 1967), poliovirus (Penman &
Summers, 1965) and vesicular somatitis virus, VSV (Yaoi et al., 
1970). In Encephalomyocarditis (EMC) virus infected ascites 
cells, inhibition is said to be due to competition between host 
and viral mRNA's for elf-4B ■ (Golini ^t , 1976). Inactivation 
of Cap-binding protein in poliovirus infected cells appears to 
be responsible for inhibition of capped host-mRNA translation 
(Rose _£t a_l. , 1978; Trachsel ejfc aA. , 1980; Sonenberg _et, aJL. ,
1980) . Initiation factors isolated from jpoliovirus infected 
HeLa cells are defective in the translation of capped mRNA 
in vitro whereas initiation factors from EMC virus infected HeLa 
cells are not (Jen£t_^., 1980).
There is a report of host mRNA degradation in HSV-1 infected 
Friend erythroleukemia cells (Ni'shioka & Silverstein 1978b).
In H8V-2 infected vero cells inhibition is caused by a component(s) 
of the infecting virus (Fenwick & Walker 1978). As a first step 
in the study of inhibition of protein synthesis in PRV infected 
cells investigations were carried out to find out the extent of 
inhibition of protein synthesis in different cell lines after 
herpesvirus infection.
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5.2. Inhibition of protein synthesis in HeLa cells after 
herpesvirus infection.
HeLa cells were infected with PRV and protein synthesis
in the course of viral infection was examined by pulse-labelling 
3 5with [ methionine. The synthesis rate was determined in
terms of the radioactivity incorporated into TCA precipitable 
material and the result of a typical experiment is shown in 
Fig, 5.2.1. Inhibition of protein synthesis in the infected 
cells was rapid and occurred soon after infection. By 6 hrs 
infection almost 70^ inhibition was observed. Analysis of the 
infected cell lysates by SDS-polyacrylamide gel electrophoresis 
and fluorography showed few virus specified proteins by 2 hrs 
after infection (Fig. 5.2.2). The number of' virus specified 
proteins increased between 2 and 5 hrs after infection. By 5 hrs 
post-infection, the number of host cell proteins decreased 
markedly.
Virus protein synthesis appeared not to be sensitive to the 
process that inhibited cellular protein synthesis. This 
insensitivity was suggested by the observation that when cellular 
protein synthesis was declining sharply,viral protein synthesis 
was increasing. This switch-over from host, specific to virus 
specific protein synthesis may indicate a selective inhibition 
that suppresses cellular protein synthesis without affecting 
viral protein synthesis.
Kinetic studies of protein synthesis in HeLa cells infected 
with HSV-1 (KOS) also showed a rapid decline in protein synthesis 
and by 6 hrs post-infection inhibition was about 70^ (Fig. 5.2.3.)
Fig. 5.2.1. Protein synthesis in HeLa cells
infected with PRV.
Confluent monolayers of HeLa cells grown on coverslips
in 50mm petridishes were infected with PRV at 50 p.f.u./cell.
At different times after infection cells were labelled with 
3 515juCi [ S]- methionine per petridish for 30 min in methionine-
free medium. Determination of TCA precipitable radioactivity, 
after labelling, was carried out as described in Materials 
and Methods.
100% protein synthesis (Mock-infected cells) =
10,8 X 10^ cpm.
“ 68 —
100
75
Protein
synthesis
25
0
642I
Hours post-infection,
Fig. 5.2.2. Polypeptides synthesized in cells 
infected with PRV.
HeLa cells grown in 90 m.mdia. petridishes were mock- 
infected or infected with PRV at 50 p.f.u./cell. At different 
times after infection cells were labelled with 25 /ixG± 
methionine per petridish in methionine-free medium for 30 min 
before being harvested. After lysis, the cell lysates were 
processed for analysis by SDS-polyacrylamide gel electrophoresis 
The gel contained 10^ (w/v) acrylamide and 0.3% (w/v) bis- 
acrylamide. After electrophoresis, the gel was processed for 
fluorography.
EquI 'al. amounts of proteins were applied to each 
track.
Track 1 Mock- infected;
Track 2 1 hr infected;
Track 3 2 hrs infected;
Track 4 3 hrs infected;
Track 5 5 hrs infected;
Track 6 7 hrs infected.
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Fig. 5.2.3. Protein synthesis in HeLa cells infected 
with HSV-1 (KbS).
Confluent monolayers of HeLa cells grown on coverslips 
in 50mm petridishes were infected with HSV-1 (KGS) at 
50 p.f.u./cell. At different times after Infection cells 
were labelled with 15 juCi S] methionine per petridish 
for 30 min in methionine-free medium. Determination of TCA 
precipitable radioactivity, after labelling, was carried out 
according to the procedure described in Materials and 
Methods.
100% protein synthesis (Mock-infected cells) =
5
6.5 X 10 cpm.
70-
100
Protein
synthesis
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5*3. Inhibition of protein synthesis after FRY infection 
in other cell lines.
For comparative studies G13 and BS-C-1 cells were infected 
with PRV to study the kinetics of protein synthesis in these 
cell lines.
In PRV infected C13 cells the extent of inhibition was 
followed by determining ^S]-methionine incorporation into TCA 
precipitable material, as had been done for HeLa cells (Fig. 5.3.1 
After infection there was an initial 50^ stimulation of 
methionine incorporation at 1 hr post-infection. A decline in
protein synthesis followed thereafter. By 6 hrs post-infection 
protein synthesis was reduced by 68^. Few virus specific 
polypeptides appeared in the first 2 hrs of infection, their 
number increased by 5 hrs post-infection (Fig. 5.3.2).
The kinetics of protein synthesis in BS-C-1 cells infected 
with PRV are shown in Fig. 5.3.3. Here also there was an initial 
stimulation of 50$ at 1 hr post-infection. But unlike HeLa 
and C13 cells, inhibition in BS-C-1 cells was slow and by 7 hrs 
post-infection only 30$ inhibition was observed. At 5 hrs post­
infection a few virus specific proteins were found (Fig. 5.3.4) 
but there was little decline in host protein synthesis.
. ■ '
5.4. Discussion
Protein synthesis in eukaryotic cells requires specific 
and selective interactions between initiation factors, mRNA 
and ribosomal sub units. It is possible that the selectivity of 
interaction varies in different cell lines. As such, the same
Fig. 5.3.1. Protein synthesis in BHK-21 (C13) cells
infected with PRV.
Confluent monolayers of C13 cells grown on coverslips
in 50mm petridishes were infected with PRV at a multiplicity
of 50 p.f.u./cell. At different times after infection cells
3 5were labelled with 15 ^Ci [ Sj-methionine per petridish for 
30 min in methionine-free medium. Determination of TCA 
precipitable radioactivity was carried out according to the 
procedure described in Materials and Methods.
100$ protein synthesis (Mock-infected cells) =
10.4 X lO'^  cpm.
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Fig. 5.3.2. Polypeptides synthesized in C13 cells 
infected with PRV.
013 cells grown in 90mm dia. petridishes were infected 
with PRV at 50 p.f.u./cell. Labelling of cells for 30 min 
at different times after infection, harvesting, lysing and 
processing of the cell lysates for analysis by SDS- 
polyacrylamide gel electrophoresis were carried out as 
previously described. The gel contained 10^ (w/v) acrylamide 
and 0.3% (w/v) bis-acrylamide. After electrophoresis the 
gel was processed for fluorography.
Equ. alv amounts of proteins are applied to each 
track.
Track 1 Mock-infected;
Track 2 Infected for 1 hr;
Track 3 Infected for 2 hrs ;
Track 4 Infected for 3 hrs ;
Track 5 Infected for 5 hrs;
Track 6 Infected for 7 hrs ,
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Fig. 5.3.3. Protein synthesis in BS-C-1 cells
infected with PRV.
Confluent monolayers of BS-C-1 cells grown on coverslips 
in 50mm dia. petridishes were infected with PRV at 50 p.f.u,/ 
cell. At different times after infection cells were labelled 
with 15 /xCi [^^S] methionine per petridish in methionine-free 
medium for 30 min. After labelling TCA precipitable radio­
activity was determined as described in Materials and Methods.
100% protein synthesis (Mock-infected cells) =
4.2 X lO"^  cpm.
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Fig. 5,3.4. Polypeptides synthesized in BS-C-1 
cells infected with PRV,
Confluent monolayers of BS-C-1 cells grown in 90mm 
dia. petridishes were infected with PRV at 50 p,f.u./cell, 
Labelling of cells with methionine for 30 min at
different times after infection, harvesting, lysing and 
processing of the cell lysates for analysis by SDS- 
polyacrylamide gel electrophones were carried out as done 
previously. The gel contained 10^ (w/v) acrylamide and 
0.3% (w/v) bis-acrylamide, After drying the gel was 
exposed to X-ray film for autoradiography.
Equ. al amounts of protein were applied onto each 
track.
Track 1 Mock-infected;
Track 2 1 hr infected;
Track 3 3 hrs infected;
Track 4 5 hrs infected; -
Track 5 7 hrs infected.
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mRNA's may not be translated equally well in different systems. 
Here it was found that PRV and HSV-1 cause a rapid decline in 
protein synthesis in HeLa cells. In 013 cells, though 
inhibition is again rapid, at 1 hr post-infection with PRV there 
is a stimulation of protein synthesis. Since few virus specific 
proteins are present even at 2-3 hrs post-infection, this 
induction is not due to activation of viral protein synthesis. 
Possibly the cells after infection undergo some form of 
sensatisation, as a result of which the translation machinery 
becomes more active than before infection. A similar stimulation
is observed in PRV infected BS-C-1 cells. In BS-C-1 cells
inhibition is not rapid but gradual. These results emphasize 
the importance of the host cell in modulating virus infection, 
in this project most of the experiments were carried out on HeLa 
cells as this cell line showed a gradual decrease in the protein 
synthesis after PRV infection,with no stimulation.
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Chapter 6. Effect of herpes virus on the polyribosome
disaggregation in the infected cells.
6.1. Introduction
When certain animal viruses infect their host cells there 
is observed a decrease in the number of functioning polyribosomes 
concomitant with an abrupt drop in the amino acid incorporation 
into protein. For example, in Picorna virus infected cells 
cellular mRNA’s, after being released from the decaying poly­
ribosomes, appear to be incapable of reentering the ribosomes 
(Willems & Penman, 1966). But on the other hand, in the case 
of the Rhabdovirus, VSV, there is no significant alteration in 
the polyribosome pattern during the course of infection 
(Nishioka & Silverstein, 1976a). In HSV-1 infected cells dis­
aggregation of host polyribosomes is followed by the gradual 
appearance of virus specific polyribosomes which have a higher 
sedimentation value (Sydiskis & Roizman, 1966), Faster 
sedimenting virus specific polyribosomes have also been detected 
in PRV infected RK cells at 2.5 hrs after Infection (Ben Porat 
et al., 1971), The initial decrease in polyribosomes at 2 hr 
post infection in HSV-1 infected vero cells, possibly due to a 
decrease in the rate of polypeptide chain initiation, coincides 
with an overall decrease in protein synthesis at that time.
As infection proceeds the polyribosomes increase in size by 
recruiting released monosomes and protein synthesis also 
increases. But late in infection the protein synthetic activity 
of the infected cell polyribosomes declines progressively 
(Silverstein & Engelherdt, 1979). Fenwick & Walker (1976)
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have shown that in HSV-2 infected vero cells the polyribosome 
disaggregation is caused by the infecting virus particles.
It has been reported that as an indication of the inhibition 
of protein synthesis in PRV infected HeLa cells, the polysome/ 
monosome ratio decreases significantly at 3 hrs post infection 
(Vass, 1975). Since the evidence of Fenwick & Walker (1978) 
with HSV-2 is in contrast to the previous results with HSV-1 
(Sydiskis & Roizman, 1966). it was of particular interest to 
study the effect of PRV in the absence of virus protein 
synthesis.
6.2. Polyribosome disaggregation after virus infection.
The disaggregation of polyribosomes in HeLa cells'after 
PRV infection was approached in three different ways.
6.2.1. Disaggregation in the presence of Cycloheximide.
Confluent monolayers of HeLa cells were infected with PRV 
in the presence of cycloheximide (50/ig/ml) for 2 hours. 
Cytoplasmic extracts were analysed by sucrose gradient centri­
fugation to determine the polyribosome content. The results 
(Fig, 6.2.1.1) show a marked^disaggregation of polyribosomes 
after infection, under conditions which prevented synthesis 
of viral proteins. To show more clearly the effects on 
disaggregation the data from a typical experiment are presented 
as percent polyribosoma1 RNA calculated from the polyribosome 
profiles (Table 6.2.1.1). HSV-1 strain MP17, was found to 
exhibit a similar inhibitory effect (Table 6.2.1.1). Since 
cycloheximide at a concentration of 50jng/ml caused more than
7?'
Fig, 6.2.1,1. Polyribosome disaggregation in herpes
virus infected cells.
Confluent monolayers of HeLa cells were mock-infected or 
infected with PRV and HSV-1 (MP17 Strain) in the presence of 
Cycloheximide (50ug/ml). At 2 hrs post infection cells were 
harvested and the cytoplasmic extracts, made according to 
the procedure described in Materials and Mei^ds, were 
analysed by sucrose gradient centrifugation on 15 - 30% (w/v) 
sucrose in RSB at 27,000 r.p.m. for 110 min at 4°0 in the 
Beckman SW27 rotoh. Gradients were then pumped through a 
Gilford recording spectrophotometer at 260nm, The poly­
ribosome profiles were traced.
Mock-infected
Infected with PRV, 20 p.f.u./cell. 
XnfectAd with HSV-1, 20 p.f.u./cell
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Table 6.2.1.1,
Polyribosorne disaggregation after herpes
virus infection.
Nature of the virus p.f.u./cell % polyribosomes
- - 70.0
PRV 20 42.0
HSV--1, MP17 20 47.0
Confluent monolayers of HeLa cells were mock-infected or 
infected with PRV and HSV-1 at a multiplicity of 20 p.f.u./ 
cell in the presence of Cycloheximide (50jug/ml). At 2 hr post- 
infection, cytoplasmic extracts from both mock-infected and 
infected cells were analysed by sucrose density gradient 
centrifugation at 27,000 r.p.m. at for 110 min in the
Beckman SW27 rotor to determine the polyribosome content 
(Materials and Methods). The percent polyribosomes were 
determined by cutting and weighing the tracing paper under 
appropriate areas of the tracing.
The polyribosome area taken was the area under the 
curve due to polyribosomes with more than 2 ribosomes.
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95^ inhibition of protein synthesis (Fig. 6.2.1.2) the results 
indicate that polyribosome disaggregation occurs in cells 
infected with PRV and HSV-1 even when there is a maximum 
Inhibition of the synthesis of virus proteins.
6.2.2. Effects of multiplicity of infection.
Confluent monolayers of HeLa" cells were infected with PRV 
at different multiplicities in the presence of cycloheximide 
(50/ig/ml). Analysis of the cytoplasmic extracts 2 hrs after 
infection showed a gradual decrease in the polyribosome content 
with the use of increasing numbers of infecting virus particles. 
The data from a typical experiment is shown in Table 6.2.2.1.
This is an added evidence supporting the involvement of virus 
component(s) in polyribosome disaggregation.
6.2.3. Use of inactivated PRV.
HeLa cells were infected with normal and inactivated PRV 
at a multiplicity of 50 p.f.u./cell. Details of the inactivation 
of PRV by u.v. irradiation and heat are given in Materials and 
Methods. At 2 hr post infection cytoplasmic extracts were 
analysed to determine the polyribosome content. The results of 
a typical experiment showed that with normal PRV there was little 
decrease in the polyribosome content but with inactivated virus 
there was a marked disaggregation (Table 6.2.3.1). Since the 
measurement is made at only 2 hr post infection the minor decrease 
after normal PRV infection is expected though at later times 
disaggregation is marked. The substantial disaggregation by 
inactivated PRV definitely suggests the involvement of the virus
#2.
Fig, 6.2.1.2. Protein synthesis in Cycloheximide treated
cells.
Confluent monolayers of HeLa cells grown on cover slips
in 50mm petridishes were infected with PRV at 50 p.f.u./cell
in the presence of Cycloheximide. At 2 hrs post infection cells
3 5
were labelled for 30 rain with uCi S-methionine per petridish 
in methionine-free medium containing the same concentration of 
Cycloheximide. After labelling TCA precipitable radioactivity 
was determined, as described in Materials and Methods.
100% protein synthesis = 0.98 x 10 cpm.
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Tahle 6.2.2.1.
Polyribosome disaggregation at different
multiplicities of infection.
p.f.u./cell % polyribosomes
0 67
10 40
20 38
30 28
Confluent monolayers of HeLa cells were Infected with PRV 
at 10, 20 and 30 p.f.u./cell in the presence of Cycloheximide 
(50#g/ml). At 2 hrs post-infection cells were harvested and 
the cytoplasmic extracts were analysed on sucrose gradient 
centrifugation to determine the polyribosome content (Materials 
and Methods). The percent polyribosomes were determined by 
cutting and weighing of the tracing paper under appropriate 
area (as in Table 6.2.1,1.),
— 8 4 “
Table 6.2.3.1.
Polyribosome disaggregation by inactivated virus
Nature of virus Multiplicity 
of Infection
% polysome
- - 67.0
Normal PRV 50 p.f.u./cell 60.4
u.v. Irradiated PRV 
(1000 ergs/mm^)
50 p.f.u./cell 37.5
u.v. Irradiated PRV 
(64000 ergs/mm )
50 p.f.u./cell 42.7
Heat-inactivated PRV 
(60°C 60 min)
50 p.f.u./cell ' 35.2
Confluent monolayers of HeLa cells were mock-infected or 
infected with normal and inactivated PRV, At 2 hrs post­
infection, cytoplasmic extracts were analysed by sucrose 
gradient centrifugation at 27,000 r.p.m. for 110 min in the 
Beckman SW27 rotor to determine the polysome content (Materials 
and Methods). The percent polysomes were determined by cutting 
and weighing the tracing paper under appropriate areas of the 
tracing, as before.
The polysome area taken was the area under the curve due 
to polysomes with more than 2 ribosomes.
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particles in polyribosomes disaggregation.
6.3. Discussion.
The experiments described here suggest that the infecting 
PRV and HSV-1 particles cause polyribosome disaggregation even 
when infected cell protein synthesis is inhibited almost 
completely. This indicates that disaggregation does not involve 
any virus specific proteins synthesized in the infected cells. 
That the active material(s) is a structural component(s) of the 
virus is supported by the increase in polyribosome disaggregation 
which occurs when the number of the infecting PRV particles is 
increased. Moreover, inactivated PRV also causes substantial 
disaggregation of polyribosomes. It seems clearer, therefore, 
that polyribosome disaggregation occurs due to the effects of 
the infecting virus particles themselves.
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Chapter 7. The effects of hypertonicity on
protein synthesis in PRV infected cells
f
7.1. Introduction.
Exposure o/HeLa cells to hypertonic medium results in a 
complete and reversible Inhibition of protein synthesis 
(Saborio e^jt a_l. , 1974) . The inhibition occurs at the level 
of peptide chain initiation and is accompanied by the breakdown 
of polyribosomes. In polio-, VSV- and reo-virus infected cells 
the mRNA's that are translated after exposure of cells to 
hypertonic medium are predominantly' viral mRNA ' s (Nuss et al., 
1975, Oppermam& Koch, 1976a). This selective inhibition of 
host peptide chain initiation by hypertonicity indicates that 
the initiation of viral mRNA translation is more efficient than 
that of host mRNA. Exposure of infected cells to hypertonic 
medium provides a unique tool with which to study early events 
in the infectious cycle of at least some viruses by permitting 
the efficient unmasking of virus specific polypeptide synthesis 
(Nuss a_l. , 1975) as well as the study of the viral proteins
in cells where host protein synthesis is not inhibited after 
viral infection (Oppermann & Koch, 1976b).
There have been a few similar studies in herpesvirus 
infected cells. In PRV infected HeLa cells, both HeLa cell 
protein synthesis and. Infected cell protein synthesis late 
after infection, are susceptible to a high NaCl concentration, 
(Stevely & McGrath, 1978). Again in HSV-2 infected vero cells 
host proteins and viral proteins are equally sensitive to an 
increased concentration of NaCl in the medium (Fenwick &
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Walker, 1978). In the case of MCMV infected cells, though 
hypertonicity causes selective inhibition of host protein 
synthesis, inhibition of a few 1-ate viral proteins does occur.
This system allowed a more careful examination of Immediate- 
early viral proteins than had previously b^en possible (Chantier, 
1978) . From similar findings ,i.t was proposed that the trans­
lational efficiency of viral mRNA’s was greatest for early mRNA’s 
and markedly less for late mRNA’s (Oppermann & Koch 1976a).
Thus it was of interest to study the effects of hypertonicity on 
Immediate-early protein synthesis in PRV infected cells.
7.2. Immediate-early protein■synthesis under hypertonic conditions
Host cell protein synthesis and Immediate'^ ^ -early protein
synthesis in PRV infected HeLa cells were compared by determining
the incorporation of [ sj methionine into TCA precipitable
materials after removal of the inhibitor when infected cells were
grown for 5 hrs in the presence of Cycloheximide (50^g/ml). The
details of the procedure are described in Materials and Methods.
Cells grown on coverslips were infected at 50 p.f.u./cell in the
presence of Cycloheximide. At 5 hrs post infection cells were
washed six times to remove cycloheximide and incubated for 5 min
in normal medium. Then after another 10 min incubation in medium
containing different concentrations of NaCl, cells were labelled 
3 5with I 83 methionine for 15 min. The cells were harvested and 
acid precipitable radioactivity was determined, as described in 
Materials and Methods,
To obtain a clearer idea of the effects of hypertonicity 
on the synthesis of host proteins and Immediate-early proteins
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the results are plotted in terms of the percent incorporation 
relative to the incorporation in cells grown in medium containing 
the normal concentration of NaCl (Fig 7.2.1). It appears that 
hoth host proteins and viral proteins are susceptible to high 
salt concentrations almost to the same extent, IE protein 
synthesis showed slightly more sensitivity at 50mM added NaCl 
concentration.
7.3. Analysis of proteins synthesized in the infected cells 
under hypertonic conditions.
It was important to see whether all proteins of the mock- 
infected and infected cells were equally sensitive to the high 
NaCl concentration. When IE proteins are being made, cell 
protein synthesis is not inhibited completely and it has been 
shown that the Immediate-early mRNA preparation contains a large 
number of host mRNA*s (Table 2.4.1). So it could be that in 
the infected cells host proteins show greater sensitivity than 
IE proteins to hypertonic medium. For this reason, host 
proteins and infected cell proteins were analysed by SDS- 
polyacrylamide gel electrophoresis and and autoradiography. 
Procedures for the preparation of cell lysates and electrophoresis 
are described in Materials and Methods. The autoradiogram 
(Fig 7.3.1) shows that host and viral proteins are equally 
sensitive to high salt concentration in the medium. None of 
the infected cell proteins showed any resistance to hypertonicity.
7.4. Discussion.
It has been found that the synthesis of both host cell
Fig. 7.2.1. Effect of different concentrations of NaCl 
solutions on IE protein synthesis in PRV 
infected HeLa cells.
HeLa cells grown on coverslips in petridishes were mock-
infected or infected with PRV at 50 p.f.u^6ell in the presence
of Cycloheximide, (50pg/ml). At 5 hrs post infection, cells
were washed six times to remove Cycloheximide. Then both
mock-infected and infected cells were grown in normal medium
for 5 min before being treated with different concentrations
of NaCl. After 10 min incubation in NaCl' containing medium,
3 5cells were labelled with [ 8]-methionine ( 15/^Ci/petridish) for
30 min in methionine free medium again containing NaCl. Cells 
were harvested and acid precipitable radioactivity was determined 
Results are presented here as percent of those obtained with 
medium containing the normal amount of NaCl,
o---------- o Mock-infected- cell protein
_# IE proteins
100% Mock-infected cell protein = 2.26 x 10 cpm 
100% IE proteins = 1.2 x 10*^  cpm.
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mM KaCl added to the medium
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Fig 7.3.1. Autoradiography of electrophoretlcally
separated proteins synthesized in mock- 
infected and infected cells under hypertonic 
conditions.
Cells grown in 90mm petridishes were mock-infected or 
infected with PRV at 50 p.f.u./cell in the presence of Cyclo­
heximide ( 50jng/ml) . At 5 hrs post infection cells were washed 
to remove Cycloheximide and incubated for 5 min in normal 
medium. After an additional 10 min incubation in the presence
of different concentrations of NaCl, cells were labelled with 
3 525 jLtCi S methionine per petridish for 30 min in methionine 
free medium again containing NaCl, The cells were washed with 
BSS, harvested and lysed. The cell lysates were processed for 
polyacrylamide gel electrophoresis, as described in Materials 
and Methods. The gel contained 10^ (w/v) acrylamide and 0.3% 
(w/v) bis-acrylamide. The dried gel was exposed to X-ray films 
for autoradiography..
An equ al . amount of protein was applied onto each gel 
track.
Tracks 1 to 6 for mock-infected cell lysates and 7-12 for 
infected (IE) cell lysates. Tracks 1 and 7 with no added NaCl;
2 and 8 with 50mM NaCl; 3 and 9 with lOOmM NaCl; 4 and 10 with 
150mM NaCl; 5 and 11 with 200mM NaCl; 6 and 12 with 300mM NaCl,
“90“
î
^177,000
68,000
^ 21,000
50 100X50 200 3 00 
m M  N a C l
50 100 150 200 3 00 
mM NaCl
HeL a  p r o t e in IE p r o t e i n
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proteln and IE proteins from PRV infected cells are equally 
susceptible to high salt concentrations in the medium. 
Autoradiography shows that none of the infected cell proteins 
is resistant. Thus, PRV infected cell proteins behave 
differently from picornavirus infected cell protein and MCMV 
infected cell proteins in that the latter show some resistance 
to hypertonicity.
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Chapter 8. - The effects of inactivated PRV on host
macromolecule synthesis.
8.1. Introduction.
In studying the fact that infection of animal cells with 
viruses results in the inhibition of host macromolecule synthesis 
it has been shown, using metabolic inhibitors like actinomycin D 
and Cycloheximide and also u.v. irradiated virus, that in 
vaccinia virus infected cells a component(s) of the infectious 
particle can cause the inhibition (Moss 1968, Shatkin, 1963), 
and this effect requires no virus specific macromolecule 
synthesis.
Similarly, heat inactivated Frog virus can inhibit host 
macromolecule synthesis almost to the same extent as does the 
normal virus (Goorha & Granoff 1974; Raghow & Granoff, 1979), 
again indicating the involvement of a structural component(s) 
of the virion. In picornaviruses, mutants defective in the
ability to inhibit host protein synthesis map in the regions
e
of the genome coding for structural proteins (Steiner-Pryor & 
Cooper, 1973) .
Within two hours of infection with herpes virus, host 
polyribosomes are dispersed, host protein synthesis declines and 
is superseeded by viral protein synthesis (Sydiskis & Roizman, 
196.6) . With HSV-2 substantial inhibition of host protein 
synthesis occurs in whole cells after infection with u.v. 
irradiated virus and also in cytoplasts, the cells having been 
enucleated before 'infection (Fenwick & Walker, 1978). Thus
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in many cases inhibition of host protein synthesis is caused, 
at least in part, by a structural component(s) of the virus. 
Inactivated PRV was used to investigate whether any structural 
component(s) could exert an inhibitory effect on host macro­
molecule synthesis.
8.2, Inactivation of PRV.
8.2.1. U.V. Irradiation.
A PRV preparation was diluted 15 times with PBS containing
1% (w/v) glucose and irradiated as required by a 15 w germicidal
lamp, as described in Materials and Methods. The viability of
the irradiated virus was checked by plaque assay. The
inactivation is shown in Fig. 8.2.1.1. It was found that at
500 ergs/mm input, virus inactivation was 90% and at 64,000 
2
ergs/mm input, inactivation was about 99.9% (Table 8.2.1,1.). 
8.2.2. Heat treatment.
A 15 times diluted PRV preparation in PBS containing 1% 
(w/v) glucose was heated at 60°C for 60 min. The extent of 
heat inactivation was determined by plaque assay and was found 
to be more than 99.7% (Table 8.2.1.1).
To study the effects of inactivated PRV on host macro-
2
molecule synthesis, viruses irradiated at 64OOO ergs/mm and 
heat inactivated at 60°G for 60 min were used at a multiplicity 
of 50 original p.f.u./cell.
9f
Fig, 8.2.1.1. Inactivation of PRV by u.v. Irradiation
Virus stock was diluted 15 times with PBS containing 
1% (w/v) glucose and irradiated at different energy levels, 
taking 2ml of diluted preparation per 50mm petridish, as 
described in Materials and Methods, The irradiated virus 
stock was tested for inactivation by plaque assay.
94'
10
500 1000
2
Ergs per mm
64000
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Table 8.2.1.1.
Inaotlvatlon of PRV by u.v. irradiation 
and heat.
Nature of 
treatment Dose $ inhibition (a)
2
500 ergs/mm 90.0
U.V. Irradiation
2
1000 ergs/mm 98.5
2
64000 ergs/mm 99.88
Heat treatment 6O^C. 60 min 99.78
A virus stock diluted 15 times with PBS containing (w/v)
glucose was irradiated at different energy levels. 
Similarly, 10ml aliquots of dilute virus preparation were 
heated at 60^C for 60 min. The extent of inactivation was 
followed by plaque assay, as described in Materials and 
Methods.
(a) Inhibition was determined by measuring the p.f.u./ml
of the untreated PRV preparation and comparing the p.f.u./ml
of the inactivated virus preparation with it. In the original
10PRV preparation the titre was 1 x 10 p.f.u./ml.
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8.3. Protein synthesis in cells infected with 
inactivated PRV.
Incorporation of methionine into TCA precipitable
material in mock-infected cells as well as in cells infected
with normal and inactivated PRV was used as a tool to study
the effect of inactivated PRV on host protein synthesis.
Confluent monolayers of HeLa cells grown on coverslips in
petridishes were mock-infected or infected with normal and
inactivated PRV at a multiplicity of 50 original p.f.u./cell.
At different times after infection, cells were labelled for
3 530 min with 15 juCi [ Sj methionine per petridish in methionine- 
free medium. Determination of radioactivity in TCA precipitable 
material was as described in Materials and Methods. The results 
of a typical experiment are plotted as a percentage relative to 
the incorporation into mock-infected cells (Fig 8.3.1). At 8 hr 
post infection, normal PRV caused almost 70% inhibition of host- 
protein synthesis. Heat inactivated and u.v. irradiated PRV 
also caused an almost equal extent of inhibition. Infection 
was continued up to 24 hrs in further experiments with 
inactivated PRV to determine whether recovery could occur in 
the absence of new virus formation. Here inhibition was 95% 
with normal virus compared to about 70% inhibition by inactivated 
virus at 24 hrs post infection (Fig 8.3.2). In this case early 
inhibition was less rapid. The reason is unknown. However, 
at 24 hrs post infection the differences between protein 
synthesis in cells infected with normal virus and inactivated 
virus are significant. The higher degree of inhibition by 
normal, untreated virus, at 24 hrs post infection compared to
97  0.
Fig. 8.3.1. Protein synthesis in HeLa cells infected
with inactivated PRV.
Cells grown on coverslips in 50mm dia. petridishes
were mock-infected or infected with normal and inactivated
PRV at a multiplicity of 50 original p.f.u./cell. At
different times after infection cells were labelled with 
3 515 juCi [ S] - methionine per petridish in methionine-free 
medium for 30 min. Then TCA precipitable radioactivity 
of the labelled cells was determined, as described in 
Materials and Methods.
5
100% = 4 X 10 cpm (Measured in mock-infected cells)
Infected with normal virus
1Û Infected with heat inactivated virus.
■m Infected with u.v. irradiated virus .
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Fig. 8.3.2. Protein synthesis in HeLa cells infected
with inactivated PRV.
Confluent monolayer of HeLa cells grown on coverslips 
in 50mm petridishes were mock-infected or Infected with 
normal and inactivated PRV at a multiplicity of 50 original 
p.f.u./cell. At different times after infection cells were 
labelled with 15 juCi methionine in methionine-free
medium for 30 min. The TCA precipitable radioactivity of 
the labelled cells was determined.
100% = 2.08 X 10^ cpm (Measured in mock-infected cells) 
•—--------- # Infected with normal PRV.
-o Infected with u.v. irradiated PRV
-A Infected with heat inactivated PRV.
“ 9 Ô “
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75
50
Protein
synthesis
25
0
Hours post-infection
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that by the inactivated virus could be due to the cytopathic 
effect which is exerted by the normal virus but not by the 
inactivated virus. Thus it appears that inhibition of 
protein synthesis in HeLa cells after PRV infection does not 
necessarily require infective virus particles.
Inactivated PRV was also used to study the extent of 
inhibition of protein synthesis in C13 cells. Infection, 
labelling and determination of TCA precipitable radioactivity 
were carried out essentially in the same way as with HeLa cells. 
The results are plotted as percent cpm in infected cells 
compared to that in mock-infected cells (Fig 8.3.3). At 6 hr 
post infection normal PRV caused 75^ inhibition and inactivated 
PRV inhibited in the range of 55 - 65%. Still the extent of 
inhibition by inactivated virus was substantial enough to argue 
that in 013 cells inactivated PRV could cause marked inhibition 
of protein synthesis.
8 .4 . RNA synthesis in cells infected with PRV.
Since it was found that inactivated PRV could inhibit host 
protein synthesis, it was of interest to study whether it could
inhibit RNA synthesis as well. Infection and labelling of HeLa
cells as well as determination of TCA precipitable radioactivity 
were essentially the same as for protein synthesis, except that
q
H - uridine was used to label the cells at 15 jnCi/petridish for
30 min. The results are shown as percent cpm in infected cells
compared to that in mock-infected cells (Fig 8.4 .I). It is 
found that 8 hrs post infection RNA synthesis was inhibited by
) O O  a
Fig. 8.3.3. Protein synthesis in CI3 cells infected
with inactivated PRV.
Confluent monolayer of C13 cells grown on coverslips 
in 50mm petridishes were mock-infected or infected with 
normal and inactivated PRV at a multiplicity of 50 original 
p.f.u./cell. At different times after infection cells 
were labelled with 15 uCi [ SJ-methionine per petridish 
in methionine-free medium for 30 min-. TCA precipitable 
radioactivity was then determined.
5
100% = 15.5 X 10 cpm (Measured in mock-infected
cells)
Infected with PRV.
-o Infected with u.v, irradiated PRV 4 ^
Infected with heat inactivated PRV.
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Fig. 8.4.1. RNA synthesis in HeLa cells infected
with inactivated PRV,
Confluent monolayer of HeLa cells grown on coverslips 
in 50mm petridishes were mock-infected or infected with 
normal and inactivated PRV at a multiplicity of 50 original 
p.f.u./cell. At different times after infection, cells were 
labelled with 15 /iCi - uridine per petridish for 30 min.
Then TCA precipitable radioactivity was determined.
lOOÿ = 1 .48 X 10^ cpm (Measured in'mock-infected
cells)
Infected with normal virus.
Infected with u.v. irradiated virus
Infected with heat inactivated virus
—  101 “
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normal PRV to the extent of 85^ hut to less than 25^ hy 
inactivated virus. So inactivated PRV is much less effective 
than normal virus in inhibiting at the level of transcription 
in infected cells.
8.5, Discuss ion.
The experiments show that inhibition of protein synthesis 
in the infected cells is caused not only by normal infective 
PRV but also by inactivated PRV. The extent of inhibition by 
inactivated PRV is almost to the same level as for normal virus. 
The effects of inactivated PRV are found both in HeLa and C13 
cells. At 24 hr post infection normal PRV shows cytopathic 
effects but inactivated viruses do not. Studies of the è*ffects 
of inactivated virus on host RNA synthesis show no marked 
inhibition. From the differential ^ffects of inactivated PRV 
on translation and transcription, it appears that a component(s) 
of the virion can inhibit host protein synthesis by acting at 
some stages in the translation process, but no similar component 
acts on the RNA synthetic pathways though there is some 
inhibition of RNA synthesis by inactivated PRV. The significance 
of this inhibition is unknown. But if the extent of protein 
inhibition is taken into account, it appears unlikely that 
inhibition of protein synthesis is a consequence of inhibition 
of RNA synthesis. It could be a direct action of PRV on the 
translation process. In herpes virus infected cells, more than 
one mechanism is likely to be involved in causing inhibition of 
protein synthesis and one of them is due to the involvement of 
a virion component(s).
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Chapter 9. Effects of FRY on protein synthesis
in the MDL system,
9.1. Introduction
Inhibition of translation of host mRNA has been observed 
in cell free extracts from pollovirus infected cells (Rose e^ t al. , 
1978; Trachsel e_t , 1980). It is also known that cytoplasm 
from poliovirus infected cells inhibit protein synthesis in 
reticulocyte lysates (Hunt & Ehrenfeld, 1971) . The cytoplasm 
contains enough free virus protein to cause inhibition.
Isolated nucleocapsids and empty caps ids can also inhibit 
translation in cell free extracts (Levintow, 1974).
In vaccinia virus infected cells, a component(s) of-the 
virion is responsible for inhibition (Moss 1968) and in rabbit 
reticulocyte lysates inhibition is caused by the core (Racevskis 
et a_l. , 1976; Ben-Hamide & Beand 1978) and even heat disrupted 
virus can exert an inhibitory effect. In a coupled transcription- 
translation system, protein synthesis is again depressed by the 
cores (Cooper & Moss, 1978).
Very little is known about the regulation of herpes virus 
specific mRNA translation in cell-free system except that in 
mouse and rabbit reticulocyte lysates protein synthesis is not 
significantly enhanced by the addition of ribosomal salt wash 
fractions from HSV-1 infected cells whereas an equivalent 
fraction from mock-infected cells can stimulate translation of 
HSV specific mRNA, BHK mRNA and Globin mRNA (Preston, 1977),
Since it has been shown that PRV particles can cause poly-
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ribosome disaggregation and protein synthesis inhibition 
in the whole cell it is of interest to study the effect of 
the particles on cell-free translation.
9.2. Inhibition of protein synthesis in the MDL system
Details of the assay procedure for protein synthesis
in the MDL system are described in Materials and Methods.
Purified PRV was dialyzed overnight against O.OIM Tris-HCl
(pH 7.4) at 4°C. Each assay of lljul contained 20 jtlCi i^^Sj
methionine, a specified amount of mRNA and an appropriate
amount of virus or its protein equivalent. At different
time intervals during incubation ljt(l aliquots were taken in
duplicate onto filter discs to determine TCA precipitable
radioactivity. There was a marked inhibition of protein
synthesis in the presence of virus when an Immediate-early
mRNA preparation (Fig 9.2.1), or a late mRNA (Fig. 9.2.2) or
Globin mRNA (Fig 9.2.3) were being assayed. These results
are also presented as percent inhibition of protein synthesis
(Table 9.2.1). The extent of inhibition varied from 6l to
74^ which is substantial. Normal and heat inactivated PRV
did not show any significant difference in their inhibitory
potential. As a control for the addition of exogenous protein
to the MDL system, the effect of an equivalent amount of BSA
was studied. The results (Table 9.2.2) show that added BSA
3 5caused only a small decrease in [ Sj- methionine incorporation 
compared to that caused by PRV, It was also found that the 
inhibition was dose dependent. The extent of inhibition 
increased with the addition of increasing amounts of virus 
(Fig. 9.2.4).
Fig. 9.2.1. Effects of PRV on protein'synthesis, in
vitro, in the MDL system specified hy IE 
mRNA.
Details of the assay of protein synthesis in the MDL
system are described in Materials and Methods. The 11/xl
assay mixture contained 0.25)Ug IE mRNA preparation, 20^01 
35S-methionine and dialyzed PRV. After incubation at 
30°G, Ifil aliquots were taken in duplicates, at different 
time intervals, onto filter paper discs and TCA precipitable 
radioactivity was determined.
IEmRNA.+ dialyzing buffer*
^lEmRNA + 4^g protein equivalent of PRV
^  IE mRNA + protein equivalent of heat
inactivated PRV.
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Fig. 9,2,2. Effects of PRY on protein synthesis
in the MDL system specified by late 
viral mRNA.
3 5The lljiil assay mixture contained 20 juCi S methionine, 
Oo25jiig late viral mRNA and Aiig protein equivalent of PRV. 
Incubation was at 30°C and at different times reactions 
were stopped by quick transfer onto ice . ljul aliquots 
were taken in duplicate on filter paper discs to determine 
TGA precipitable radioactivity.
Late mRNA + dialyzing buffer.
Late mRNA + AliS protein equivalent of PRV
-A Late mRNA + 4jUg protein equivalent of
heat inactivated PRV.
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Fig. 9.2,3. Effects of PRV on protein synthesis in
the MDL system specified by Globiix mRNA.
The assay mixture contained 20 /ttCi methionine,
0.25juig Globin mRNA and 4 fxg protein equivalent of PRV, normal 
and heat inactivated. After incubation at 30°G the reaction 
was stopped at different time intervals by quick transfer 
onto ice. Ifj^ l aliquots were taken in duplicate onto 
filter discs to determine TCA precipitable radioactivity.
Globin mRNA + dialysing buffer.
Globin mRNA + 4jUg protein equivalent of 
PRV.
^  Globin mRNA + 4|Lig protein equivalent of heat
inactivated PRV,
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Table 9.2.1.
Inhibition of protein synthesis in the
MDL system by PRV.
Nature of Virus, A-fxg 1o
mRNA protein Inhibition
equivalent
Immediate-early PRV 61.0
PRV mRNA A PRV 62 . 5
Late PRV PRV 72.2
mRNA 4PRV 71.0
Globin PRV 70.0
mRNA A PRV 74.0
A purified and dialyzed PRV preparation was added to 11 ^1 
assay mixture containing 20 juCi methionine, 0.25jug
IE mRNA or 0.2 5jug late mRNA or 0.2 5/4 g globin mRNA. After 
60 min incubation at 30°C Ij^ 1 aliquots were taken on to 
filter paper discs to determine TCA precipitable radioactivity
-10 9“
Table 9.2.2.
synthesis, in vitro, in the MDL system
Nature of 
mRNA
Nature of protein 
added
%
Inhibition
NO PROTEIN 0
G mRNA BSA 20
PRV 75
3 5The 11 fxl assay mixture contained 20 juCi [ Sj-methionine, 
0.25jUg 0 mRNA, 4jLlg BSA or 4-jUg protein equivalent of PRV. 
After 60 min incubation at 30°G, I/4I aliquots were taken 
in duplicates on filter paper discs to determine TCA 
precipitaable radioactivity.
Fig. 9.2,4. Effects of different concentration of
PRV on protein synthesis in the MDL 
system, specified by Globin mRNA
The 11 jj,l assay mixture contained 20 /j,Ci - methionine,
0.25jtlg Globin mRNA and different concentrations of PRV.
After Incubation at 30°C the reaction was stopped at different 
time Intervals by quick transfer onto ice. 1^1 aliquots were 
taken in duplicates on to filter discs to determine the TCA 
precipitable radioactivity.
Globin mRNA + dialysing buffer.
-o Globin mRNA + 1.6jug protein equivalent of PRV 
■a Globin .mRNA + 4-OjLig protein equivalent of PRV
^  Globin mRNA + 1.6^g protein equivalent of
.heat inactivated PRV.
^ G lobin mRNA + 4.Pug protein equivalent of
heat inactivated PRV.
-1 1 0 -
-4
X 10
CPM
(^ S^-Met) 2.0
45"0
Minutes
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Analysis of the translation products was carried out 
using SDS-polyacrylamide gel electrophoresis and auto­
radiography, This showed no increase in small molecular 
weight products, (Fig 9.2.5), which Indicated that the 
inhibition was not apparently due either to premature 
termination or mRNase activity.
9.3. Discussion.
In these studies it has been found that PRV causes 
a marked inhibition of protein synthesis in the MDL system. 
Since in this system, there is absolutely no possibility of 
any virus specific macromolecule synthesis,inhibition appears 
to be due to some structural component(s) of the virus.
This is supported by the dependence of inhibition on the 
concentration of virus added. The inhibition does not appear 
to be due to mRNA degradation or to premature termination. 
Since heat inactivated virus is equally active in causing 
inhibition, it is possible that some heat stable component(s) 
of the virus bind to items of the translation system causing 
inhibition.
In the intact cells virus causes selective inhibition of host 
protein synthesis whereas in the MDL systemthe virus particles 
cause a general inhibitionpresumably by binding to some component 
of the translation system^Probably in the cell a different mecha­
nism is responsible for selectivity* In this experiment cent per 
cent purity of the virus preparation is not guaranteed so inter­
ference any impurity cannot be ruled out*
Fig. 9,2.5. Polypeptides synthesized in the MDL
System in the presence of PRV particles.
The assay mixture of lljul contained the MDL system 
3 5plus 40/iCi S-Methionine, 0.25/iig late mRNA with or
without 4)Ug protein equivalent of dialyzed PRV. After
60 min incubation at 30°C, the translation products were
processed for polyacrylamide gel electrophoresis and 
autoradiography (Materials and Methods).
Equ;' al<" ' amounts of protein were applied on to each 
gel track.
Track A Late mRNA + dialysing buffer
B ■ Late mRNA + PRV particles.
- 1 1 2 -
B
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Chapter 10. Effects of low concentration of Cycloheximide
on protein synthesis and virus replication.
10.1. Introduction.
In EMC virus infected cells competition between host and 
viral mRNA'8 causes suppression of host protein synthesis 
(Lawrence & Thach, 1974). In the cat se of poliovirus, 
preferential synthesis of infected cell proteins at high 
salt concentration supports the speculation that there are 
differences in the efficiencies of initiation of host and 
viral messages (Nuss ejt aj^ . , 1975).
The high efficiency of many viral mRNA's in the initiation 
of protein synthesis (Lawrence & Thach', 1974; Nuss _et al. ,
1975; Golini _ejb a^. , 1976; Jen £t , 1978) might be used 
as a signal for discrimination between host and viral mRNA's.
As such translation of these viral mRNA's is likely to be 
limited by the elongation rate whereas the translation of host 
mRNA's should be inhibited by the initiation rate. So any de­
crease in the elongation rate should Inhibit elongation-limited 
viral mRNA's fcgr more than initiation-limited host mRNA ' s .
The elongation inhibitor, cycloheximide, when present 
at low concentration during the,infectious cycle, suppresses 
replication of VSV and EMC viruses (Reunabhadran & Thach, 1980) 
whereas cellular protein synthesis and synthesis of MLV proteins 
are inhibited to a much lesser extent (Yau ejb aA. , 1978). 
Attempts were made to study the effect of cycloheximide on PRV 
infected cell protein synthesis. Virus yield was monitored 
in these experiments' to check that the concentration"’of
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inïiibitor used did not completely inhibit virus replication.
10.2. Inhibition of protein synthesis and virus 
replication.
Mock-infected and PRV infected cells (50 p .f .u ./cell) were 
treated with different concentrations of Cycloheximide from 
the start of infection. At 4.5 hrs post infection, when ,viral
protein synthesis is almost maximum cells were labelled for
1 3 52 hr with [ 8]-methionine in the presence of the drug.
Total cell protein synthesis was -determined by counting the 
TCA precipitable radioactivity. It was found that at IjUM 
cycloheximide infected ceil protein synthesis was inhibited by 
00% compared to 65^ inhibition of mock-infected cell protein 
synthesis (Fig 10.2.1) but Cycloheximide caused a substantial 
reduction in virus yield which was about ^0% at l^ ^^ M Cycloheximide.
10.3. Discussion.
The data presented here suggest that the inhibition of
infected cell protein synthesis is not significantly different from
that of mock-infected cells. Inhibition of infected cell protein
t i c onoen L r^t i on.
synthesis coincides with the reduction in virus yield^ Since the
elongation rate of viral and host mRNA's are comparable (Silver-
stein & Engelhardt, 1979) this implies that initiation of viral
protein synthesis is little different from that of host protein
synthesis.
Fig, 10.2.1. Effect of Cycloheximide on Protein Synthesis
and Virus Replication.
(a) HeLa cells grown on coverslips in petridishes were mock- 
infected or infected with PRV in the presence of different 
concentration of Cycloheximide. After 4.5 hrs infection,
O  C
cells were labelled with 15 uCi [ Sj methionine per petri- 
dish in methionine-free medium for 30 min again containing 
Cycloheximide. Protein synthesis was monitored by determining 
TCA precipitable radioactivity (Materials and Methods),
'«---------- #. Mock-infected, 100% = 8.9 x lO'^  cpm
-o Infected, 100% = 8.0 x 10^ cpm
(b) Confluent monolayers of HeLa cells in petridishes were
infected with PRV for 12 hrs in the presence of different 
concentrations of Cycloheximide, Virus yield was determined 
by plaque assay as described in Materials and Methods.
a---------- Ù Virus yield, 100% = 0.25 x ,10^  p.f.u./ml
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Chapter 11. RNase activities in cells infected
with PRV.
11.1 Introduction
In plcornavirus infected cells cellular mRNA's appear 
to be as stable as in mock-infected cells and as such inhibition 
of host protein synthesis is not due to nucleolytic degradation 
of host mRNA (Abreu & Lucas-Lenard 1976; Fernandez-Munoz & 
Darnell, 1976). Neither has host mRNA degradation been 
observed in cells Infected with vaccinia virus (Rosemond- 
Hornbe&k & Moss, 1975) or VSV (Nishioka & Silverstein 1978a). 
However, in Friend erythroleukemia cells infected with HSV-1 
inhibition of host protein synthesis is accompanied by 
degradation of mRNA (Nishioka & Silverstein 1978a) and the' 
cellular mRNA's are released from polyribosomes prior to 
degradation. Degradation does not occur in the presence of 
inhibitors of protein or RNA synthesis and thus expression of 
early virus function is found to be required for the degradation 
of cellular mRNA to occur (Nishioka & Silverstein, 1978b).
In HSV-1 infected cells there is also an increase in the activity 
of RNase HI at times late in infection (Muller _et ^1. , 1980) . 
However this increased RNase activity is likely to be required 
for the degradation of RNA primers in HSV DNA synthesis (Biswal 
^  BJL* j 1974, Muller ^  , 1979). This enzyme hydrolyzes
specifically RNA from DNA-RNA hybrids and is normally inactive 
against ds RNA or SS-RNA (Hausen & Stein 1970) and so does not 
appear to be a candidate for the mRNase activity which has been 
reported. Thus it is of interest to study the presence of
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RNase activities in PRV Infected cells, which could he 
responsible, in part, for the inhibition of protein synthesis.
11.2. Degradation of jnRNA in PRV infected cells.
Mock-infected and 6 hrs infected cells were homogenized
and centrifuged at 50,000 r.p.m. for 3 hrs at 4°C to prepare
a post ribosomal supernatant, as described in Materials and
Methods. This post ribosomal superhatant was used to study
Ï ft/.
mRNase activities. An aliquot of^labelled mRNA was incubated 
for 30 min at 25°0 with the post ribosomal supernatant to study 
the degradation of mRNA. The percent of mRNA recovered after 
incubation, in a typical experiment, is given in Table 11.2.1. 
Using a supernatant from mock-infected cells the percent 
recovery of HeLa mRNA was 94-3 whereas with supernatant from 
Infected cells the percent recovery was 70.0. When late mRNA 
was used the recovery was close to 100% after incubation with 
either mock-infected or infected cell supernatants. The actual 
figure was 97% in both cases. From these results it appeared 
that the post ribosomal supernatant from infected cells, 
possessed some RNase activities which degraded HeLa mRNA to 
an appreciable extent but did not degrade late mRNA from PRV 
infected cells.
11.3. RNase activities in PRV preparation.
PRV was purified and dialyzed overnight against O.OIM'
Tris HCl (pH 7.4), as described in Materials and Methods. 
Aliquots of labelled mRNA were incubated with the virus 
preparation. Degradation of mRNA was studied by determining
- 118-
Table 11.2.1.
mRNA degradation by cell free extracts from 
PRV infected cells.
Nature of the 
post ribosomal
f 9, ^supernatant^
Nature
of
mRNA
Input 
cpm fig
Recovery 
cpm jUg
%
Mock-infected ^H-HeLa 1500 1.4 1420 1.32 94.3
Infected ^H-HeLa 1500 1.4 1062 0.99 70.7
Mock-infected ^H-late 5500 2.5 5335 2.42 97
Infected late 5500 2.5 5324 2.42 96.8
Cells were mock infected or infected with PRV at 50 p.f.u./cell. 
At 6 hrs post infection cells were harvested and post ribosomal 
supernatant was prepared as described in Materials and Methods. 
The assay mixtures contained 30 fj,l and 20 jul of post ribosomal
supernatants from mock-infected and infected cells respectively
and a specified amount of labelled mRNA. After 30 min 
incubation at 25°C, lOjul aliquots were collected on Whatman No. 1 
filter discs, washed with TCA and then ethanol and then dried.
The radioactivity of TCA precipitable material was determined 
by liquid scintillation counting.
(a) Protein content of the post ribosomal supernatants : 
from mock-infected cells = 3.0mg/ml.
from infected cells = 4.4mg/ml.
- 119 -
the radioactivity of the TCA precipitable material in the 
assay mixture after incubation. The results of a typical 
experiment are shown in Table 11.3.1. The PRV preparation did 
not cause any degradation of host or virus specific mRNA's. 
This was true both for the normal and the heat inactivated PRV 
preparations.
11.4 . Discussion.
The results show that in the infected cells there is an 
RNase activity which selectively degrades host mRNA. But no 
RNase activity is associated with either normal or heat 
inactivated PRV preparations and therefore the component(s) 
of the infecting virions which causes inhibition of protein 
synthesis cannot itself be an mRNase.
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Table 11.3.1.
mRNA degradation by PRV preparation
Nature of Nature of Input Recovery
the virus the mRNA cpm Atg cpm fJtg %
Normal PRV ^H-HeLa 1500 1.4 1390 1.29 93.0
Normal PRV ^H-Late 11000 5.0 10540 4.78 96.0
Heat-
ina ctivate d 
PRV
^H-HeLa 1500 1.4 1462 1.36 97.0
Heat-
inactivated
PRV
3
H-Late 11000 5.0 10780 4.91 98.0
A purified PRV preparation was dialyzed against O.OIM Tris HCl 
(pH 7.4) and some of the preparation was inactivated by heat­
ing at 60°C for 60 min (Materials and Methods). The assay 
mixture contained 20 jul of the PRV preparation and a specified 
amount of labelled mRNA. After 30 min incubation at 25°C 
aliquots were collected on filter discs to determine TCA 
precipitable radioactivity.
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Chapter 12. Discussion and Conclusions
The aim of this project was to examine a number of aspects 
of PRV infection in order to explain the mechanism(s) by which 
the virus causes inhibition of host protein synthesis. This 
problem was approached by undertaking experiments both ^^ n vivo 
and im vitro.
In general, virus induced inhibition of host protein 
synthesis could involve any one or more of a number of effects, 
for example, degradation of host mRNA, or inhibition of
initiation or elpngation of host peptide chain formation.
c . -,
However ^ in this project the aim waS;first, to answer the 
question whether inhibition of host protein synthesis is 
selective j!n‘PRV infected cells and second, what effects do 
contribute to the overall inhibitory mechanism.
A number of experiments were carried out to study selectivity 
of inhibition, of which the first ones discussed involved the use 
of different cell lines to examine protein synthesis following 
infection to investigate, therefore, whetheh selectivity resides 
in the host cell. Initiation of protein synthesis in eukaryotes 
is a complex phenomenon, involving at least eight initiation 
factors in addition to mRNA, Met-tRNA^, 40 S and 60 S ribosomal 
subunits, ATP and GTP (Weissbach & Ochoa, 1976), Different cell 
lines might have different capabilities of translating the same 
mRNA. It was found that both PRV and HSV-1 (KOS) caused a 
rapid and marked inhibition of protein synthesis in HeLa cells.
But in PRV infected 013 cells though inhibition was rapid and 
substantial, there was an initial stimulation at 1 hr post­
infection. A similar stimulation was found in PRV infected
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BS-C-1 cells, in which case the subsequent inhibition was 
gradual. It is possible that the initial stimulation is not a 
real increase in protein synthesis but a change in the 
methionine pool in BS-C-1 and C13 cells early after infection. 
Alternatively, initial stimulation may be due to a sensitization 
of the translation machinery resulting in rapid initiation. 
Modification of ribosomal protein(s) or initiation factor(s) 
soon after infection might contribute to this phenomenon. 
Phosphorylation of ribosomal proteins has been observed in 
vaccinia virus infected cells (Kaerlin & Horak, 1976). Similar 
phosphorylation has been observed in HSV-infected cells (Fenwick 
& Walker, 1979) and in PRV infected C13 cells (Kennedy, personal 
communication), but no connection between phosphorylation and 
alterations in protein synthetic ability has yet been established. 
It was found that early after infection almost all the host 
mRNA's are active in each of these cell lines as shown in the 
autoradiographs in Chapter 5, which indicates that the cellular 
translation machinery probably utilizes all the mRNA's available. 
Late in infection it is lively that translatable host mRNA's 
are scanty and the translation machinery then synthesizes mainly 
viral proteins. In HeLa cells the kinetics of inhibition seemed 
to be most simple and so this cell line was used in most 
subsequent experiments. However, these results indicate that 
selectivity does not reside in the host cell.
Selective effects on the inhibition of host protein synthesis 
can also be studied in cell-free systems, in which case it is 
necessary to isolate the mRNA's present in the cell and to 
translate them in an efficient cell-free translation system.
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In PRV infected cells inhibition of protein synthesis 
occurs early after infection and so most of the studies were 
concentrated on events immediately after infection. Following 
the published results of Ben-Porat e_t a l . , (l97l) and Rakusanova 
et al., (1971), Immediate-early and Late PRV mRNA's were isolated 
from HeLa cells infected for 5 hrs in the presence and in the 
absence of Cycloheximide respectively. Filter disc hybridisation 
studies showed the presence of at least 5% viral transcripts in 
the IE mRNA preparation. Since hybridisation did not reach the 
saturation level, the proportion of the genome represented in 
the transcripts was not estimated. Translation studies vitro 
showed the presence of viral transcripts in the preparation 
(see 3.3). Rakusanova e_t £l. , (1972) have shown that most of 
the polysome bound mRNA's late in infection are viral and 
McGrath (1978) has found that at least 50% of the poly(A) RNA 
isolated from the polysomes of PRV infected cells are viral 
transcripts.
The mRNA activity of a transcript is judged by its ability 
ho stimulate incorporation of radioactive amino acids into TCA 
precipitable material in a cell-free translation system. The 
cell-free translation system mostly used in this project was the 
unfractionated Messenger Dependent Lysate (MDL) system which 
is capable of efficient and reproducible translation of exogenous 
mRNA's (3 .1). Wheat germ extracts which had been used 
previously in this lab (McGrath, 1978) suffer from premature 
termination of polypeptide synthesis. Moreover, Shih et al., 
(1980) have shown that EMC coat protein is not synthesized 
completely under standard conditions in the wheat germ extract
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unless it is supplemented with a reticulocyte ribosomal salt■ 
wash. So proteins synthesized in the MDL system appear to be 
more representative of the mRNA species. Two MDL systems used - 
one prepared in the lab and the other commercially prepared - 
showed good agreement in their ability to translate exogenous 
mRNA's. Analysis of the translation products specified by IE 
mRNA preparation showed the presence of a large number of host 
proteins in addition to a few viral proteins. This is in 
agreement with some studies on HSV-1 (Preston, 1979) but 
co:i bi-'-'-G t to previous studies (Roizman ejt s^. , 1974) which claimed 
that in Cycloheximide treated HSV-1 infected HEp-2 cells IE 
proteins are mainly synthesized when the drug is removed. Our 
results showed that host protein synthesis was not inhibited 
completely in PRV infected HeLa cells when IE proteins were made. 
The hybridisation data also showed the presence of a large number 
of. host mRNA's in the IE mRNA preparation. Thus it appears that 
active host mRNA's are present in abundance in the infected cells 
early after infection. Probably differences in the nature of 
the host and in the nature of the virus result in differences in 
the extent of inhibition described in the literature. But our 
experimental results confirm our observation that no selective 
inhibition of host protein synthesis occurs at least for the 
first few hours of infection.
In HSV-1 infected cells viral mRNA's are said to be 
selectively translated even though host specific mRNA's are 
present on the polysomes at times late in infection (Stringer 
_et , 1977). Certainly, this may be true for other viruses. 
For example, in a cell-free translation system, EMC viral mRNA
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is preferentially translated when both host and viral mRNA^s. 
are present in saturating amounts (Lawrence & Thach, 1974).
Again in a cell-free system prepared from mengovirus infected 
EAT cells viral mRNA is selectively translated (Egberts et al.,
1978). 70^ of the selectivity is due to the initiation factors
and 30^ due to pH 5.0 enzyme fractions. Globin mRNA can 
compete with calf lens mRNA and TYMV mRNA in the MDL system 
(Asselbergs _et aj.. , 1980). Competition of mRNA/s for 
initiation factor and/ribosomes might be part of a cellular 
mechanism to regulate the relative ratio of synthesis of different 
proteins (Lodish, 1974). Conversely, selectivity may be 
promoted by the particular ratio of various initiation factors 
(Revel & Groner, 1978). Since globin mRNA and TYMV mRNA have 
the same nucleotide sequence at the 5 ^ side of AUG (see Asselbergs 
et a 1 ., 1980), it is possible that the binding affinities of 
initiation factors and ribosomes and different mRNA^ s vary due 
to differences in the nucleotide sequence of points other than 
the initiation regions of the mRNA’s.
Studies in the MDL system using equal amounts of host and 
viral mRNA*s showed no preferential translation of viral mRNA. 
Though we do not know the structure of either HeLa or PRV mRNA's, 
at least based on this criterion it could be argued that any 
selectivity of translation does not reside in the mRNA. Again 
it was found that cytoplasmic and polysomal poly(A) mRNA's 
from PRV infected cells did not differ in the pattern of the 
proteins specified in the MDL system. Cumulatively these 
results make it clear that host protein synthesis is not 
inhibited substantially early after infection as translatable
f
host mRNA s are found on the polysomes when IE proteins are
-126-
made. Viral mRNA is not selectively translated in the cell? 
free system when present with host mRNA’s. And since both 
cytoplasmic and polysomal poly(A) mRNA’s gave the same 
translation products it appears that viral mRNA's are not 
preferentially localized on the polysomes.
Another explanation for the selective inhibition of host 
protein synthesis in virus infected cells comes from the model 
proposed by Carrasco (1977). He proposes that a viral 
structural protein binds to the cell membrane and thus, causes 
a change in the permeability of the membrane. Under such 
conditions the intracellular ion distribution changes (high Na*, 
low ) and is favourable for the translation of viral mRNA's 
but inhibits host protein synthesis.
The apparent loss of the permeability barrier in animal 
cells after virus infection has been reviewed by Kohn (1979). 
Binding of a ligand to a macromolecule in the plasma membrane 
causes lateral displacement of the protein-lipid complex 
(Nicolson» 1976) and this is also found in the binding of mengovirus 
capsid protein to membrane receptor (Gschwender & Traub, 1979) . 
Thus adsorption of normal or even heat or u.v. inactivated virus 
to the membrane receptor may result in a distortion of membrane 
permeability with the consequent distortion of ion gradients 
across the membrane. Carrasco (1978) suggests that changes in 
the permeability barrier are a general phenomenon-for virus 
infected cells and this involves disturbance in the distribution 
of not only Na^ ions (Carrasco, 1978) but also Mg** and Ca** ions 
as well (Durham, 1977).
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In support of this model it has been found that Picorna- 
virus, Papovavirus, Rhabdovirus, Togavirus and Myxovirus mRNA,s 
are translated in cell free systems at K* optima higher than 
that of corresponding host mRNA’s (Carrasco & Smith, 1976; 
Carrasco ejb a_l. , 1979) and that the EMC virus infected cell 
membrane becomes leaky to monovalent ions when ’’shut-off” 
occurs (Carrasco, 1977, 1978, 1979). Picorna and Papovavirus 
infected cell membranes become leaky to low molecular weight 
translation inhibitors when viral proteins are being made 
(Contreras & Carrasco, 1979), Again membrane leakiness is 
detectable in VSV infected L-cells and in HSV-1 and Sendai virus 
infected 37RC cells at times late in infection (Bendetto et al., 
1980) .
In the Krebs II ascitq> cell-free translation system an 
elevated K* concentration is required for complete translation of 
EMC viral mRNA (Mathews & Osborn, 1974). However, this 
phenomenon is not universal. In VSV infected cells the 
intracellular K* concentrations do not change early after 
infection but changes are observed late in infection when the 
cells are already showing obvious signs of deterioration 
(Francoeur & Stanners, 1978). Again in mengovirus infected EAT 
cells, an initial K* influx is balanced by Na* efflux, leaving 
the total ion concentration unchanged (Egberts e_t a_l. , 1977) . 
Whether such changes in Na^/K^ ratio early in infection have 
any effect on the regulation of host protein synthesis is not 
yet known. Here also the Na^ concentration increases late in 
infection.
Studies were carried out to investigate K* optima for host
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and viral mRNA translation in the cell-free systems on the • 
assumption that if variation in the ionic concentrations 
in the infected cells is responsible for selective inhibition 
of host protein synthesis, PRY mRNA’s would have a higher K 
optima. In a wheat germ system late PRV mRNA has K* optima 
identical to that of host mRNA (McGrath & Stevely, 1980),
In Carrasco's model, it is the virus structural protein(s) 
whose binding to the membrane causes permeability changes on 
infection and so it was important to examine early events.
IE, Late and HeLa mRNA’s all showed an identical K* optima for 
translation in the MDL system. Since the IE mRNA preparation 
contained 5^ of the viral transcripts, a major change in the 
K* optima curve, if there is any, could not be expected.
However, analysis of the translation products did not show any 
major difference though at least one IE protein and one host 
protein showed weak resistance at elevated K* concentrations.
A similar result was found in the wheat germ extract system.
So the idea of preferential translation of viral mRNA's early 
and late in infection in the presence of high salt concentrations, 
in other words, Carrasco's model, is not applicable to this PRV 
infected cell system, though it could be relevant to the general 
inhibition.
The model was tested vivo also since it is possible that 
the cell-free system is unable to respond faithfully to the 
elevated salt concentration. In the light of Lodish’s 1/fodel 
(1974) the effect of hypertonic initiation block (HIB), observed 
at high salt concentrations, implies that under conditions 
when the overall rate of protein synthesis is decreased the
mRNA's having higher affinities for ribosomes or initiation
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factors e.g. viral mRNA’s would be translated preferentially, 
whereas host mRNA's having lower affinities or rate constants 
would not be translated.
In MCMV infected cells the synthesis of both host and a 
few viral proteins is inhibited at high salt concentrations 
Cchantler i.., 1978). On the other hand, synthesis of HSV-2 
proteins (Fenwick & Walker, 1978) and Late PRV proteins (Stevely 
& McGrath, 1978) are susceptible to high salt concentrations. 
Again in order to study the effects on early events IE protein 
synthesis was studied at elevated NaCl concentrations and it was 
found that IE protein synthesis was inhibited to the same degree 
as the host protein synthesis when the salt concentration of the 
medium was increased. So it seems unlikely that hypertonic 
initiation block has anything to do with preferential inhibition 
of host protein synthesis in PRV infected cells.
The high efficiency of many mRNA’s in the initiation of , 
protein synthesis (Lawrence & Thach, 1974; Nuss £t , 1975;
Jen ejb a_l. , 1978; Ramabhadran & Thach, 1980) implies that 
translation of these mRNA's is limited by the elongation rate.
So any decrease in the elongation rate would preferentially 
inhibit viral mRNA translation and any decrease in the initiation 
rate would inhibit slow initiating host mRNA translation. In 
this project PRV infected cell protein synthesis was studied in 
the presence of an inhibitor of elongation rate. Studies were 
carried out at 5 hrs post infection when viral protein synthesis 
is maximum. PRV protein synthesis was inhibited almost to the
t
same extent as host protein synthesis. It is known that in 
herpesvirus infected cells the elongation Yates of host and
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vlral protein synthesis are comparable (Silverstein & Engelhardt,
1979). So it appears that initiation of PRV protein synthesis 
is little different from that of host protein synthesis which 
indicates that apparently there is not selective initiation of 
viral protein synthesis.
Nishioka & Silverstein (1978b) have suggested that an early 
viral protein, possibly an IE polypeptide, is required for the 
degradation of host mRNA in the infected cells and host mRNA 
is released from the polysomes before being degraded. Such a 
degradation of host mRNA in HSV-1 infected cells is thought by 
them to be responsible for selective inhibition of host protein 
synthesis. An mRNase activity was observed in PRV infected cells 
Cell-free extracts from 6 hrs infected cells caused about 30^ 
degradation of host mRNA and apparently no degradation of late 
viral mRNA. Probably this extent of degradation of host mRNA 
is sufficient to cause the marked inhibition of protein synthesis 
observed in the. intact cells. Selective degradation of mRNA 
by RNase is not unique, . The antiviral state in interferon 
treated infected cells is thought to be the result of an 
induction of an mRNase activity and degradation of viral mRNA 
(see 1.8), The PRV genome has higher G + C content than the 
host (1.3.3) and so the viral mRNA is likely to contain a higher 
proportion of G + C. This difference in the nucleotide 
composition may contribute to selective degradation of host mRNA 
since ribosomal RNA, which also has.a high G + C content is 
apparently not cleaved by this RNase. Further experiments to 
characterize this RNase are necessary to determine its properties 
more fully.
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All these studies suggest that in PRV infected cells 
except for the role of the RNase activities mechanisms for the 
selective inhibition of host protein synthesis has not been found
In examining the general inhibition of protein synthesis 
in infected cells we first examined the phenomenon of polysome 
disaggregation which is known to occur in the infected cells. 
Disaggregation of polysomes within 2-3 hrs of herpesvirus 
infection is considered to be an index of the inhibition of 
protein synthesis (Sydiskis & Roizman, 1966). Virus induced 
polysome disaggregation has a general effect on host protein 
synthesis (6.1). Of the various elements responsible for 
polysome disaggregation a viral structural component(s) is 
considered as an active candidate in the case of many animal 
viruses (see 1,7.5). Raghow & Granoff (1979) have observed that 
inactivated Frog Virus 3 can disaggregate both free and membrane 
bound polysomes in the absence of viral protein synthesis and 
this effect is not due to host mRNA degradation. U.V. inactivated 
HSV-1 can also disaggregate FL cell polysomes (Nishioka & 
Silverstein, 1978b). Fenwick & Walker (1978) have observed 
that in HSV-2 infected cells polysome disaggregation is caused by 
a component(s) of the virus.
To study the particle effect on polysome disaggregation in 
PRV infected cells both normal and inactivated viruses were used. 
Ross ^  , (l972t) have found that a high dose of u.v. irradiation
does not affect adsorption and penetration of cells by herpes­
viruses. Similarly heat inactivated HSV can adsorb to mammalian 
C6 cells (lanez, 1980). Experiments described in this thesis 
showed that both PRV and HSV-1 (MP17) could disaggregate host
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polysomes in the absence of viral protein synthesis. This is 
supported by the observation of increased disaggregation when 
the number of infecting PRV particles was increased in the 
presence of Cycloheximide and thereby in the absence of protein 
synthesis. Moreover the use of both heat and u.v. inactivated 
PRV showed sufficient disaggregation of host polysomes to make 
it clear that polysome disaggregation is due to a structural 
component(s) of the virus.
It is also important to interpret the possible effects of 
Inactivation processes employed on the virus particles themselves, 
The replicating capacity of VSV is destroyed upon irradiation 
whereas it has little effect on the inhibitory potential of the 
virus (Yaoi et. 1970). U.V. irradiation at high doses or
heat inactivation causes an alteration in the polio virus 
structure as RNA becomes sensitive to RNase treatment and empty 
capsids are formed (Katagiri e_t aA. , 1967; Briendl, 1971) but 
the inactive virus can still inhibit host macromolecule synthesis 
(Relentjaris & Ehrenfeld, 1977). U.V. irradiation of mengovirus 
makes the capsid fragile and some virion proteins become 
covalently linked to viral mRNA, but high doses of irradiation 
cause disaggregation of the virus (Miller & Plagemann, 1974).
At high u.v. doses reverse transcriptase activity of Rauscher 
Leukemia Virus is inhibited completely (Lovinger ejt a_l., 1974). 
Heat inactivation of HSV results in the destruction of the 
replicating capability of the virus while exerting minimal 
effects on the gross physical integrity of the virus particles 
as well as their adsorbing capacity (Lancz, 1980). Inactivation 
of PRV by heat and u.v. irradiation might involve any of these
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effects on the virus particles. Though u.v. irradiation is. 
normally found to act on the nucleic acid causing thymidine 
dimer formation or even destruction of part of the genome, it 
might cause binding of certain viral proteins to DNA rendering 
it inexpressable. An effect on regulatory viral proteins can 
not be ruled out. Similarly, heat inactivation might involve 
dénaturation of an active component(s) required for proper 
functioning of the viral genome or binding of viral proteins 
to DNA rendering it inactive. Even some sort of modification 
of the viral DNA which does contain a number of nicks (1.3.3) 
can not be ruled out after heat treatment.
The effects of inactivated virus on host protein synthesis 
have been discussed (1.7.5). Experiments carried out in this 
project showed that both normal and inactivated PRV caused an 
almost equal extent of inhibition of total protein synthesis in 
HeLa and G13 cells at 8 hrs post infection. When infection was 
studied up to 24 hrs, infective virus was found to exert 
cytopathic effects whereas inactivated viruses did not. The 
inhibitory effect of inactivated virus was almost the same at 8 hrs 
and 24 hrs post infection. Since no new viral structural 
proteins are likely to be made in cells infected with inactivated 
virus it is not surprising that no further increase in the 
inhibition was observed. inactivated viruses caused only 25% 
inhibition of RNA synthesis whereas infective viruses caused 
more than 80^ inhibition. The significance of this inhibition 
is not clear. It is not known whether this 2 5^ inhibition of 
RNA synthesis is sufficient to cause the greater inhibition of 
protein synthesis (70% approx.) which is observed. Furlong
(personal communication) has found that u.v. inactivated PRV
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caused about 20% Inhibition of rRNA synthesis whereas heat 
inactivated PRV had little effect. The significance of these 
data with respect to RNA and protein synthesis in PRV infected 
cells is not clear. However, the marked inhibition of protein 
synthesis and little effect on RNA synthesis Indicate that 
inactivated viruses appear to exert selective effect on the 
translation process directly. Some heat and u.v. resistant 
component(s) of the virus must play this role.
The inhibitory effects of the virion component(s) can be 
understood more clearly if studied in cell-free systems. The 
effects of various viruses and their components on protein 
synthesis have been discussed (9.1). These studies reveal 
either the involvement of the virus particles themselves in 
exerting inhibition or indicate the effects of infection on some 
property of a component essential for protein synthesis. A 
viral protein solubilized from Frog Virus 3 suppresses protein 
synthesis in cell free systems (Aubertin jet ^ ., 1978) and a 
similar inhibitory effect of poliovirus core is observed in 
reticulocyte lysates (Racervskis ^  , 1976).
In the MDL system addition of both normal and heat inactivate 
PRV caused substantial inhibition of protein synthesis. Since 
in this system virus macromolecule synthesis is not possible, 
it indicates that virus structural component(s) are responsible 
for the inhibition. This is substantiated by the finding that 
the inhibition increased with the addition of increasing 
number of particles. Analysis of the translation products 
showed that inhibition did not appear to be due to mRNA 
degradation.
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In the MDL system substantial inhibition was observed 
when the viral protein was about 1.8% of the protein content 
of the system, whereas in HeLa cells infected with PRV at 
50 p.f.u./cell a similar inhibition was observed when viral 
protein was about 0.2% of the total cell protein. The 
relatively, high quantity of viral proteins needed to cause 
inhibition in the MDL system does not necessarily reflect the 
in vivo situation where compartmentalization and membrane 
effects might drastically alter the mechanism of action and 
the magnitude of the effects. Since inhibition has normally 
been found to occur at the level of initiation, the large 
number of nuclear proteins in HeLa cells might not be involved 
and so the calculation should be modified on the basis of 
cytoplasmic protein content. In the MDL system during the 
inhibition studies total protein content of the virus was 
considered, but during infection of HeLa cells the envelope 
of the virus is left on the membrane, not taken into the cells. 
So the relative variation in the percent of viral proteins 
during inhibition in the MDL system and in theHeLa cells may 
not be absolute. However, these experiments again support the 
idea of involvement of viral structural component(s) in 
inhibition.
A further possibility for virus induced inhibition of 
protein synthesis which was studied- is the degradation of mRNA. 
About 30% degradation of host mRNA was observed when HeLa mRNA 
was incubated with postribosomal supernatant from the cells 
infected for 6 hrs. This could be a contributing factor in 
addition to the particle effects observed. . However, neither
-136-
normal nor heat Inactivated PRV showed any RNase activities• 
associated with them. So it seems clear that the particle 
effect on the inhibition is not due to mRNA degradation but 
is a separate feature of infection.
Final conclusions on the mechanism of inhibition or 
protein synthesis in herpesvirus infected cells include a few 
suggestions and rule out a few possibilities which are 
applicable in other virus infected cell systems. Inhibition 
of IE protein synthesis at high Na - concentrations and 
susceptibility of Immediately early mRNA translation at elevated
■f*
k concentrations in the cell free systems rule out a simple 
application of Carrasco's model to explain inhibition in PRV 
infected HeLa cells. Viral mRNA does not show any high 
efficiency of initiation of protein synthesis when elongation 
rate is Inhibited. Neither does selective translation of viral 
mRNA's occurs when both host and viral mRNA's are present in 
equal amounts in the cell-free system. Except for selective 
degradation of host mRNA by an RNase induced in cells at 6 hr 
post infection no other selectivity was observed which could 
lead to the preferential translation of viral mRNA's after 
infection.
Though Carrasco's model is not applicable in terms of 
selectivity it could contribute towards an understanding of 
inhibition in general. Both in the intact cell and in the 
cell free systems synthesis of both host and viral proteins 
was inhibited and no selective translation of viral mRNA 
was observed. If we consider the hypothesis put forward by 
Lodish (1974) that when overall protein synthesis is decreased
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an mRNA having a high efficiency of initiation will he 
translated, we found no such mRNA's. But our translation 
studies showed the translation of all available mRNA's 
present in the preparation. This is in agreement with Preston 
(personal communication) who claims that in HSV-1 infected 
cells the spectrum of proteins synthesized is a true reflection 
of the mRNA's available in the cells at that time. Nonetheless, 
it is possible that changes in the ionic strength may contribute 
to the overall inhibition which occurs.
Particle effects on protein synthesis have been observed 
both in intact cells and in cell free systems. It is known 
that the average size of the polysome is proportional to the 
rate of initiation and inversely proportional to the rate of 
elongation (Lodish, 1976). Since in HSV infected cells the 
elongation rates of host and viral protein synthesis are 
comparable (Silverstein & Engelhardt, 1979), the particle 
effects on polyribosome disaggregation may occur at the level of 
initiation and do not appear to be due to mRNA degradation.
Induction of an RNase activity indicates that of the possible 
causes of inhibition host mRNA degradation must be taken 
seriously.
The project gives some understanding of the mechanism of 
inhibition of protein synthesis in PRV infected cells. Any 
further work should include.
(a) a study of the effect of virus particles on the polysomes 
in a cell-free system, e.g. the MDL System,
(b) studies on the specificity of the mRNase.
MATERIALS AND METHODS'
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Materîals
Appendices A :
A.I. Biological Materials
A.1.1. HeLa cells : A human cell line derived from cervical
carcinoma (Gey ejt a_l. , 1952)
A,1.2. 013 cells (BHK-21) : A kidney cell line derived from
1-day-old baby hamster. The 013 clone was first 
Isolated by Stoker & Macpherson (1962).
A.1.3. BS-0-1 cells : A continuous cell line derived from
primary cultures, by Hopp s _et aJL. , (1963) from African 
Green Monkey Kidney.
A.1.4. Pseudorabies Virus (PRV) : PRV (Pig Herpes virus 1)
was originally derived from a stock preparation 
(Kaplan & Vatter, 1959) and has subsequently been 
plaque purified several times. Virus stocks were 
prepared from infected monolayers of 013 cells.
A.1.5. HSV-1, MP17 : This strain of Herpes Simplex virus,
type 1 was isolated following infection of Friend
erythroleukemia cells with HSV-lmp (Hoggan & Roizman, 
1959). Our stocks were obtained from Dr. J. Morrison 
of the Biochemistry Department, Glasgow University.
A.1.6. HSV-1,KGS : Stocks of this strain were obtained from
Prof. Y. Becker of Hebrew University, Jerusalem.
A.2. Ohemicals
A.2.1. Materials for mRNA isolation :
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Cycloheximide
Heparin (159 u/mg) 
freeze dried.
Oligo- [dT] -cellulose
Sigma Chemical Co.,
Evans Medical Ltd., Speke, 
Liverpool.
Collaborative Research, 
Waltham, Mass.
A.2,2. Materials for DNA preparation ;
pronase : Calbiochem. La Jolla, Ca.
CsOl ;
A.2.3. Materials for in vitro translation system.
Adenosine 5'-triphosphate 
(ATP)
L-Amino acids
Creatine Kinase
Creatine phosphate
Dithiothreitol (DTT)
N'-2-ethanesulfonic acid 
(HEPES)
Ethylene glycol-bis 
(2-amino ethylether)- 
NN '-tetraacetic acid 
(EGTA)
Glutathione, reduced from 
Guanosine 5’-triphosphate 
(GTP)
Haemin, Bovine
Micrococcal nuclease 
(800 u/mg)
Phenylhydrazine hydro­
chloride
Spermidine trihydroch­
loride
P-L Biochemicals Inc., 
Milwaukee, Wis.
Calbiochem Ltd., La Jolla, Ca
Boehringer Mannheim, GnbH, 
Mannheim, West Germany.
Sigma Chemical Co.,
P-L Biochemicals Inc 
Milwaukee, Wis.
Sigma Chemical Co.,
Boehringer Mannheim, 
West Germany.
Sigma Chemical Co.,
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Spermine tetrahydro- 
chloride
Sephadex G 25 (coarse)
Sodium phenobarbitone 
(Nembutal)
Rabbit Reticulocyte 
lysate
Wheat germ extract
: Sigma Chemical Co.,
: Pharmacia Ltd., Uppsala,
Sweden.
: May & Baker Ltd., Dagenham.
: New England Nuclear, Mass.
Amersham, Bucks.
: Bathesda Research Laboratories
A.2.4
N.Y.
Chemicals for Liquid Scintillation Spectrophotometry
2.5-diphenyloxaz ole 
(PPO)
Toluene, Analar
p-bis-(0-methylstyryl) 
benzene (bis MSB)
Triton X-100
Koch-Light Laboratories, 
Colnbrook, Bucks.
n n I
Eastman Biochemicals Kodak Co.
A.2.5
: Rohn & Haas (U.K.) Ltd.,
Croydon.
Materials for polyacrylamide gel electrophoresis
Acrylamide (specifically : B.D.H. Ltd. 
purified for electrophoresis)
NN'-Methylene-bis- : B.D.H. Ltd.
acrylamide (specifically 
purified for electrophoresis)
Ammonium persulfate : B.D.H. Ltd.
NNN’N '-tetramethylene- ; Koch-Light Laboratories Ltd. 
diamine (TEMED)
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Kodak Ltd., London.
A.2.6. Photographic materials
Kodak X-omat HI X-ray films 
Kodak DX-80 developer : " ” "
Kodak FX-40 Liquid fixer : " " "
A.2,7. Radiochemicals
These were obtained from the Radiochemical Centre, 
Amersham, Bucks.
L- [ 4 . ]  leucine 50 - 60 Ci/mmol.
[5,6-^H] uridine 40 - 60 Ci/mmol.
L- Methionine 8OO Ci/mmol.
op
P-orthophosphate (carrier free)
A.2.8. Other Materials
Actinomycin D
Absolute Alcohol, Analar
Dextran 10
Glacial Acetic acid 
Dimethyl sulfoxide
P-mercaptoethanol
3-Methy1-1-butanol 
(IsoamylaIcohol)
Molecular weight standards
(BSA, Trypsin inhibitor, 
RNA polymerase)
Trichloroacetic acid
Whatman No. 1 filter paper 
discs (2,5 cm diameter)
Sigma Chemical Co.,
James Burroughs Ltd., 
London.
Pharmacia Fine Chemicals, 
Uppsala, Sweden.
Sigma Chemical Co.,
Koch-Light Laboratories 
Limited.
Boehringer Mannheim
Koch-Light Laboratories 
Limited.
Whatman Ltd., Maidstone, 
Kent.
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Newborn calf serum, 
foetal calf serum.
Gibco Biocult.
Phenyl hydrazine hydrochloride : Sigma Chemical Co.
Tryptose phosphate broth : Gibco Biocult,
Difco-bacto.
Other materials were purchased from BDH or Sigma 
and were of Analar Grade or its equivalent.
A.3. Standard Solutions
A.3.1. Cell culture media
I . IT
This is the Glasgow modification of Eagle's Minimum 
Essential Medium (MEM), which is supplied by Flow 
Laboratories as a lOX concentrate (Busby et al., 1964)
Components mg/litre Components mg/litre
D-glucose 4500 L-leucine 52.46
Magnesium sulfate VH^O 2 00 L-lysine hydrochloride 73.06
Potassium chloride 400 L-methionine 14.92
Sodium chloride 6400 L-phenylalanine 33.02
Sodium dihydrogen L-threonine 47.64
phosphate, 140 L-Tryptophan 8.16
Calcium chloride, ZHgO 264.9 L-Tyrosine 36.22
L-Arginine hydrochloride 126.4 L-valine 46 .86
L-Cystine, disodium 28.42 »
L-glutamine 584.6 D-Ca-pemtothenate 2.00
L-Histidine hydrochloride Choline chloride 2.00
H^O 21.0 Folic acid 2.00
L-lsoleuc ine 52.46
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Components mg/litre
I-Inositol 4.00
Nicotinamide 2.00
Pyridoxal hydrochloride 2.00
Riboflavin 0.2
Thiamin hydrochloride 2.0
Phenol Red, sodium 17.0
11. Earl|e's Balanced Salt Solution, BSS.
NaCl 0.13M Phenol Red 0.015% (w/v)
KCl 0.006M chloroform to a final conc. of
MgSO, O.OOIM 0.1% (v/v)
4
I.
CaCl^ 0.002M
NaH .PO O.OOIM sterilized by 15 H>/in^ for 20 min.
«L 4
111. Eagle’s Stock, lOX concentrated (ESlO-Met)
MEM amino acids (-Met) XlOO 20ml
MEM vitamins XlOO 20ml
glucose 4 g
glutamine 0.6375 g
pH to 7.1 with 5M NaOH, Final volume 220ml. Sterile filtration 
through 0.22 micron millipore membrane.
IV. Sodium bicarbonate
5.6% (w/v) NaHCO^, 0.0015% (w/v) phenol red. Sterilized by 
millipore filtration using 0.22 micron membrane.
V. Penicillin and Streptomycin
Penicillin 10 units/litre
Streptomycin 10 g/litre
Sterilized by millipore filtration through 0.22 micron membrane.
VI. Tryptose phosphate Broth
Tryptose phosphate broth (Difco bacto.) 29.5 g/litre
Sterilized by 15 Ib/in^ for 15 min.
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VII. EC, Medium for HeLa Cells
Dist. H^O 450 ml
IF 50 ml
NaHCO^ 20 ml
Penicillin/streptomycin 5 ml
Newborn calf serum 50 ml
VIII. ETC, Medium for BHK-21 (C13) cells
Dist. H^O 400 ml
IF 50 ml
Tryptose phosphate broth 50 ml
Calf serum 50 ml
NaHCO^ " 20 ml
Penicillin/streptomycin 5 ml
IX. EFC, Medium for B;
Dist. HgO 450 ml
IF 50 ml
Foetal calf serum 50 ml
NaHCCy 20 ml
Penicillin/streptomycin 5 ml
X . EC —Me t , Methioni:
BSS 450 ml
ESIO (-Met) 50 ml
Calf serum 50 ml
NaHCO^ 20 ml
Penicillin/streptomycin 5 ml
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XI, Trypsin/Versene 
Trypsin
0.2 5% (w/v)Trypsin
Tris odium 
citrate
0.29% (w/v)
Sodium chloride 0.61% (w/v) 
Phenol red 0.15% (w/v)
pH 7.8 with NaOH 
Sterilize by membrane filtration 
through 0.22 micron membrane.
Versene
Sodium chloride
Potassiamchloride
Sodium dihydrogen 
phosphate
0.8% (w/v] 
0.02%(w/v]
0.115%(w/i
Potassin dihydrogen
phosphate 0.02%(w/v]
Versene (Ethylene 
diamine tetra­
acetate disodium 
salt) 0.02%(w/v] 
Phenol red 0.15%(w/v]
Sterilized by 15 Ib/in^ for 
15 min.
1 volume Trypsin + 4 volumes Versene.
XII. BSS + Bicarbonate
BSS 450 ml
NaHCO^ 20 ml
XIII. Fdrmol Saline
NaCl 0.077M
O.IM
Formaldehyde 3.6% (v/v)
Na^SO^
XIV. Giemsa Stain
0.75% (w/v) Giemsa in Glycerol: Methanol
1:1 (v/v)
-14-6 -
NaCl
KCl
NaH^PO^
XV. Phosphate buffered saline, PBS.
0.17M 
3 .
lO.OmM
KHgPO^
CaCln
MgCl,
1. 8mM 
0.7mM 
0. 5mM
pH 7.2
A.3.2. Solutions for mRNA Preparation
I. Reticulocyte Standard Buffer, RSB.
NaCl O.OIM
MgClg 0.003M pH 7.4 with HCl
Tris-HCl O.OIM
(a) 15% (w/v) Sucrose in RSB
(b) 30% (w/v) Sucrose in RSB
II. Extraction buffer.
NaCl O.IM ; EDTA O.OOIM ; 8DS 2.0% (w/v)
Tris-HCl O.IM. pH 9.0
. Ill. Phenol 
Redistilled phenol saturated with extraction buffer
IV. Buffers for oligo [dT] cellulose chromatography 
(a) Loading buffer : LiCl 0.5M
EDTA O.OOIM
SDS 0.1% (w/v) pH 7.5
Tris-HCl O.OIM
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(b) Intermediate buffer : LiCl
EDTA
SDS
O.IM
O.OOIM
0,1% (w/v) pH 7.5
Tris-HCl O.OIM
(c) Elution buffer EDTA O.OOIM
Tris-HCl O.OIM pH 7.5
A.3.3. Hybridisation Solutions
I . Standard saline citrate, SSC 
NaCl 0.15M, Na^-citrate 0.015M.
II. Hybridisation buffer :
NaCl 0.75M; EDTA 0.005M; SDS 0.25% (w/v) ; Tris-HCl O.OIM 
pH 7.5.
A,3.4. Solutions for Reticulocyte Lysate Translation System.
I. Glutathione 
0.5M Glutathione in H^O, pH 6.0 with IM NaOH.
II. Phenylhydrazine 
2.5% (w/v) phenylhydrazine hydrochloride in H^O containing 0.5% 
(v/v) 0.5M Glutathione, pH 7.0 with NaOH. Stored in 10ml
aliquots in light free tube at -20°C.
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III. Haemin
Haemin lOmM; Tris-HCl 0.2M pH 8.2 
KCl 0.5M;
The prep was in 95% (v/v) ethylene glycol,
IV. Creatine Kinase 
5mg/ml in 50% (v/v) glycerol.
V, K*/Mg** solution
MgClg O.OIM, KCl 2.0M, Autoclaved.
+ +
K concentration made 0.8M when the prep was used in K
dependence studies.
VI. Creatine phosphate 
Creatine phosphate 0.2M in sterile water
VII. Amino acids
Approximately 1.4mM solution was made in sterile deionized 
water with mild heating to dissolve and sterile filtration 
through 0.45 micron membrane.
glycine, alanine, arginine,aspertate, histidine, isoleucine, 
lysine, phenylalanine, proline, serine, threonine, tryptophan, 
tyrosine, valine, cysteine, glutamine, glutamate, aspargine, 
methionine or leucine.
VIII. Master mix
K /Mg solution : Creatine phosphate : Amino acids
1 : 1 : 1  (v/v/v)
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IX. CaCl^
O.IM CaCl^. Autoclaved,
X. Micrococcal nuclease 
Img/ml in sterile deionized water, stored at -20°C.
X I . EGTA
0. IM EGTA, pH 7.4 with KOH, stored at 4°C.
XII. Assay mixture 
Messenger dependent lysate, MDL 50 jul 
H^O/mRNA and isotope 7.5 {j.1
A,3.5. Solutions for Wheat Germ Extract Preparation and 
Translation Studies.
I. Extraction buffer.
Hepes 20mM; KOI lOOmM; MgCoAc)^ ImM; CaCl^ 2mM;
Mercaptoethanol 6mM. Solutions were made in deionized water, 
pH 7.6 with KOH and autoclaved before addition of Mercaptoethanol
II. Column buffer 
Hepes 20mM; KOI 120mM, MgCoAc)^ 5mM. Mercaptoethanol 6mM, 
as in extraction buffer.
Ill. Energy mix 
ATP ImM; GTP 0.02mM; Creatine phosphate 5.5mM; pH 7.6 with 
KOH ; solution in sterile deionized water. Stored at -70°C.
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IV. DTT
0.12M DTT In sterile deionized water, gas bubbled through
for 10 min. Stored at -70°C.
V. Creatine Kinase 
Img/ml in 50^ (v/v) sterile glycerol.
V I . Salt Solutions
IM Hepes, pH 7.6. Autoclaved.
+
0.9M KCl and some other concentrations when K dependence 
studied.
0.05M Mg (oAc)^
VII. Spermidine • 
lOmM Spermidine trihydrochloride, pH 7.6 with IM KOH in sterile 
deionized water. Stored at -20°C.
VIII. ATP mix, (prepared fresh for eaçh set of
assays)
Energy mix 25 fj.1
Hepes 10 jlîI
KCl 10 (jil
Mg( oAc)^ 10 /il
DTT 10 #1
Spermidine 10 ^ 1
Creatine Kinase 5 jul
Sterile deionized water 20 ul
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IX. Assay mixture
ATP mix 10 fxl
Wheat germ extract 15 jul 
H^O/mRNA and isotope 2 5 jul
A. 3.6.. Solutions for Gel Electrophoresis.
I . Electrode buffer
glycine 0.192M, SDS 0.1^ (w/v), Tris-HCl 0.025M, pH 8.5
II. Main gel solution
SDS 0.1% (w/v); TEMED 0.1% (v/v); Ammonium persulfate 0.14% (w/v); 
Tris-HCl 0.375M, pH 8.8, with acrylamide and bis-acrylamide in 
the ratio of 1: 0.033.
III. Stacking gel solution
SDS 0.1% (w/v), TEMED 0.1% (v/v); ammonium persulfate 0.09% (w/v); 
agarose 1.0% (w/v), Tris-HCl 0.125M, pH 7.0 with acrylamide 
3% (w/v) and bis-acrylamide 0.1% (w/v).
IV. Staining solution
Coomassie brilliant blue 0.25% in 45% (v/v) Methanol and 5% (v/v) 
glacial acetic acid.
V. Destaining solution 
45% (v/v) methanol, 5% (v/v) glacial acetic acid.
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A.3.7. Solutions for PRV purification
I . Phosphate buffer 
ImM KH^PO^
ImM K„HPO, pH 7.4 Autoclaved.
iL 4
II. Tris-HCl solution 
Tris-HCl O.OIM, pH 7.4 Autoclaved
III. Dextran 10 
12% (w/v) and 32% (w/v) in ImM phosphate buffer, pH 7.4. 
Mild heat treatment for dissolving and then sterilized by- 
filtration through 0.45 micron membrane filter.
A.3.8. Scintillation solutions
I. Toluene- P.P.O.
5% (w/v) P.P.O. in Toluene.
II. Triton-Toluene-P.P.O.
5% P.P.O., 0.05% (w/v) bis-MSB, 35% Triton X-100 in Toluene
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Methods
Appendices B :
B.l. Cell culture technique.
B.1.1. Propagation of cells.
HeLa, C13 and BS-C-1 cells were cultured as monolayers in 
80 oz Winchester bottles (burlers) according to the procedure of 
House and Wildy (1965). Cells were normally seeded in sterile 
hurler containing l80ml media with 16-22 x 10^ cells per burler 
in an atmosphere of 95% air and 5% CO^. Cells grew to a 
confluent monolayer in 72 hrs incubation at 37°C.
/
For serial passage cells were dislodged from the burler 
surface by, Trypsin-Versene (A.3.1.XI) treatment, suspended in 
a small volume of the medium, counted and then seeded as before.
Maintenance of cell culture, contamination check of the 
medium and cells for bacterial, fungal and PPLO were carried out 
by the staff of the Wellcome Cell Culture Unit.
B.l.2. Propagation of virus.
Pseudorabiesvirus (PRV) stocks were prepared from infected 
CI3 cell culture according to the procedure of Chantier & Stevely 
(1973).
Monolayers of C13 cells were infected at a multiplicity of 
5 p.f.u./cell in 25 ml medium. After 1 h adsorption, the medium 
was poured off and fresh medium was added. At 36 hrs post­
infection, cells were shaken off from the burler surface and 
transferred aseptically to centrifuge bottles. Cells were 
pelleted by centrifugation at 6OO g for 10 min at 4°C. The 
supernatant was recentrifuged at 15,000 g for 2 hrs at 4°C.
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The pelleted virus was suspended in a small volume of EClO 
(A.3.1.VII), dispersed and aliquoted at -70^0.
Cell associated virus prepared by resuspending the cell 
pellets and sonicating the suspension, normally gave a low 
titre and was rarely used for infection studies, but mainly 
used for production of virus stocks.
The infectivity of the virus preparation was determined 
by plaque assay. .
B.l.3. Plaque assay for PRV.
Confluent monolayers C13 cells grown in 50mm petridish, 
seeded at 8 x 10  ^ cells/petridish, were infected with serial 
dilutions of the PRV preparations in 0.2ml medium. After 1 hr
adsorption, the medium was poured off, 2ml medium added and
incubation continued. After another 1.5 hrs incubation,
250jug heparin was added to the contents in each dish to restrict 
the vertical transmission of the virus. At 30 hrs post­
infection, cells were fixed by removing the medium and adding 
enough formol saline (A.3.1.XIII) to cover the cell sheet.
After 30 min at room temperature, the formol saline was poured
off and cells were stained with Giemsa Stain (A.3.1.XIV) for 
30 min. Excess stain was removed very gently with water and 
plaques were counted under a low power microscope.
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B.1.4. Purification of PRV.
Purified PRV was made by following the procedure of Spear 
& Roizman (1972).
Confluent monolayers of C13 cells were infected at a multi­
plicity of approximately 20 p.f.u./cell and harvested as before 
after 18 hrs infection. Cell pellets were swollen in 2 volumes 
of ImM phosphate buffer (pH 7.4) (A.3 .7.1) for 10 min on ice and 
then disrupted with six strokes of Bounce homogenizer.
Immediately afterwards, a concentrated sucrose solution was 
added to give a final concentration of 0.25M. Cytoplasmic extracts 
were separated by centrifugation at 1500 r.p.m. for 10 min in the 
MSE Major Centrifuge. 2ml of the extract was layered on ^ 4ml 
dextran 10 gradients (12-32% w/v) (A.3.7.Ill) made up in ImM 
phosphate buffer, pH 7.4 and filtered through a 0.45 micron 
membrane filter prior to use. Centrifugation was at 20,000 r.p.m. 
for 1 hr in the SW27 Beckman Ultracentrifuge rotor. Virions 
were found in a diffuse light scattering band just above the 
middle of the gradient. The band was aspirated with a needle and 
a syringe, diluted four fold with O.OIM Tris-HCl (pH 7.4) and 
virions were pelleted by centrifugation at 25,000 r.p.m. for 2 hrs 
in SW 27 rotor. The virus pellets were suspended"in a small 
volume of O.OIM Tris-HCl (pH 7.4) (A.3.7.II) and dialyzed over­
night against 500 volumes of O.OIM Tris-HCl (pH 7.4) at 4°C.
The preparation was aliquoted and stored at 70^C.
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B.1.5. Inactivation of PRV.
B.l.5.1. U.V. Light Irradiation
A PRV stock was diluted 10 fold with PBS (A.3.1.XIV) 
containing 1% (w/v) glucose. 2 .5ml of this dilute preparation was 
put in each 50mm petridish and put under a 15 w germicidal lamp 
(calibrated by Dr. J. Pitts, Biochemistry Dept., University of 
Glasgow). The preparation was irradiated at appropriate energy 
level. Plaque assay was carried out to determine the extent 
of inactivation.
B.l.5.2. Heat
A dilute PRV preparation was heated at 60°C for 60 min and 
the infectivity was checked by plaque assay.
B.l.6 . Isolation of PRV-DNA.
PRV DNA was isolated according to the procedure of Stevely 
(1977).
Viral pellets, obtained as in (B.l.2.), were suspended in a
small volume of 1 x SSC. Pronase (50#l/ml) was added to the
suspension, to which a few drops SDS (5% w/v) were also added
until the suspension became clear. It was then incubated
* o
undisturbed in a water bath at 37 C for 30 hours. CsCl solution 
as well as powdered CsCl was added to give a density of 1.4002g/cm. 
Mild centrifugation removed the SDS precipitate. The preparation 
was then centrifuged at 30,000 r.p.m. for 72 hrs at 17°C in the 
50 Ti Beckman rotor. 0.5ml fractions were collected by needle 
and syringe and their refractive indices were measured.
Fractions containing PRV DNA were pooled and dialyzed overnight 
against 500 volumes of distilled water at 4°C. The DNA concen-
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tyatlon was determined by spectrophotometry and samples were 
aliquoted and stored at -20^C.
B.2. Preparation of polysomes
B.2.1. Infection
The procedure for isolating Immediate-early (IE) mRNA 
was basically that of Rakusanova £t a_l. (1971).
HeLa cells seeded at 20 x 10^ per burler formed confluent 
monolayers on the third day at about 80-100 x 10^ cells per 
burler. Cells were infected in the presence of cycloheximide 
(50^l/ml) in 25ml medium at a multiplicity of 50 p.f.u./cell. 
After 1 hr adsorption, the excess was decanted and fresh medium 
containing cycloheximide was added. At five hours post-infection 
cells were washed six times with normal medium to remove cyclo­
heximide and then incubated in normal medium for 15 min. The 
cells were then harvested for IE mRNA preparation.
When late PRV mRNA's were to be prepared, cells were
infected in normal medium and harvested after five hours. For
3labelling the mRNA's with H- uridine, radioactive isotope 
was added at appropriate times after infection and before 
harvesting. Normally more than twelve burlers were used for
preparing each batch of poly(A) containing mRNA.
For labelled mRNA prépara tion infected cells are treated for I hr* 
with 5H”Uridine at 4 hrso post infection and mock infected cells 
are labelled for I hr.
B.2.2. Preparation of polysomes
After mock infection or infection, medium was poured off 
and 10 ml BSS-bicarbonate mixture (A.3.1.XII) was added. Cells 
were harvested from the burler surface with a rubber scraper
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while rotating the hurler on ice. Cells were then pelleted 
by centrifugation at 1500 r.p.m, for 10 min at 4^G. After 
swelling the cells in small volumes of RSB (A.3.2.1) (at
g
about 2 X 10 cells per ml), they were disrupted by 4-6 
strokes - in a Teflon glass homogeniser, at low speed.
Nuclei and cell debris were removed by centrifugation at 
2,500 r.p.m. for 10 min at 4°C. 2ml of this cytoplasmic 
extract was layered onto 34 n^l 15-30% (w/v) sucrose gradients 
in RSB containing Img/ml heparin. Gradients were centrifuged 
at 27,000 r.p.m. for 110 min at 4°C in the Beckman SW27 rotor 
and then harvested by pumping through a Gilford 2000 recording 
spectrophotometer set at 260nm. From the gradients polysomal 
fractions were separated and pelleted by centrifugation at 
20,000 r.p.m. for 16 hours.
In order to study the effects of infecting virus particles 
on host polysome disaggregation, cells were infected or mock- 
infected in the presence of cycloheximide (50#g/ml). At 
2 hrs post-infection cells were harvested and polysome profiles 
were recorded as before. The percentage of polysomes was 
determined by cutting and weighing appropriate portions of 
the recorder tracing.
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B.3. Extraction of polysomal RNA.
RNA extraction was carried out according to the procedure of 
Mendecki e_t aJL. , (1972). Polysomal pellets were rinsed with 
sterile 2M sucrose and then suspended in extraction buffer 
(A.3.2.II) at a concentration of 10 units per ml. The
suspension was diluted with an equal volume of phenol:chloroform: 
isoamylalcohol (50:50:1, v/v/v), mixed vigorously for 10 min and 
centrifuged for 10 min at 2,000 r.p.m. at 10°C. The aqueous 
layer was removed and the organic layer reextracted with an 
equal volume of extraction buffer. The two aqueous phases were 
pooled together, then extracted with phenol,chloroform solution. 
From the final aqueous phase, RNA was precipitated by the addition 
of 2 volumes of ethanol. Precipitates were allowed to form 
overnight at -20°C.
B.4. Isolation of poly(A) containing RNA.
A modification of the technique followed by Aviv & Leder 
(1972) was used.
Approximately O.lg oligo-[dT] -cellulose powder was used 
for isolating RNA from 120 -A-26onm The oligo-[d^-cellulose
was suspended in a small volume of loading buffer (A.3.2.IVa) 
for 5 min to make a paste and poured into a mini-column made 
from a pasteur pipette plugged with glass wool and baked at 
250^0 for 4 hours. Polysomal RNA, pelleted by centrifugation 
at 11,000 r.p.m. for 10 min at 4°G, was dissolved in loading 
buffer and cycled thrice through the column at a rate of 0.5ml 
per min. The column was washed with the intermediate buffer
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(A.3.2.IVb) until the washings had A260nm less than 0.01.
Bound RNA was then eluted with 1.5ml of elution buffer (A.3.2.IVc%
made 0.4-M with 4M NaCl and the RNA was precipitated with 2 volumes
of ethanol, by standing overnight at -20°C. The RNA, pelleted
o
by centrifugation at 11,000 r.p.m, for 10 min at 4 0, was 
dissolved in 0.4M NaCl and reprecipitated with 2 volumes of 
ethanol at -20°C. Finally the RNA was dissolved in a small 
volume of sterile deionized water and stored at -20^0.
B.5. Filter disc hybridisation.
Filter disc hybridisation consisted of dénaturation of DNA, 
fixation to millipore filters, hybridisation with labelled RNA 
and determination of the amount of labelled mRNA bound to the 
DNA.
DNA purified by overnight dialysis was made 0.1 x SSC 
(A.3.3.1) and sheared by passing 12 times through a 2 5g needle.
It was then denatured by addition of anequal volume of IM NaOH, 
which was neutralized 20 min later with 3 volumes of a solution 
containing 3M NaCl, IM Tris-HCl (pH 8.0), IM HCl in the ratio 
of 2:1:1, v/v/v. DNA was immobilized on 13mm HAWp millipore 
filters, presoaked for 2 hrs in 2 x SSC, by slow filtration 
(Gillespie & Spiegelman 1965).' Filters were washed with 2 x SSC,
dried 1 hr in air, 2 hrs at 80°G and then stored at -20°C.
When required, filters were soaked for 2 hrs in 2 x SSC
prior to use in hybridisation studies. Labelled mRNA in 0.1 x SSC
was denatured by heating at 115°C for 5 min. Aliquots of RNA 
was then added to the filter discs placed at the bottom of the
baked glass scintillation vials with the DNA side up and
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approxlmately 400/^1 hybridisation buffer (A.3.3.II) was added 
to allow the discs to float freely. Hybridisation was at 66°G 
for 20 hrs. The filters were washed thrice in 500 ml 2 x SSC for 
30 min each time at room temperature. These were then incubated 
in 5ml 2 x SSC at room temperature with pancreatic RNAse, 50jug/ml 
(Jacquemont & Roizman 1975), Filter discs were washed twice 
with 2 X SSC and dried under a heat lamp. Radioactivity bound 
to the discs was determined by liquid scintillation counting in 
Toluene-PRO.
B.6. Translation, i/a vitro, in a wheat germ extract.
This employed a modification of the techniques followed by 
Roberts & Paterson (1973) and Marcu & Dudock (1974).
B.6.1. Preparation of Wheat germ extract
2g wheat germ and 2 g acid washed (2M HCl) baked sand were 
ground in a baked mortar and pestle (precooled to 4°C) for 2 min. 
4ml extraction buffer (A,3.5.1) was added and the paste was 
centrifuged at 16,000 r.p.m, for 12 min at 4°C in Sorvall SS34 
rotor. The supernatant was carefully removed avoiding the fat 
layer and 1.5ml was applied to a 1,7 x 21 cm Sephadex (coarse)
column preequilibrated with column buffer (A.3.5,II). The 
eluant, Iml/min, was collected in sterile tubes and its O.D. 
at 260nm was measured. Fractions having greater than
90/ml were pooled and centrifuged at 16,000 r.p.m. for 12 min 
at 4°C in Sorvall SS34 rotor. The supernatant was aliquoted and 
stored at -70°C. The whole operation was done at 4°C,
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Sephadex suspended in deionized water was autoclaved 
before use, All column tubings were filled with HgOg 
20 min and then rinsed with sterile deionized water before 
packing.
B.6.2. Translation assay.
Assays were started by adding wheat germ extracts to ATP 
mix (A.3.5.VIII) mRNA, isotopes and other ingredients, if any.
The assay mixture (A.3.4.IX) was incubated at 25°C for 60 min. 
Reaction was stopped by quick transfer of the assay tube onto 
ice. The incorporation of labelled amino acid into TCA pre- 
cipitable material was determined by filter disc method 
(Bollum 1968).
A commercially available wheat germ extract (A.2.3.) used
for dependence studies contained 26mM Hepes, 66mM K"** (34mM
+ +
endogenous and 30mM from added reagents), 2.5mM Mg , 1.2mMATP, 
O.lmM GTP, 5.5mM Creatine phosphate, 0.2mg/ml Creatine Kinase, 
1.7mM g-mercaptoethanol, 80^M Spermidine and 50;xM each of 19 
amino acids (-Met). To it were added appropriate concentrations 
of KOAc, mRNA’s and £^^SJ methionine. Incubation was at 25^C 
for 60 min, after which TCA precipitable radioactivity was 
determined by the filter disc method.
B.6.3. Determination of TCA precipitable radioactivity.
Aliquots (5/ils or as mentioned in the legends) were spotted 
onto 2.5cm diameter Whatman No. 1 filter paper discs supported 
on pins and when dried were placed in ice cold TCA, 10% (w/v)
containing 1 0 " of the amino acid used for labelling the
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proteins. After 10 min, the filter discs were washed in the 
following order : 10 min in TCA 5% (w/v) at room temperature,
10 min in TCA 5% (w/v) at 90^C, 10 min ethanol:diethylether 
(50:50 v/v) and finally 10 min in diethylether. The discs were
dried first in air under the hood and then under heat lamp.
The radioactivity was determined in,a Liquid Scintillation Counter 
using Toluene-PPO as the scintillation fluid.
B.7. Translation in reticulocyte lysate system.
B.7.1. Reticulocytosis (According to the procedure of Waxman &
Rahinovitz, 1966).
Rabbits were made anaemic by injecting subcutaneOusly on 4 
successive days approximately 0.4^1 phenyl hydrazine solution 
(A.3.4.II) per kg body weight. After 2 days rest, on the 7th 
day rabbits were anaesthetized by injection of a solution of equal 
volume of heparin (1% w/v) and Nembutal into the ear vein (2.0ml 
per 2,5kg body weight). They were bled out by heart puncture into 
heparinised syringes and blood was transferred to sterile tubes.
To ensure that the animal was dead the chest cavity was opened 
and drained of blood. (Prof. A.R. Williamson gave assistance 
with these procedures) .
B.7.2. Lysis of reticulocytes
The red blood cells were pelleted by centrifugation at 
2,000 r.p.m. for 10 min at 4°0 in an MSE Major Centrifuge. The 
serum was removed and cell pellets were suspended in 4 volumes of 
BSS and centrifuged again at 2,000 r.p.m. The supernatant was
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discarded and the huffy coat of white cells was removed by 
suction This procedure was repeated thrice to remove all white 
cells. Cells were lysed by addition of an equal volume of 
sterilized deionized water and after vigorous mixing left on 
ice for 4 min. The cell lysates were centrifuged at 10,000 r.p.m. 
for 10 min at 4°C. The ruby red supernatant was collected and 
stored in SOOjul aliquots at -70°C.
B.7,3. Preparation of the Messenger Dependent Lysate (MDL)
MDL was prepared according to the method of Pelham & Jackson 
(1976).
To SOOjLil reticulocyte lysate were added 25%1 haemin (A. 3.4.II] 
lOjul Creatine Kinase (A.3.4.IV) and 150^1 Master mix (A. 3.4.VIII). 
The lysate was made ImM in CaCl^ and 10/ig/ml in micrococcal 
nuclease by the addition of lO/ttl CaCl^ solution (A.3.4.IX) and 
lOjul of a nuclease solution (A.3.4.X). After a thorough mixing, 
it was incubated at 20^C for 15 min in a water bath. The 
nuclease action was arrested by the addition of 10^1 EGTA 
solution (A.3.4-XI) to chelate Ca*^. The MDL was stored in 
200/.tl aliquots at -70°C.
B.7.4. Translation assay.
To 50/il MDL was added mRNA and isotope to a total volume of 
57.5^1. Incubation was at 30°C for 90 min. The reaction was 
stopped by quick transfer onto ice. TCA precipitable radioactivity 
was determined by the filter disc method.
The commercially available vitro translation kit (A,2,3.) 
was also made according to the same procedure (Pelham & Jackson,
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1976) and the assay mixture contained all the ingredients in 
the same proportion.
B.8. Protein synthesis, vivo, in herpes virus infected cells
Cells were set up on 13mm diameter cover slips in 50mm 
petridishes at 4 % 10^ cells/dish. When the cells had formed 
a confluent monolayer (approximately after 40 hrs). They were 
infected at a multiplicity of 50 p.f.u./cell or otherwise as 
mentioned in Results. For U.V. irradiated and heat inactivated 
virus, the amount equivalent to original 50 p.f.u./cell was 
used. After 1 hr adsorption, the medium was removed and infection, 
continued in fresh medium. At different time intervals after 
infection cells*were labelled in methionine-free medium with 
15/nCi methionine per petridish for 30 min.
When the effects of NaCl on Immediate-early protein
synthesis were studied, infection was continued in the presence
of cycloheximide (50#g/ml). At 5 hrs postinfection, cells were
washed six times with normal medium to remove cycloheximide and
then incubated in normal medium for 5 min. Cel%8 were then
incubated for 10 min in NaCl containing medium and then labelled 
3 5with 15jfiCi C. methionine for 30 min in methionine free medium.
After labelling, all medium was decanted and 10% (w/v) TCA 
was added. 30 min later cover slips were washed in absolute 
alcohol and absolute alcohol: ether (50:50 v/v) mixture, TCA 
precipitable radioactivity was determined in the liquid 
scintillation counter in Triton-Toluene-PPD,
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B.9. Preparation of cell lysates
Cells were seeded in 90mm petridishes at 8 x 10^ cells 
per dish. When the cells formed confluent monolayers (usually 
after 40 hrs), Cells were infected with PRV at 50 p.f.u./cell 
(Detailed in the Results), Cells were then labelled in
3 5 —
methionine free medium with 25 jxOi. [ Sj-methionine per petri­
dish for 30 min. Before harvesting, cells were washed with 
BSS to remove cell bound serum. After harvesting, using a 
rubber s&raper, cells were pelleted. The pellets were 
suspended in ImM phosphate buffer (pH 7.4), which was made 
2% (w/v) SDS, 5% (v/v) p-mercaptoethanol and 10% (v/v) glycerol. 
These were heated for two minutes in a boiling water bath until 
a clear solution was obtained. The cell lysates were analyzed 
by SDS-polyacrylamide gel electrophoresis and autoradiography.
B.IO. Separation and detection of polypeptides by 
polyacrylamide gel electrophoresis.
B.10.1, Polyacrylamide gel electrophoresis.
A discontinuous system of polyacrylamide gel electrophoresis 
was used, basically as described by Laemmli (1970) and Dimmock 
& Watson (1969).
The gel apparatus consisted of two 18 x l8cm glass plates, 
separated by 0.15cm thick perspex spacers on three sides and 
held together by bulldog clips. Vacuum grease was applied on the 
outside edge of the spacers to prevent leakage. The bottom of 
the gel was sealed by a thin layer (icm) of plug gel of 10%
(w/v) acrylamide. The main gel was poured in and overlaid
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with water to form a smooth upper edge. After polymerisation 
the excess water was poured off and the stacking gel was applied.
A silicone coated plastic comb was inserted into the stacking 
gel before it polymerized to form wells for sample application.
The perspex spacer at the bottom was removed and the gel was 
fixed vertically to the perspex gel apparatus. Electrode 
buffer (A,3.6.1) was poured into the top and the bottom tanks 
so that the top and the bottom of the gel were immersed in buffer. 
Proteins were denatured by making them 2% (w/v) in SDS. 5% (v/v) 
in 3-mercaptoethanol and 20% (v/v) in glycerol and heating for 
two min in a boiling water bath. lOjul of 0.002% (w/v) 
bromophenol blue containing little glycerol was applied at two end 
wells as a marker dye. Appropriate amounts of denatured proteins 
were applied in the wells. Electrophoresis was at iSmA over­
night at room temperature.
B.IO.2. Detection of polypeptides.
After electrophoresis gels were stained for 1 hr in 
staining solution (A.3.6.IV) and then destained by several 
changes of destaining solution (A.3.6.V). Gels were dried 
under vacuum, exposed to Kodak X-omat H X-ray films and developed. 
Standard proteins of known molecular weights were also applied 
to the gel electrophoresis. The standards used were RNA 
polymerase (mol. w t , 165,000; 155,000; 39,000), BSA (.68,000 mol. 
wt.). Trypsin inhibitor (mol. w t . 21,000). From the position 
of these proteins in the dried gels, the molecular weight of 
the unknown proteins were determined.
Occasionally to increase the sensitivity of detection a
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fluorographic method was followed (Bonner & Laskey, 1974).
After staining and destaining, gels were soaked in 20 volumes 
of Dimethylsulfoxide (DM80) for 30 min, followed hy a second 
immersion in fresh DM80 for another 30 min. The gels were 
then immersed in 4 volumes of 20% (w/v) PPO in DM80 for 3 hrs
with constant shaking, followed by washing in tap water over­
night. After drying, the gels were exposed to Kodak X-omat 
X-ray film at -70^0 and then developed.
B.ll. RNase activities in PRV infected cells 
B.11.1. Preparation of post-ribosomal supernatant
Cells, mock infected or infected for 6 hrs with PRV, were 
homogenized in 2 volumes of ImM phosphate buffer (pH 7.4) and 
centrifuged at 1500 r.p.m. for 10 min to remove nuclei and 
cell debris. The cytoplasmic extracts were then centrifuged 
at 50,000 r.p.m. for 2 hrs in the SW50.1 rotor. The top 2/3rd 
of the supernatant was taken and aliquoted at -70°G.
B.ll.2. Assay of RNase activities
To an aliquot of the post ribosomal supernatant from either
3mock infected or infected cells, was added H- uridine labelled
mRNA. Incubation was at 25°C for 30 min. TCA precipitable
radioactivity was determined by taking lOjLtl aliquots onto 
filter discs, which were washed in 10% (w/v) TCA and then in 
ethanol and finally dried under a heat lamp. The discs were 
counted in a Liquid 8eintillation Counter in Toluene-PPO.
8imilarly dialyzed PRV as well as heat inactivated PRV 
was used to study RNase activities.
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